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Understanding the mechanisms of virus-host interactions and the factors that 
regulate memory T cell responses are important for generation of efficient 
vaccines. The factors that regulate the contraction of the CD8+ T cell response 
and the magnitude of the memory population against localized mucosal 
infections like influenza are currently undefined. In this study, we use a mouse 
model of influenza to demonstrate that the absence of IFN-γ or the receptor, 
IFN-γR1 leads to aberrant contraction of antigen-specific CD8+ T cell 
responses. The increased accumulation of the effector CD8+ T cell population 
was independent of viral load and rates of proliferation of the cells. Direct ex 
vivo analysis revealed an increased amount of cell death in influenza-specific-
CD8+ T cells from infected WT mice compared to the IFN-γ-/- mice. Reduced 
contraction was associated with an increased fraction of influenza-specific 
CD8+ T cells expressing the interleukin-7 receptor at the peak of the response, 
resulting in enhanced numbers of memory precursor cells in IFN-γ-/- and IFN-
γR-/- compared to WT mice. Blockade of IL-7 within the lungs of IFN-γ-/- mice 
restored the contraction of the influenza-specific CD8+ T cells, indicating that 
expression and signaling through IL-7R is important for survival and is not 
simply a consequence of the lack of IFN-γ signaling. Finally, enhanced CD8+ 
T cell recall responses and accelerated viral clearance were observed in the 
IFN-γ-/- and IFN-γR-/- mice after re-challenge with a heterologous strain of 
influenza, confirming that higher frequencies of memory precursors are 
formed in the absence of IFN-γ signaling and these can contribute to 
heterosubtypic immunity. In summary, we have identified IFN-γ as an 
 	   xii 
important regulator of localized viral immunity that promotes the contraction 
of antigen-specific CD8+ T cells and inhibits memory precursor formation, 
thereby limiting the size of the memory cell population after an influenza 
infection. 
 	   xiii 
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Chapter 1: Introduction 
 
1.1 Influenza Virus 	  
Influenza virus is a negative single stranded RNA virus from the 
Orthomyxoviridae family. It is one of the most studied viruses in recent times 
because of the huge economic burden it causes. The influenza viruses 
comprise the 3 genera out of the five of the family Orthomyxoviridae: 
Influenza A, B and C. Influenza viruses A, B and C are very similar in their 
overall structure and protein composition. They are made of a viral envelope 
containing glycoproteins, wrapped around a central core containing the viral 
RNA genome. There are minor differences in their structure: Influenza A 
viruses have three membrane proteins (Hemagglutinin (HA), Neuraminidase 
(NA) and Matrix (M2) and a ribonucleoprotein core consisting of eight viral 
RNA segments and three proteins: PA, PB1 and PB2. Influenza B viruses have 
four proteins in the envelope: HA, NA, NB and BM2 and eight RNA 
segments. The Influenza C viruses however have a major envelope protein 
called HEF (Hemagglutinin-esterase fusion) that performs the functions of 
both the HA and NA proteins and hence contain only 7 RNA segments.  
The influenza A viruses are the most studied because of their ability to cause 
severe illness in humans, birds, pigs and other animals. They are classified by 
their surface HA and NA proteins, of which there are 16 HA subtypes and 9 
NA subtypes.  
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1.1.1 Structure and Genetics of the Influenza A virus 	  
The Influenza A virus particle (virion) is 80-120nm in diameter and can exist 
in both spherical and filamentous forms, although the spherical forms are more 
common. The virion is made up from the lipid bilayer, derived from the host 
plasma membrane as the virus buds out of the host. This viral envelope 
contains two main types of glycoproteins on the surface, hemagglutinin (HA) 
and Neuraminidase (NA) and encapsulates the ribonucleoprotein core. This 
central core contains the viral RNA genome made up of 8 strands of negative-
sense single-stranded RNA and the other viral proteins that package and 
protect this RNA (McGeoch et al. 1976). These eight strands of RNA encode 
for 11 different proteins (listed in table 1.1).  
The HA and the NA are the two large spike-like glycoproteins on the surface 
of the virus. HA is a lectin that mediates the binding of the virus to target cells 
and facilitates the entry of the virus into the target cell. The proteolytic 
cleavage of the HA molecule (HA0) into HA1 and HA2 is carried out by 
trypsin-like enzymes found in the respiratory tract and is necessary for the 
infectivity of the virus (Klenk et al. 1975). This cleavage exposes the 
hydrophobic N-terminus of the HA2 subunit, which contains a highly 
conserved fusion peptide that inserts into the endosomal membrane (Stegmann 
et al. 1991). Proteolytic cleavage also leads to a conformational change in the 
HA molecule in response to endosomal acidification and hence leads to the 
fusion of viral and host membranes, allowing the viral genome to enter the 
host cell (Bullough et al. 1994). The NA protein is a glycoside hydrolase 
enzyme that catalyses the hydrolysis of terminal sialic acid residues from the 
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host cell receptors and is involved in the release of newly formed progeny 
virus particles from infected cells. The NA is also able to cleave sialic acid 
residues bound to surface viral proteins, hence preventing the aggregation of 
the newly formed viral particles, which may hamper infectivity. This function 
of NA to cleave sialic acid is a pre-requisite for the spread of the virus. These 
surface proteins are ideal targets for antiviral drugs as interference of their key 
roles can hamper infectivity of the virus. Influenza neuraminidase inhibitors 
Zanamivir and Oseltamivir, also known as Relenza and Tamiflu respectively, 
are effective antivirals known today which act by binding to the active site of 
the NA and render the virus unable to escape from the host cell, thereby 
preventing spread of the virus (Hayden 1997; Hayden et al. 1999). 
Furthermore, the surface HA and NA proteins form antigens against which 
antibodies can be raised. Neutralizing antibodies against HA and NA also help 
to prevent virus from spreading. 
Another protein that is embedded on the surface of the virus but at a much 
lower frequency is the M2 matrix protein, a small protein generated by the 
alternative splicing of the RNA segment encoding the matrix protein. The M2 
protein comprises of the ectodomain M2e, a small part exposed to the cell 
surface, a transmembrane domain with the rest of it localized within the 
internal portion of the virus (Lamb et al. 1985). The M2 is a proton channel 
and is also involved in mediating viral entry into the host cell. During the 
fusion with the host membrane, the M2 proton pump lowers the pH of the 
virus to permit the dissociation of viral Ribonucleoprotein complexes from the 
structural M1 protein (Kemler et al. 1994). This allows the viral RNPs tethered 
to the M1 proteins to be released into the cytoplasm where they can be 
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imported into the nucleus by nuclear localization signals found on the NP 
molecule (O'Neill et al. 1995). Antivirals like Rimantidine and Amantidine 
target the M2 protein prevent the import of the protons into the viral core by 
blocking the M2 channel (Schnell and Chou 2008), thereby preventing the 
release of viral RNPs from the M1 protein, and ultimately into the host cell. 
The M1 protein is present beneath the lipid-envelope and is the most abundant 
protein in the virion. It functions as an internal scaffold for the viral RNPs to 
be anchored together, mediated by interactions between the non-structural 
NS2 protein bound to the viral RNA and the M1 protein (Yasuda et al. 1993). 
The M1 protein is also essential for viral assembly and release by resulting in 
the spontaneous formation of virus-like budding particles at the cell surface 
(Gomez-Puertas et al. 2000). 
Inside the viral core, each viral RNA segment is associated with several viral 
proteins: the nucleoprotein NP and PA, PB1 and PB2 which are components 
of the viral RNA dependent RNA polymerase. Each of the 8 viral RNA 
segments encodes for one or two proteins, the details of which are summarized 
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Figure 1.1 Schematic representation of the influenza A virus.  
The two major surface glycoproteins of the influenza virus are hemagglutinin 
(HA) and neuraminidase (NA), which form spike-like projections from the 
viral envelope. The ribonucleoprotein complex comprises a viral RNA 
segment associated with the nucleoprotein (NP) and three polymerase proteins 
(PA, PB1 and PB2). The matrix protein is associated with both the 
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1.1.2 The threat of influenza 	  
Influenza A is one of the most successful viruses in terms of the numbers of 
people it infects each year, not to mention the different pandemics it has 
caused in the last century. The success of the influenza virus is mainly 
attributed to the fact that it can undergo antigenic shift and antigenic drift. 
Antigenic shift is a specialized form of re-assortment, which confers a change 
in the phenotype of the virus. This occurs normally in a host simultaneously 
infected with two or more subtypes of the virus, where the surface proteins 
and viral RNAs recombine to form newer variants of the virus, even different 
subtypes. This enables the virus to change its surface proteins and hence evade 
neutralization by host antibodies resulting from an earlier infection. 
Reassortment of the influenza viruses is known to occur in pigs, which are 
known to be mixing vessels for the virus and also in waterfowl, as these are 
natural hosts for multiple subtypes of the virus. Antigenic drift is a mechanism 
that involves the accumulation of point mutations over time within the genes 
that can encode for antibody-binding sites. This results in newer strains of 
viruses, which cannot be inhibited as effectively by the antibodies that were 
originally targeted against the previous strains. Both antigenic shift and 
antigenic drift make it easier for the virus to spread in a moderately immune 
population. 
Due to these properties, the influenza A virus is partially able to elude host 
immunity and hence is able to cause multiple cases of inflection each year 
through the influenza seasons as well as the pandemics that have been 
responsible for millions of deaths in the last century. The 1918 influenza 
pandemic was the most severe pandemic caused by the H1N1 strain, and 
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resulted in the death of approximately 40 million people worldwide (Reid et 
al. 2001). There were also pandemics that occurred in 1957 and1968, albeit 
not as serious as the one in 1918. In fact the most recent scare came only a few 
years ago in the form of the 2009 H1N1 virus or “swine flu” that claimed 
many lives (Chowell et al. 2009; Garten et al. 2009). In addition, H5N1 
viruses (or bird flu) are also extremely virulent in humans but have not yet 
acquired the ability for efficient human-to-human transmission. The more 
recent scare with the new bird flu H7N9, which has already caused 104 
confirmed human cases and 21 deaths (Watanabe, T. et al. 2013). The 
emergence of these new viruses remind us that we are still in danger from 
influenza and that more research and health preparedness is necessary to 
combat any further outbreaks. 
 
1.1.3 Clinical symptoms of infection and pathology 	  
Influenza is an acute respiratory infection characterized by the sudden onset of 
high fever, sore throat, cough, headache, myalgia, malaise and inflammation 
of the upper respiratory tract and trachea. It is very difficult to diagnose an 
influenza infection by the clinical symptoms alone as the disease 
manifestations are very similar to those caused by other respiratory viruses 
such as Para influenza virus, respiratory syncytial virus and rhinovirus. Acute 
symptoms and fever can last for 5 to 7 days but weakness and fatigue may 
linger for weeks. Influenza usually occurs in winter outbreaks or epidemics in 
the temperate climates. People of all ages are generally afflicted, but the most 
affected are the children and the aged and those with underlying illnesses. 
Influenza A and B viruses are the most common causes of Influenza-like-
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illnesses (ILI) and at the peak of an influenza epidemic, about one-third of 
patients with ILI are positive for influenza A (2000). 
 
Influenza A viral replication peaks about 48-72 hours after inoculation and 
then declines slowly with little virus shedding after about 6 days. The virus 
can replicate in both the upper and lower respiratory tract. Influenza can be 
diagnosed by viral culture, demonstration of viral antigens or the viral genetic 
material or the presence of specific antibody in serum (Taubenberger and 
Layne 2001).  
Although influenza is a self-limiting illness in most individuals, complications 
and death can occur in groups of people with reduced immune function such 
as the very young and elderly. People with chronic pulmonary or cardiac 
disease are also at high risk for developing complications from influenza. 
Complications include hemorrhagic bronchitis and pneumonia, which can 
develop within hours followed by dyspnea, cyanosis, pulmonary edema and 
death may occur in as little as 48 hours after the onset of symptoms 
(Taubenberger and Morens 2008). Secondary bacterial infections can also 
contribute to the complications after an influenza infection and was a 
significant cause for the high mortality during the 1918 pandemic (Morens et 
al. 2008). 
Influenza virus replicates in epithelial cells throughout the respiratory tract and 
the virus has been recovered from both the upper and lower respiratory tract of 
people infected naturally or experimentally with influenza. Analysis of lung 
biopsies by both light and electron microscopy show that influenza results in 
diffuse inflammation of the larynx, trachea and bronchi, with lymphocyte and 
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histiocyte cellular infiltration (Walsh et al. 1961). Infection of the ciliated 
epithelium leads to initial shrinkage and vacuolization of the cells hence 
leading to necrosis and desquamation of the cells in the luminal space. The 
lung interstitium may show signs of congestion as the airspaces are filled with 
fluid, fibrin and the neutrophil infiltration (Taubenberger and Morens 2008). 
 
 1.1.4 Natural hosts for Influenza 	  
The influenza virus binds to cell surface glycoproteins containing terminal 
sialic acid residues, through the HA molecule. The cell tropism of the virus 
depends on the type of sialic acid glycosylated on the proteins of the 
glycolipids on the cell surface. Through the HA molecule, the human-specific-
viral strains bind to residues with a terminal α2, 6-linked sialic acid. In 
contrast, the HA of the avian-specific strains binds to α2, 3-linked sialic acid 
residues. Consequently, α2,6-linked sialic acid linkages are mainly expressed 
on the apical surfaces of ciliated cells in the tracheal epithelium of humans, 
whereas the α2,3-linked sialic acid linkages are abundantly present in the 
upper airways of birds.  
α2,3 linked sialic acid residues are also present on the non-ciliated cells of the 
human trachea, but there are few of these cells and the density of sialic acid 
residues is also low, which may account for the relatively low transmissibility 
of avian influenza strains into humans (Matrosovich et al. 2004). In pigs 
however, the tracheal epithelium expresses both kinds of sialic acid residues 
and this leads to the infection of pigs with both the avian and human strains of 
influenza. This facilitates viral reassortment and the generation of novel 
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human viral strains with the potential of transferring genetic material from the 
highly pathogenic avian influenza strains. 
Wild birds are also known to be natural hosts for all known subtypes of 
influenza A viruses although they do not become sick when infected. Fowl are 
also asymptomatic carriers of influenza A viruses and can transmit the virus to 
birds, pigs, horses, seals, whales and humans. 
Ferrets have been identified as excellent models for human influenza after the 
isolation of human influenza A viruses in 1933. It was reported in a series of 
papers that the histopathological changes in the respiratory tracts of pigs, 
ferrets and mice were compatible with those in human influenza virus 
infection (Shope 1931; Shope 1934; Shope 1935). However, although mice 
were susceptible to infection with both avian and human strains of influenza, 
they could not transmit the infection to other mice. In contrast (Shope 1935), 
both ferrets and pigs were able to transmit the virus to animals they were in 
contact with (Shope 1934). 
 
1.2 Host innate immune response to influenza 	  
The innate immune system is the first line of defense against the influenza 
virus. Viral replication peaks in a matter of hours, whereas the adaptive 
immunity takes days to be initiated and then for the response to peak. In the 
interim, it is the innate immune response that combats viral replication in the 
initial phase of the infection, buying precious time until the adaptive immune 
responses come into play. It consists of components that aim to prevent 
infection of the respiratory epithelium and control virus replication. Some of 
these responses are outlined below: 
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1.2.1 Mucus secretions and the lung epithelium 	  
In the lung, the first line of protection against the influenza virus is provided 
by the mucus lining of the respiratory tract which contains sialic-acid bearing 
glycoproteins with anti-hemagglutinating properties. These serve as decoy 
receptors for the virus and hence prevent binding of the virus to the underlying 
epitahelial cells. The mucus also contains collectins, such as mannose binding 
lectin, and surfactant protein D which can bind to glycosylated residues on the 
HA protein, resulting in either direct blockade of viral binding or opsonization 
of the virus for clearance by phagocytosis (Reading et al. 1997). The surface 
of the lung epithelium also has cilia, which push the viral particles trapped in 
the mucus to the larynx to be swallowed and destroyed by the high acidity in 
the stomach. Upon infection, the alveolar epithelial cell layer is also able to 
actively recruit immune cells such as monocytes to the site of infection by up 
regulating adhesion molecules and secreting chemokines to facilitate 
leukocyte transepithelial migration (Herold et al. 2006). 
 
1.2.2 Intracellular innate sensing of influenza virus infection 	  
When influenza virus infects respiratory epithelial cells or alveolar 
macrophages, the single stranded RNA is recognized by PAMP (pathogen 
Associated Molecular Patterns) via receptors such Toll Like receptor 7 
(TLR7), Retinoic acid-inducible gene-I (RIG-I) (Diebold et al. 2004; 
Pichlmair et al. 2006) and the NOD-like receptor family pryin domain 
containing 3 (NLRP3) protein (Pang and Iwasaki 2011).  
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Signaling through these receptors leads to production of pro-inflammatory 
cytokines and type I interferons, which have strong antiviral activities that 
inhibit host cell protein synthesis and viral replication (Kumagai et al. 2008). 
Further, NLRP3 is a part of the inflammasome, a cytoplasmic complex that is 
associated with immunity against influenza virus. The receptor is activated by 
influenza virus infection and M2 ion channel activity, leading to the 
conversion of pro-IL-1β into IL-1β, a cytokine that is involved in the 
expansion of antigen-specific CD4+ T cells and induction of Th17 responses 
(Acosta-Rodriguez et al. 2007; Ben-Sasson et al. 2009).  
1.2.3 Type I Interferons 	  
Type I interferons (IFNs), IFN-α/β are secreted by epithelial cells and innate 
immune cells such as macrophages, monocytes and plasmacytoid dendritic 
cells and are crucial in limiting viral replication in the initial phases of an 
influenza infection. Type I IFNs also induce IFN stimulated genes (ISGs) via 
the JAK-STAT signaling pathway. One of the important ISGs is the 
myxovirus (MX) gene that encodes the MxA protein, a GTPase with strong 
antiviral activity that can inhibit influenza virus replication (Holzinger et al. 
2007). In addition, type I IFNs can induce the production of several 
inflammatory cytokines and chemokines mediated by NF-kB activation, eg. 
IL-1β, IL-6, IL-8, TNF-α, CCL2, CCL3, CCL5 and CXCL10, which in turn 
recruit cells like macrophages and neutrophils to the site of infection (Perrone 
et al. 2008).  
Type I interferons stimulate cells to up regulate their expression of MHC I and 
hence enhance presentation of viral peptides on the cell surface. They also 
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stimulate dendritic cells to enhance their antigen presentation to CD4+ and 
CD8+ T cells thus contributing to initiating the adaptive immune response. 
 
1.2.4 Phagocytes 	  
Macrophages and neutrophils play a critical role in controlling early viral titers 
during an influenza infection. Depletion of either macrophages or neutrophils 
prior to a lethal infection with the 1918 HA/NA: Tx91 recombinant virus 
resulted in uncontrolled virus growth and mortality (Tumpey et al. 2005). But 
depletion of these cell types 3 or 5 days after infection did not alter disease 
outcome, indicating that macrophages and neutrophils act primarily to control 
viral replication during the early stages of infection (Kim, H. M. et al. 2008b). 
It is likely that the principal contribution of macrophages and neutrophils 
during early infection is to phagocytose the virus or infected cells, as the 
introduction of phagocytosis inhibitors into the airways of mice lead to 
increased lethality after influenza infection (Watanabe, Y. et al. 2005). 
Although macrophages are highly susceptible to influenza infection, the 
infection is not productive as synthesis of viral proteins is halted midway and 
the macrophage undergoes apoptosis before progeny virus can be released 
(Hofmann et al. 1997). On the other hand, once macrophages become 
activated, they produce nitric oxide synthase 2 (NOS2) and tumor necrosis 
factor alpha (TNF-α) and in this way can contribute to the influenza virus 
induced lung pathology (Jayasekera et al. 2006). 
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1.2.5 Dendritic cells 	  
Dendritic cells (DCs) are professional antigen-presenting cells in influenza 
virus infections. DCs act as sentinels of the immune system. They are situated 
beneath the airway epithelium and monitor the airway lumen via their 
dendrites that are extended through the tight junctions between the airway 
epithelial cells. DCs can pick up antigen from infected and dying cells but can 
themselves, also be infected by the influenza virus. Upon capturing antigen in 
the lung, the DCs then migrate to the lung draining lymph node, specifically to 
the posterior mediastinal lymph node and here they present the influenza virus 
derived antigens to naïve T cells and activate them(GeurtsvanKessel et al. 
2008; Ho et al. 2011). 
The DC degrades the viral proteins and subsequently presents the peptide 
bound to MHC I or MHC II molecules on the cell surface. For MHC class I 
presentation, the virus-derived peptides are liberated into the cytosol by 
proteasomes and subsequently are transported to the ER where they bind to 
MHC I molecules. These complexes are then transported to the cell surface for 
recognition by cytotoxic CD8+ T cells. For MHC II presentation, viral proteins 
are degraded in endosomes/lysosomes and the resulting peptides bind to MHC 
II molecules. These complexes are then transported to the cell membrane for 
recognition by CD4+ T cells. 
 
1.2.6 Natural Killer cells 	  
Natural Killer (NK) cells are important effectors of the innate immune 
response to influenza infection. They can recognize antibody-bound influenza 
infected cells and lyse them by a process known as antibody-dependent cell 
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cytotoxicity (ADCC). These cells can recognize influenza-infected cells by 
their receptors (NKp44, NKp46) and upon binding of the influenza HA; the 
receptors trigger the NK cells to lyse the infected cell (Arnon et al. 2001; 
Mandelboim et al. 2001). It has also been suggested that invariant NKT cells 
stimulate the induction of cellular immunity and regulate infection-induced 
pathology (Paget et al. 2011). 
 
1.3 Host adaptive immune responses to influenza 	  
The adaptive immune response is the second line of defense against influenza 
virus infection and comes into play later in infection to eliminate the influenza 
virus from the system. It consists of humoral and cellular immune elements 
mediated by virus-specific B cells/antibodies and T cells respectively. Cellular 
immunity is mainly mediated directly by cytotoxic CD8+ T cells but CD4+ T 
cells provide indirect help for optimal generation of antibodies and cytotoxic 
responses. 
 	  	  	  	  
1.3.1 Humoral immunity against influenza 	  
Influenza virus infection induces virus-specific antibody responses (Potter and 
Oxford 1979). These antibodies mediate long-term protection from re-
infection by an identical or antigenically similar viral strain. Antibodies 
specific for the two surface glycoproteins HA and NA are most critical since 
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immunity (Gerhard 2001). The HA specific antibodies bind to the trimeric 
globular head of the HA1 subunit and inhibit virus attachment and entry into 
the host cell. HA-specific antibodies can hence neutralize the virus and 
facilitate phagocytosis of virus particles by Fc receptor expressing cells. HA-
specific antibodies form a solid correlate of protection against influenza 
provided that they match the virus causing the infection. In contrast to the 
antibodies targeted to the HA head region, antibodies formed against the 
highly conserved stem region can recognize and bind to HA molecules from 
different subtypes and have broad neutralizing ability (Ekiert et al. 2009; 
Prabhu et al. 2009). Antibodies against the NA protein are protective as well. 
By binding to NA, antibodies do not directly neutralize the virus but inhibit 
NA enzymatic activity and thus limit viral spread. Further, NA-specific 
antibodies facilitate ADCC and also contribute to the clearance of virus-
infected cells (Mozdzanowska et al. 1999). 
The main antibody subtypes in the influenza-specific humoral immune 
response are IgA, IgM and IgG. Mucosal or secretory IgA antibodies are 
produced locally and are transported along the mucus of the respiratory tract 
by transepithelial transport and afford local protection from infection of 
airway epithelial cells. These antibodies are also able to neutralize the virus 
intracellularly (Mazanec et al. 1995). The presence of serum IgA is an 
indicator of recent infection as these are produced rapidly after influenza A 
infection (Rothbarth et al. 1999). Serum IgGs chiefly transudate into the 
respiratory tract and afford long-term protection (Murphy, B. R. et al. 1982). 
IgM antibodies initiate complement mediated neutralization of influenza virus 
and are a hallmark of primary infection (Jayasekera et al. 2007). 
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1.3.2 CD4+ T cell responses to influenza 	  
CD4+ T cells are activated after recognizing virus-derived MHC class II 
associated peptides on antigen presenting cells that also express co-stimulatory 
molecules. The role of CD4+ T cells in influenza has not been as extensively 
studied as their CD8+ counterparts due to the difficulty of detecting antigen-
specific CD4+ T cells using MHC II multimers owing to their low binding 
avidity (La Gruta et al. 2007). Also, unlike the CD8+ T cell response that has 
several immunodominant epitopes, which account for 75% of total virus-
specific CD8+ T cells (Doherty et al. 2006), CD4+ T cell epitopes are widely 
distributed (Crowe et al. 2006) and hence pose a challenge when trying to 
obtain a sufficiently large amount for estimating the virus-specific response. 
The main role of virus-specific CD4+ T cells during influenza infection is to 
provide T cell help to augment B cell antibody production and CD8+ T cell 
cytolysis of infected cells to clear the virus from the respiratory tract. Different 
subsets of Th cells are distinguished based on their cytokine expression 
profiles. Th1 cells produce IFN-γ and IL-2 and are involved mainly in cellular 
immune responses. Th2 cells produce IL-4 and IL-13 and promote B cell 
responses. Also, regulatory T cells (Tregs) and Th17 cells have been identified 
that regulate the cellular immune response to influenza virus infection. 
Th1 CD4+ T cell responses are important for viral clearance as adoptive 
transfer of Th1 virus-specific CD4+ T cell clones were able to confer 
protection against a lethal dose of influenza whereas mice that received Th2 
clones fail to survive (Graham et al. 1994). CD4+ T cells are also important for 
the development of CD8+ T cell memory responses and the absence of CD4+ T 
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cell help during primary infection resulted in a weaker secondary memory 
CD8+ response after a heterologous virus challenge (Belz et al. 2002).  
 
1.3.3 CD8+ T cell responses to influenza 	  
The establishment of a robust CD8+ T cell response is a key factor in 
determining the outcome of a primary influenza infection. Mice deficient in 
CD8+ T cells exhibit delayed clearance of influenza virus, elevated pulmonary 
viral titers and increased mortality (Bender et al. 1992). Conversely, adoptive 
transfer of virus-specific CD8+ T cells confers protection against lethal doses 
of influenza (Cerwenka et al. 1999; Hamada et al. 2009). This protection was 
seen even in mice lacking B cells (Graham and Braciale 1997). 
Upon influenza infection, CD8+ T cells are activated in the lung draining 
lymph nodes and are recruited to the site of infection. CD8+ T cells have 
several effector functions that lead to their antiviral activity and this can be 
categorized into three groups: First CD8+ T cells promote the lysis of infected 
cells by the exocytosis of perforin and granzyme containing granules. Perforin 
permeabilize the membrane of the infected cells and subsequently granzymes 
enter the cell and induce apoptosis. Second, CD8+ T cells induce tumor 
necrosis factor receptor (TNFR) family-dependent apoptosis of infected cells 
by expressing CD95 ligand (FAS-L) or TNF-related apoptosis-inducing ligand 
(TRAIL). The abrogation of any of these effector molecules results in reduced 
cytolytic activity and delayed viral clearance (Topham et al. 1997; Brincks et 
al. 2008). Third, CD8+ T cells also produce pro-inflammatory cytokines such 
as IFN-γ, TNF-α and GM-CSF in response to virus-infected cells. IL-17 
secreting CD8+ T cells have also been identified during influenza infection and 
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adoptive transfer of these cells conferred protection against lethal challenge 
(Hamada et al. 2009).  
Although effector CD8+ T cells contribute significantly to pro-inflammatory 
responses, they were also shown to have a crucial immunomodulatory role 
during acute influenza infection. CD8+ T cells were observed to 
simultaneously produce large amounts of IL-10 to counterbalance pro-
inflammatory responses and the blockade of T-cell derived IL-10 resulted in 
enhanced pulmonary inflammation and increased viral lethality (Sun, J. et al. 
2009). 
Antigen specific T lymphocytes recognize antigen in the context of self MHC-
class I molecules. During many infections, all T cells undergo cytokine-driven 
phenotypic changes (called by-stander activation) but only antigen specific T 
cells undergo multiple rounds of replication to generate robust numbers of 
effector CD8+ T cells. Although the quality of the CD8+ T cell response is 
crucial to viral clearance, the quantity of virus-specific cells generated is 
equally important in determining the outcome of infection. Tetramer staining 
of CD8+ T cells reveals that there is a strong correlation between the number 
of virus-specific CD8+ T cells in the lung and viral titer reduction (Flynn et al. 
1999; Lawrence et al. 2005). This highlights the importance of generating 
sufficiently large numbers of effector CD8+ T cell populations during 
influenza infection. 
Naïve CD8+ T cells circulating in the blood and secondary lymphoid organs 
are quickly recruited to the lung draining lymph node during an influenza 
infection (Ho et al. 2011). In the lymph node, they encounter viral antigens, 
presented by MHC class I molecules on the surface of the dendritic cells and 
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undergo massive proliferation and differentiate into effector cells 
(GeurtsvanKessel et al. 2008; Kim, T. S. and Braciale 2009). These effector 
cells then migrate to the site of infection in the lung and undergo further 
expansion (Lawrence et al. 2005). This leads to a huge increase in the number 
of antigen specific CD8+ T cells, which mediate effector function as 
mentioned earlier. Once the pathogen is cleared, the CD8+ T cell pool 
undergoes extensive contraction and the vast majority of antigen specific 
CD8+ T cells (~95%) undergo programmed cell death. Only a small proportion 
of these cells survive the contraction phase to form the memory pool. The 
magnitude of the CD8+ T cell memory pool depends on the number of cells 
that survive the contraction phase and further differentiate to form long-lived 
memory cells(Williams and Bevan 2007). The mechanisms by which this 
process is regulated are not yet completely understood. 
1.4 Memory CD8+ T cells  	  
Immune memory is the essential hallmark of the immune system and indicates 
a qualitatively and/or quantitatively improved immune response upon 
successive exposures to the same antigen. This leads to an enhanced secondary 
immune response, which is greater in magnitude, and speed, is more sensitive 
to low doses of antigen, and is more effective in the diversity or complexity of 
secondary effectors produced (Kaech and Wherry 2007; Williams and Bevan 
2007; Harty and Badovinac 2008).  
A minimal definition of memory CD8+ T cells would be a population of CD8+ 
T cells that persists long after antigen clearance. The memory cell pool 
contains two diverse populations: effector memory or TEM (CD62Llow 
CCR7low) and central memory or TCM (CD62Lhi CCR7low) (Sallusto et al. 
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1999). The two subsets are known to possess distinct functional properties. 
Studies have shown that human and murine TCM circulate between lymphoid 
organs, whereas the TEM set is found more in peripheral tissues (Sallusto et al. 
1999; Masopust et al. 2001) reflecting the expression of the CD62L lymph-
node homing marker. Apart from their anatomical compartmentalization, TCM 
and TEM memory populations are thought to display a different array of 
functional properties. TEM cells are generally considered to have a more 
limited lifespan and weaker proliferative potential compared to their TCM 
counterparts. 
Different cytokines participate in the differentiation of naïve CD8+ T cells to 
memory CD8+ T cells. Cytokines using the common gamma chain (CD132) 
receptor family are implicated in the process of memory cell generation. The 
common gamma chain cytokines act as at-cell growth and survival factors. 
There are now data to show that Interleukin (IL)-2, IL-4, IL-7, IL-15 and IL-
21 are all involved in T cell responses and some of these cytokines are 
involved in the development and maintenance of memory T cell responses. IL-
7 and IL-15 are required during or before the contraction phase to promote 
memory cell production (Schluns et al. 2000; Schluns et al. 2002).  
IL-7 is a potent survival factor for lymphocytes during development and in the 
periphery (Maraskovsky et al. 1996). The survival effects of IL-7 are due, in 
part, to the ability of IL-7 to increase expression of Bcl-2, an anti-apoptotic 
protein (Akashi et al. 1997; Maraskovsky et al. 1997). Analysis of the roles of 
IL-7 in immune responses has been hampered by the fact that IL-7 is highly 
essential in normal lymphocyte development and IL-7- and IL-7R- deficient 
mice are severely immunodeficient. Although naïve CD8+ T cells express high 
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levels of IL-7Ra, they down regulate it upon activation and slowly regain it 
throughout the contraction phase. These events are likely to be crucial for the 
transition from effector to memory T cells. This theory is supported by the 
finding that virus-specific-TCR-transgenic CD8+ T cells from IL-7Ra deficient 
mice are rapidly lost after a normal expansion phase, resulting in the poor 
generation of memory cells (Schluns et al. 2000). Memory T cells have an 
increased potential to survive in vivo compared to naïve T cells (Tanchot et al. 
1997). As IL-7 is a survival factor and memory CD8+ T cells express high 
levels of IL-7Ra (Vella et al. 1998; Schluns et al. 2000; Goldrath et al. 2002), 
the survival of memory CD8+ T cells rather than their proliferation may be 
attributed to IL-7.  
IL-15 on the other hand is a more potent proliferative agent for memory CD8+ 
T cells. This is supported by the fact that IL-15- and IL-15Rα deficient mice 
totally lack memory phenotype CD8+ T cells (Lodolce et al. 1998; Kennedy et 
al. 2000). Further, antibody mediated blockade of IL-15Rβ inhibited the 
proliferation of memory CD8+ T cells in vivo (Ku et al. 2000). Several studies 
have shown that IL-15 is involved in the maintenance of antigen-specific 
memory CD8+ T cells (Becker et al. 2002; Schluns et al. 2002). The antigen 
specific CD8+ T cell response to infection with VSV or LCMV could be 
generated in IL-15 and IL-15Rα deficient mice. However, the number of 
antigen-specific CD8+ T cells in these mice declined over time. Overall, these 
studies show that IL-15 signaling is required for the maintenance of normal 
numbers of antigen-specific CD8+ T cells. However, a recent study also shows 
IL-15 independent generation, maintenance and function of CD8+ T cell 
memory after influenza infection (Verbist et al. 2011). These studies show that 
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probably both IL-15-dependent and IL-15-independent memory populations 
exist. 
1.5 Influenza and asthma 	  
Asthma is a chronic airway disease with symptoms such as wheezing, 
breathlessness, chest tightness and coughing, with variable and reversible 
airway obstruction accompanied by airway hyper responsiveness (AHR). 
These symptoms are a result of a range of processes, including contraction of 
airway smooth muscle, airway inflammation; IgE mediated allergic responses, 
exposure to pollutants and the stimulation of cholinergic and sensory nerves 
(Bateman et al. 2008). Allergic airway inflammation and respiratory viral 
infections are known to have complex interactions. There is evidence to show 
that respiratory viral infections can initiate, maintain and exacerbate allergic 
conditions in the respiratory tract of infected individuals. Conversely, immune 
responses biased towards Th2 can make the immune response ineffective in 
combating the infection. 
T helper cells are classified as Th1 and Th2 sub-populations. Th1 responses 
are characterized by IFN-γ and promote cell-mediated immunity whereas IL-4, 
IL-5 and IL-13 are the hallmarks of Th2 responses. Th2 cells promote B cell 
proliferation, class switching and antibody production. Th1 and Th2 cytokines 
cause the immune response to polarize toward either Th1 or Th2, depending 
on the type of the pathogen. Th1 responses are more effective at getting rid of 
intracellular pathogens such as viruses whereas the Th2 responses are better at 
combating extracellular pathogens i.e. parasites.  
 
Chapter 1: Introduction 
	   25 
1.5.1 Effect of viral infections on asthma  	  
Two different hypotheses have been proposed to explain the effects of viral 
infections on allergic sensitizations; the hygiene hypothesis, which regards 
viral infection as an inhibitor of allergic sensitization and the alternative view 
that some viral infections can enhance allergic sensitization. There is evidence 
to support both theories. 
The hygiene hypothesis states that repeated exposure to diverse common 
infections and environmental microbiota during childhood are strongly 
associated with healthy maturation of the immune system and prevent the 
development of asthma and allergies later in life. It was hypothesized that 
infections especially viral infections may induce specific responses that are 
biased towards a Th1 phenotype. Due to this Th1 bias, allergic reactions 
requiring Th2 responses occur less effectively (Gern and Busse 2002). This 
view is reinforced by the fact that populations that lived in environments with 
diverse microbiological flora were associated with low incidence of asthma 
whereas populations in environments with low microbiological diversity are 
associated with a higher incidence of asthma (Ege et al. 2011). 
On the other hand, data from various studies show an association between 
viral infection in the respiratory tract in early life and subsequent childhood 
asthma. Most studies however, focus on acute bronchiolitis in infants caused 
by Respiratory Syncytial Virus (RSV). It has been debated whether viral 
infection increases the risk for asthma by damaging the developing airway and 
immune system or merely unmasks the genetic predisposition to asthma. 
Enhanced allergic sensitization after viral infection has been observed in mice. 
It was shown that IL-13 producing macrophages persisted in the lungs of mice 
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after they had recovered from viral infection and hence enhanced allergic 
sensitization (Kim, E. Y. et al. 2008a). Rhinovirus infection triggers 
exacerbation of asthma by inducing inflammation when the airway is already 
sensitized (Subrata et al. 2009). Infection causes the recruitment of APCs in 
high numbers and for long periods following pathogen clearance. Cells 
expressing CD11c display enhanced antigen presentation long after the 
resolution of an acute infection by viruses (Beyer et al. 2004). Such cells are 
long lasting suggesting that an enhanced mature APC compartment assists 
immunological responses on subsequent exposure to environmental allergens. 
Viral infection may also affect airway remodeling by up regulating matrix 
metalloproteinase MMP-9 in airway epithelial cells (Tacon et al. 2010) and 
induce matrix protein deposition on airway smooth muscle cells (Kuo et al. 
2011). 
 
1.5.2 Effect of asthma on influenza virus infections 	  
Data from several in vitro and in vivo experiments have shown that there is an 
increased susceptibility to respiratory viral infections after airway allergic 
sensitization that occurs via two mechanisms: impaired innate and specific 
immune responses and up regulation of viral receptors on airway epithelium. 
The allergic immune response is biased toward Th2 polarity. Because 
effective control and elimination of viral infection requires a Th1 response, 
pre-existing Th2 bias may interfere with the immune response to viral 
infection (Hassantoufighi et al. 2007; Message et al. 2008). This bias towards 
a Th2 response is likely to lead to impairment of interferon production and 
delayed viral clearance in response to an influenza viral infection.  
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A recent study has described an up-regulation of both α2,3- and α2,6- linked 
sialic acid which are receptors for avian and human influenza viruses 
respectively on the epithelial cells of nasal polyps of allergic individuals 
(Suptawiwat et al. 2010). Tissue explants for nasal polyps were also more 
effective for replication of both avian and human influenza viruses than those 
from normal nasal mucosa. However, it is not clear whether the up regulation 
of sialic acid resulted from the chronic inflammatory process or was specific 
to the allergic reaction. 
Epidemiological studies have shown that influenza and other respiratory viral 
infections are a frequent cause of hospitalization in patients with asthma 
(Mullooly et al. 2007; Miller et al. 2008). Hence it is clear that asthma 
exacerbation occurs in asthmatic individuals when they are infected with 
respiratory viruses. Virus-induced asthmatic exacerbations could be due to a 
combination of a few or all of the above-mentioned factors. 
 
1.6 Cytokine storm in influenza infection 	  
Cytokines (and chemokines) play an important role in the pathology 
associated with influenza virus infection. Lung epithelial cells are the principal 
targets for influenza A virus infection. These cells produce large amounts of 
virus, which can then infect alveolar macrophages (AMs) (Bender and Small 
1992). Following infection, epithelial cells and AMs die by necrosis and 
apoptosis respectively (Fesq et al. 1994). Cell necrosis/apoptosis triggers the 
production of cytokines TNF-α, IL-1 and chemokines such as monocyte 
chemoattractant protein (MCP-1), regulated on activation, normal T cell 
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expressed and secreted (RANTES), MIP-1α/β, interferon induced protein (IP)-
10 and IL-8 (Sprenger et al. 1996; Julkunen et al. 2000; Julkunen et al. 2001). 
Respiratory epithelial cells can up regulate these pro-inflammatory mediators 
following in vitro infection (Adachi et al. 1997; Chan et al. 2005). In vivo, it is 
likely that the initial release of inflammatory mediators by infected lung 
epithelium and AMs result in the extravasation of macrophages and 
neutrophils and then T cells, from the peripheral blood across the endo-
epithelial barrier into the infected lung tissue within the first three days after 
influenza A virus infection (Ada and Jones 1986). This early inflammatory 
pathology can contribute to severe disease, especially with the highly 
pathogenic H5N1 viruses. 
Although there is little direct evidence from the immunopathology caused by 
the 1918 pandemic virus, both this and the avian H5N1 viruses are believed to 
induce cytokine storms, characterized by dysregulated and exaggerated 
production of inflammatory cytokines which are in turn associated with 
massive pulmonary edema, primary and secondary pneumonias and alveolar 
hemorrhage with acute bronchopneumonia (Taubenberger et al. 1997). 
Chemokines are the main factors, which enable monocytes and T lymphocytes 
to migrate from the peripheral blood via the vascular endothelium into the site 
of inflammation. Reverse mutant viruses expressing the HA and NA of the 
1918 influenza virus induced significantly higher levels of IFN-γ, TNF-α, 
MIP-2, MIP-1α, MCP-1, MIP-1β, MIP-3α, IL-1, IL-6, IL-12, IL-18 and G-
CSF in the lungs of infected mice clearly indicating that elevated cytokine and 
chemokine levels were a hallmark of the human disease during the 1918 
pandemic (Kobasa et al. 2004; Tumpey et al. 2005). 
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The roles of TNF-α in lung pathology have been well studied (Bruder et al. 
2006) and high quantities of TNF-α can induce numerous clinical and 
pathological abnormalities, associated with acute inflammatory response in 
leukocytes and respiratory tract epithelium. Elevated levels of TNF-α have 
found to be correlated with severity of gross and histologic lung lesions in 
influenza infected mice (Peper and Van Campen 1995). Furthermore studies in 
which influenza infected mice were treated with blocking antibody to TNF-α 
showed reduced pulmonary cell infiltration and less severe pathology, 
associated with prolonged survival of the mice (Peper and Van Campen 1995; 
Hussell et al. 2001). These studies also show that neutralization of TNF-α has 
no deleterious effect on either lung viral loads or clearance of virus. 
The roles of IFN-γ however, have not been so well studied. Although, IFN-γ is 
known to have a protective role in many viral infections including vaccinia, 
herpes simplex, cytomegalovirus and lymphocytic choriomeningitis virus 
(LCMV), multiple studies of influenza virus infection in mice lacking 
functional IFN-γ, demonstrate little requirement for this cytokine in efficient 
viral clearance (Baumgarth and Kelso 1996; Bot et al. 1998; Nguyen et al. 
2000). While little attention has been paid to the possible effects of IFN-γ on 
influenza immunopathology, a study of influenza-infected mice receiving WT 
or IFN-γ-/- HA specific CD8+ T cells showed that the presence of IFN-γ 
actually ameliorated the severity of inflammation and lung damage (Wiley et 
al. 2001).  
The immunopathological effects of TNF-α and IFN-γ in influenza virus 
infections may also be indirectly mediated in individuals undergoing a 
secondary bacterial infection. This is particularly relevant, as several patients 
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infected with the highly pathogenic strains of influenza are known to develop 
and succumb to secondary bacterial pneumonia (Zhang et al. 1996). 
1.7 Interferons 	  
Interferons (IFNs) are cytokines that play key roles in the immune system, in 
the resistance of mammalian hosts to pathogens. They are glycoproteins made 
by the host cells in response to the presence of pathogens, to allow 
communication with the immune system to trigger the defenses to get rid of 
the pathogens. Interferons have been named after their ability to “interfere” 
with viral replication in host cells. They have been divided into three IFN 
classes, based on the type of receptors they signal through: 
 
Type I IFNs: 
These interferons bind to cell surface receptor complexes known as the IFN-α 
receptor (consisting of IFN-αR1 and IFN-αR2 chains). The type I interferons 
are IFN-α, IFN-β and IFN-ω. Type 1 interferon is secreted by all virus-
infected cells. 
 
Type II IFNs 
These bind to the IFN-γR that consists of IFN-γR1 and IFN-γR2 chains. It 
consists of only one interferon i.e. IFN-γ. Also known as gamma interferon, 
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Type III IFNs 
These signal through a receptor complex consisting of IL-10R2 (CRF2-4) and 
IFNLR1. Acceptance of this classification is less universal than that of type I 
and type II. This class consists of three IFN-l molecules called IFN-λ1, IFN-
λ2 and IFN-λ3. 
1.8 Interferon gamma 	  
Interferon gamma (IFN-γ) is one of the master cytokines of the immune 
system with pleiotropic roles. Although interferon gamma was originally 
defined as an agent with direct antiviral activity (Wheelock 1965), the 
properties of IFN-γ include regulation of several aspects of the immune 
response, stimulation of bactericidal activity of phagocytes, stimulation of 
antigen presentation, effects on cell proliferation and apoptosis and the control 
of several genes whose functional significance is still unknown. 
The principal cell types that produce IFN-γ are activated NK cells (Perussia 
1991), activated T helper cells of the Th1 subset (Mosmann and Coffman 
1989), and activated CD8+ T cells of the Tc1 phenotype (Sad et al. 1995). In 
NK cells, IFN-γ production is stimulated by cytokines produced by 
macrophages like TNF-α and IL-12 and is auto stimulated by IFN-γ itself. In 
T cells however, the main inducer of IFN-γ is the cross-linking of the T cell 
receptor (TCR) complex.  
Both human and mouse IFN-γ is encoded by a single gene copy, generating a 
single 1.2 kb mRNA species (Derynck et al. 1982) and a polypeptide of 166 
residues including a cleaved hydrophobic signal of 23 residues (Rinderknecht 
et al. 1984). Biologically active IFN-γ is in the form of a non-covalent 34 kDa 
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homodimer (Fountoulakis et al. 1992) and its structure has been confirmed by 
X-ray analysis (Ealick et al. 1991). IFN-γ binds to its receptor on different 
cells and signals a downstream flurry of events, which include turning on of 
several genes, which may also be transcription factors. 
IFN-γ binds to a specific cell surface receptor, which is ubiquitously but not 
uniformly present on all nucleated cells, although its expression is highest 
outside the lymphoid system (Valente et al. 1992; Farrar and Schreiber 1993). 
The IFN-γ−receptor consists of two subunits, the high affinity α chain (IFN-
γR1) with ligand binding properties and the β chain (IFN-γR2), which is 
required for signaling. Each subunit is associated with a specific Janus Kinase 
(JAK); the IFNγ-R1 chain with JAK1 and the IFNγ-R2 chain with JAK2 
(Igarashi et al. 1994). Signal transduction starts with an interaction of the IFN-
γ homodimer with two IFN-γR1 chains, thereby inducing their dimerization. 
The association of IFN-γR2 with the IFN-γR1 complex leads to the 
transphosphorylation and reciprocal activation of the JAKs. Tyrosine 
phosphorylation of the IFN-γR1 on residue 440 provides a docking site for the 
SH2 domain of the latent STAT1 transcription factor. Docked STAT1 is 
phosphorylated in the C-terminus on tyrosine Y701, enabling a homodimer of 
tyrosine-phosphorylated STAT1 to form and dissociate from the receptor. This 
phosphorylated STAT1 homodimer translocates to the nucleus and initiates 
transcription of genes containing a Gamma activated sequence (GAS) (Decker 
and Kovarik 2000) in their promoter region. To a lesser extent, IFN-γ 
stimulation can activate an ISRE binding complex (Schroder et al. 2004). The 
importance of the JAK-STAT pathway in IFN-γ signaling is clearly evident 
because defects in anti-viral immunity observed in STAT-1 deficient mice, 
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grossly resembles the phenotypes of IFN-γ/IFNγR knockout mice (Durbin et 
al. 1996; Meraz et al. 1996). Moreover, enhanced susceptibility to viral and 
mycobacterial infections in humans is associated with STAT1 mutations as 
well as IFN-γR mutations (Dupuis et al. 2001; Picard and Casanova 2004). 
The generation of mice lacking functional IFN-γ (Dalton et al. 1993) (IFN-γ-/-) 
or IFN-γ receptor (Huang et al. 1993)(IFN-γR-/-) has permitted the assessment 
of the role of this cytokine during different bacterial and viral infections. Both 
IFN-γ-/- and IFN-γR1-/- mice showed many subtle failures in immune function 
that became explicit when the mice were challenged with infectious 
organisms. Increased susceptibility to many intracellular pathogens such as 
Leishmania major (Wang, Z. E. et al. 1994), Listeria monocytogenes (Huang 
et al. 1993), mycobacteria (Cooper et al. 1993) and different viruses e.g. 
vaccinia virus (Muller et al. 1994) but not to the influenza virus (Graham et al. 
1993) have been reported. Furthermore, over-expression of IFN-γ in 
transgenic mice under the control of various tissue-specific promoters 
generates sites of inflammation with subsequent severe tissue destruction 
(Young and Hardy 1995).  
In humans, complete IFN-γR1 deficiency is associated with frequent infection 
and ultimately death from the poorly virulent mycobacterium- Bacille 
Calmette-Guerin (Jouanguy et al. 1996). Patients with partial IFN-γR 
deficiency have a similar but milder clinical presentation (Jouanguy et al. 
1997). The inability to secrete IFN-γ or the development of autoantibodies to 
IFN-γ, led to the death of a patient by overwhelming mycobacterial infection 
(Doffinger et al. 2004). More subtle immune defects have also been observed 
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in patients unable to secrete IFN-γ, these patients have poor neutrophil 
trafficking and weak NK cell activation (Davies et al. 1982). 	  
1.8.1 Immunomodulatory roles of IFN-γ on CD4+ T cell responses 
 
IFN-γ is known to play an important role in immune regulation by modulating 
T cell responses. Such a role has been studied in several models and several 
functions of IFN-γ have thus been identified. Addition of IFN-γ to CD4+ T 
cells in vitro increases the number of Foxp3+ regulatory T (Treg) cells (Wang, 
Z. et al. 2006). In addition, the numbers and function of Treg cells is reduced in 
IFN-γ-/- mice in a mouse model of experimental autoimmune 
encephalomyelitis (EAE) leading to increased severity of disease (Wang, Z. et 
al. 2006). Also, lowered Treg function in IFN-γR-/- mice contributes to greater 
disease severity in the collagen-induced arthritis model (Kelchtermans et al. 
2005). In addition, IFN-γ suppresses the development of the IL-17 producing 
effector T cells from naïve CD4+ precursor cells in both EAE (Langrish et al. 
2005) and type II collagen induced arthritis (Murphy, C. A. et al. 2003) 
models. Infection of IFN-γ-/- mice with Bacillus Calmette-Guerin results in an 
exacerbated inflammatory response, which has been attributed to increased 
numbers of Th17 cells produced due to the absence of IFN-γ (Cruz et al. 
2006). 
Several recent studies speculate on the role of IFN-γ in the homeostatic control 
of T cells. A progressive expansion of CD4+ T cells was seen in IFN-γ-/- mice 
infected with mycobacteria and this expansion was not due to persistence of 
bacteria but due to a role for inducible NO synthase (iNOS) in apoptosis of 
activated CD4+ T cells during BCG infection (Dalton et al. 2000). Aberrant 
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contraction of antigen specific CD4+ T cells has been observed in the absence 
of IFN-γ in Listeria infection (Haring and Harty 2006) and also during 
immune responses in EAE (Chu et al. 2000). The mechanism by which IFN-γ 
regulates T cell expansion, survival and contraction are unclear and several 
studies have attempted to shed light on this. One such study by Refaeli et al 
shows that IFN-γ is required in Activation Induced Cell Death of CD4+ T cells 
downstream of the ligation of Fas by the activation of the caspase-8-dependent 
apoptosis (Refaeli et al. 2002). Another study in a mycobacterial infection 
shows that IFN-γ promotes apoptosis in CD4+ T cells by inducing components 
of both the intracellular and extracellular apoptotic machinery (Li, X. et al. 
2007). Th2 cells more than Th1 cells are also known to undergo autophagy 
mediated cell death upon growth factor withdrawal (Li, C. et al. 2006). There 
is some evidence that IFN-γ may induce autophagy-mediated cell death in 
CD4+ T cells (Feng et al. 2008). 
 
1.8.2 Immunomodulatory roles of IFN-γ on CD8+ T cell responses 
 
Studies have focused on the immunomodulatory roles of IFN-γ in the CD8+ T 
cell response to systemic infections such as LCMV, CMV, VSV and 
L.monocytogenes (Badovinac et al. 2004), ((Badovinac et al. 2000; 
Christensen et al. 2004; Tewari et al. 2007; Andrews et al. 2008). Mice 
lacking IFN-γ or the IFN-γ-receptor exhibit impaired apoptosis or delayed 
contraction of activated antigen-specific CD8+ T cells in the spleen during 
immune responses to Listeria or LCMV infections (Badovinac et al. 2002). 
The contraction of CD8+ T cells in a Listeria infection is also known to be 
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controlled by early inflammation and IFN-γ production (Badovinac et al. 
2004). The responsiveness of antigen specific CD8+ T cells to IFN-γ 
correlated with the expression of IFN-γR2 but not with that of IFN-γR1 
(Haring et al. 2005). Activation induced cell death was induced by super 
antigens in human CD8+ T cells in a fratricide dependent manner (Gorak-
Stolinska et al. 2001; Gorak-Stolinska et al. 2002) and is dependent on Fas and 
granzyme B (Gorak-Stolinska et al. 2001).  
Thus far, however, no role for IFN-γ in regulating the responses after an acute 
localized infection has been reported. Although, IFN-γ was found to play a 
critical role in the contraction of CD8+ T cells following LCMV and L. 
monocytogenes infection (Badovinac et al. 2000; Tewari et al. 2007), this 
process was reported to be independent of IFN-γ in VSV and CMV infections 
(Christensen et al. 2004; Andrews et al. 2008). However it remains to be 
determined whether IFN-γ is involved in mediating CD8+ T cell contraction 
during a localized infection like influenza.  
 
1.9 Interferon gamma signaling in influenza 	  
The earliest reports show that mice lacking IFN-γ did not display a reduced 
ability to recover from primary infection with influenza and mounted 
cytotoxic T lymphocyte (CTL) activity comparable to that of their wild type 
counterparts in a killing assay (Graham et al. 1993). However, the absence of 
IFN-γ led to increased production of influenza-specific IgG1, IL-4 and IL-5 as 
compared to WT mice. Administration of anti-IFN-γ antibodies to beta-2-
microglobulin mice showed delayed viral clearance but did not switch the 
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response to a Th2 phenotype (Sarawar et al. 1994). Furthermore, CTL clones 
from IFN-γ-/- mice, adoptively transferred into wild-type recipients previously 
challenged with influenza virus mediated effective recovery from primary 
infection (Wiley et al. 2001).  
There are conflicting reports about the roles of CD8+ T cell derived IFN-γ in 
mediating influenza-virus-associated immunopathology. While CD8+ T cell 
production of IFN-γ enhanced lung pathology in one study (Moskophidis and 
Kioussis 1998), it ameliorated damage in another system (Wiley et al. 2001). 
Reduced survival rates in the IFN-γ-/- mice were observed during recall 
responses to heterologous strains of the influenza virus (Bot et al. 1998), 
although the reason for this was unclear. In another study it is reported that a 
lack of IFN-γ did not impair cross-reactive virus-specific CD8+ immune 
responses to lethal infection with influenza virus (Nguyen et al. 2000). Hence 
there is no clear consensus on the role of IFN-γ in protective role after a 
heterologous re-challenge.  
It was demonstrated that IFN-γ signaling differentially regulates both antigen-
specific CTL homeostasis in secondary lymphoid organs and trafficking to a 
site of virus infection (Turner et al. 2007). Although, IFN-γ facilitates adaptive 
immunity against influenza, it also inhibits the initial bacterial clearance from 
the lung by alveolar macrophages during a secondary bacterial infection (Belz 
et al. 1998; Sun, K. and Metzger 2008). Although there is some evidence that 
antigen-specific CD8+ T cells are destroyed in the liver during the control and 
resolution phases of an influenza infection (Belz et al. 1998), the mechanism 
by which this happens is not known. Though it has been reported that CD27 
signaling directs the IL-2 production that is essential to sustain the survival of 
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virus-specific CTLs in non-lymphoid tissue (Peperzak et al. 2010), the 
mechanism by which these virus-specific CD8+ T cells die after the infection 
is resolved is far from clear. 
IFN-γ orchestrates a remarkable range of distinct cellular programs. Although 
some of these roles have been studied in influenza infection, the role played by 
IFN-γ in programs of immune regulation is evidently of great interest but still 
remain obscure. In this study, we attempt to study the role of IFN-γ in a mouse 
model of influenza and also to identify the mechanisms by which IFN-γ 
modulates the T cell responses in a respiratory viral infection. We present 
evidence that IFN-γ has direct effects on CD8+ T cell homeostasis and plays a 
key role in mediating T cell death. 
1.10 Specific aims of this study 	  
While some studies have examined briefly, the role of IFN-γ in an influenza 
infection, there is no data so far examining the roles of IFN-γ in regulating the 
immune responses to influenza. The essential immunomodulatory role of such 
an important cytokine in a respiratory infection where it is made in large 
quantities remains poorly understood. Further there is no consensus about the 
role played by IFN-γ in the heterosubtypic immunity against a re-challenge 
with influenza virus. In the present study we sought to examine such roles of 
IFN-γ in influenza infection and studied whether this could influence rational 
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Specific Aims 
1. Establish a mouse model of influenza and broadly characterize the 
immune response. 
2. Characterize and compare the antigen-specific CD8+ T cell response in 
the presence and absence of IFN-γ signaling. 
3. Characterize the mechanisms by which IFN-γ regulates antigen-
specific CD8+ T cell responses to influenza. 
4. Establish a model for heterologous influenza re-challenge 
5. Characterize the roles played by IFN-γ signaling during a recall 
response to influenza  
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Chapter 2: Materials and Methods 
 
2.1 Buffers and Media 
 
2.1.1 PBS Buffer 	  
PBS buffer, ultrapure grade was commercially obtained from 1st Base 
(Singapore) as a 10X stock. The 10X stock consists of 137mM NaCl, 2.7mM 
KCl and 10mM Phosphate buffer. The buffer was diluted to 1X with 9 parts of 
distilled water. The pH of the buffer was then adjusted to 7.4 with 1M HCl.  
2.1.2 MACS Buffer 	  
MACS Buffer consists of 1X sterile PBS supplemented with 2% FCS and 
5mM EDTA. The pH of the buffer was adjusted to 7.4 with 1M HCl.  
2.1.3 FACS Buffer 	  
FACS buffer consists of 1X PBS supplemented with 1% FCS (Biowest, 
France; Sciencewerke, Singapore) and 5mM EDTA. Sodium Azide (0.05%) is 
added as a preservative to permit use and storage under non-sterile conditions. 
The pH of the buffer is adjusted to 7.2-7.4 with 1M HCl. 
 
Note: Although the components of the FACS and MACS buffer are similar, 
FACS buffer cannot be used in place of MACS buffer to isolate cells for 
culture because it contains sodium azide, which may inhibit certain metabolic 
functions of the cells. 
2.1.4 Permeabilization Buffer for Intracellular staining 	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Cell permeabilization buffer consists of 0.1% BSA, 0.1% Saponin and 0.1% 
sodium azide. The pH of the buffer was adjusted to 7.4 with 1M HCl. 
Alternatively, commercially available fixation/permeablization buffer and 
permeabilization buffers were purchased from eBioscience, (eBioscience, 
USA; ImmunoCell, Singapore). 
2.1.5 Red Blood Cell lysis buffer 	  
RBC lysis buffer was made as a 10X stock consisting of Ammonium Chloride 
(8.3g), Sodium Bicarbonate (0.84g) and EDTA (0.03g) in water. The pH of 
the buffer was adjusted to 7.4 with 1M HCl. The stock was diluted with water 
to a 1X working solution.  
2.1.6 Liberase Enzyme Blend for lung digestion 	  
Liberase TL Research Grade (low thermolysin concentration) was obtained 
from Roche (Roche Applied Science, Switzerland; Roche diagnostics Asia-
pacific, Singapore) and dissolved in plain RMI-1640 to obtain a concentration 
of 2mg/ml, which corresponds to a collagenase activity of 0.52 Wunsch 
units/ml. This forms a 10X Liberase stock solution, which was stored in 
aliquots at -300C. For digestion of tissues, the 10X Liberase stock solution was 
diluted 10-fold with plain RPMI-1640 and supplemented with 1% v/v FCS, 
which is added to preserve the viability of the cells during digestion. 
2.1.7 Buffers for ELISA 	  
Wash buffer for ELISA 
Wash buffer for ELISA consisted of 1X PBS with 0.5% v/v Tween-20. The 
pH of the buffer was adjusted to 7.4 with 1M HCl. 
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Blocking Buffer for ELISA 
Blocking buffer for ELISA consisted of 1X PBS with 1% w/v BSA. 
 
2.1.8 Alsever’s solution for storage of Guinea Pig RBCs 	  
Alsever’s solution was made with the following components: 
a) Citric Acid   55mg 
b) Sodium Citrate  800mg 
c) Sodium Chloride  420mg 
d) D-Glucose   205mg 
The components were dissolved in distilled water, and the pH was adjusted to 
6.1 with 1M HCl and made up to 100ml. 
2.1.9 Complete RPMI Medium for cell culture 	  
Complete RPMI was prepared using RPMI-1640 with L-Glutamine (Gibco, 
Invitrogen, Singapore) supplemented with the following: 
a) FCS (Biowest, France; Sciencewerke, Singapore),   
 10% v/v  
(heat inactivated for 30 mins at 550C) 
b)  Non-essential amino acids (Sigma-Aldrich, Singapore)  1X 
(from a 100X stock) 
c)  Sodium Pyruvate (Sigma-Aldrich, Singapore)   1mM 
d)  Beta-mercaptoethanol (Sigma-Aldrich, Singapore)  50uM 
e)  Penicillin (100IU/ml) and Streptomycin (0.1mg/ml) 1X (from a 10X 
stock) (Sigma-Aldrich, Singapore) 
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2.1.10 Complete DMEM for cell culture 	  
Complete DMEM was prepared using Dulbecco’s Modified Eagle Medium 
with L-Glutamine and 4.5g/L D-glucose (Gibco, Invitrogen, Singapore) and 
supplemented with the same components as complete RPMI. 
 
2.1.11 Plain DMEM at 2X concentration 	  
DMEM with L-Glutamine and 4.5g/L D-Glucose in powdered form was 
purchased from Gibco and dissolved in half the recommended volume of 
sterile water. 3.7g/L of Sodium bicarbonate was added. The pH of the solution 
was adjusted to 7.4 with 1M HCl and supplemented with 2% v/v Non-
essential amino acids (Sigma-Aldrich, Singapore), as well as 200IL/ml 
Penicillin and 0.2mg/ml Streptomycin (Sigma-Aldrich, Singapore) before 
sterile filtration through a 0.22micron filter (Nalgene, USA; Fisher Scientific, 
Singapore) 
2.2 Mice 	  
C57BL/6 mice (8-10 weeks old) were obtained from National University of 
Singapore (NUS) CARE. IFN-γ-/- and IFN-γR-/- mice were purchased from 
Jackson Laboratory (Bar Harbor, ME, USA). OT-1 mice were obtained from 
Charles River Laboratories (France). All mice were maintained under specific 
pathogen-free conditions within the National University of Singapore’s animal 
holding unit. C57BL/6 mice used were 8-10 weeks old. OT-1 and OT1 X IFN-
γ-/- mice were 7-10 weeks old. Mice were age and sex-matched for each 
experiment. All experiments were performed in accordance with guidelines of 
the National Advisory Committee for Laboratory Animal Research 
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(NACLAR), Singapore. The Institutional Animal Care and Use Committee 
(IACUC) of the National University of Singapore approved the protocols 
(Protocol numbers 137/08 and 087/10). All mice were maintained under 
pathogen-free conditions in the satellite animal housing unit and were 




2.2.1 Infection of mice 	  
Mice were anesthetized by intraperitoneal injection of Ketamine, 100mg/kg 
(Parnell Laboratories, Australia) and Medetomidine, 15mg/kg (Pfizer, 
NewZealand). Intranasal challenge of mice with influenza was carried out 
with the required dose of the virus in 20µl of PBS. Atipamezole (Pfizer, 
Australia), 5mg/kg was administered by intraperitoneal injection to reverse the 
effects of the anesthetic. All the experiments in this study were performed 
using C57BL/6 mice. 
2.3 Influenza virus 
2.3.1 Culture of influenza virus in embryonated chicken eggs 	  
1. 9-10 day old embryonated chicken eggs were obtained from Bestar, 
Singapore or Chew’s Poultry Farm, Singapore. 
2. The eggs were candled to mark the location of the air cell and the large 
blood vessels. 
3. A 21-gauge needle was used to puncture the eggshell just below the air 
cell, taking care to avoid any large blood vessels.
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4. A fine needle was used to inject the influenza virus stock, diluted 100 
times in sterile PBS (dilution of lower than 2HAU), into the allantoic 
cavity through the hole. 
5. The hole was then sealed with melted max in order to maintain 
sterility. 
6. The eggs were then incubated in a 370C incubator for 2.5 days and 
observed regularly to check the viability of the embryo. 
7. After 2.5 days, the eggs were then incubated at 40C for 4 hours to 
sacrifice the embryos. 
8. The shell was then cut open along the air cell and the allantoic fluid 
collected. 
9. The allantoic fluid was clarified by centrifugation at 3000g for 20 min 
and then sterile filtered using 2micron filters. 
10. The virus was then stored at -800C as small aliquots. 
 
2.3.2 Culture of influenza virus in MDCK cells 	  
1. Madine Darby Canine Kidney (MDCK) cells (ATCC CCL-34, ATCC, 
USA) were grown to confluence in T75 tissue culture flasks (NUNC, 
USA) using complete DMEM. 
2. On the day of infection, the cells were washed with sterile PBS to 
remove any traces of serum, which may inhibit viral growth. 
3. 10ml of plain DMEM supplemented with 4mg/ml of TPCK treated 
trypsin (Pierce, USA) was added to the flask followed by the virus 
stock. 
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4. The cells were incubated at 370C with 5% CO2 and visualized under 
the microscope daily to check for signs of cytopathological effects.  
5. When more than 90% of the MDCK cells exhibited cytopathological 
effects, the media was harvested and centrifuged at 3000g at 40C for 5 
min to pellet the floating cells and other large debris. 
6. The clear supernatant was decanted and frozen at -800C. 
2.3.3 Titration of virus by Plaque assay 	  
1. MDCK cells were seeded at 3-3.5 × 105 cells/well in a 24-well plate 
and cultured in complete DMEM until fully confluent and the spaces 
between cells barely distinguishable. This typically takes 24h. The 
cells were not grown for longer as this would lead to multiple layers of 
MDCK cells. 
2. Immediately before infection, the medium was aspirated and the cells 
washed once with PBS to remove any traces of serum, which affects 
the ability of the virus to bind to the cells.  
3. The influenza virus (viral stock or lung homogenate) was serially 
diluted 10-fold in plain DMEM and introduced to the MDCK cells and 
incubated for 1 hour at 370C to allow the virus to adsorb onto the cells. 
The volume of the inoculum was kept small, typically 250µl per well 
so as to ensure maximal adsorption of the virus onto the cells.  
4. During the incubation period, a 2% agarose solution in sterile water 
was prepared by microwaving the agarose solution until it was 
completely molten. The agarose solution was cooled and kept in the 
molten state by incubating in a water bath at 470C.  
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5. At the same time, 2X DMEM was warmed to 370C and TPCK Trypsin 
was added to a final concentration of 4µg/ml.  
6. After 1-hour incubation the molten 2% agarose was mixed with an 
equal volume of 2X DMEM to obtain a 1X DMEM agarose solution. 
This solution was kept in the molten state inside the BSC by placing it 
in a beaker of water taken from the 470C water bath.  
7. The virus inoculum was quickly removed starting from the highest 
dilution to minimize any carry-over effect and gently overlaid with the 
DMEM-agarose solution. The agarose overlay was left to cool inside 
the BSC until it hardened before incubating for 3 days at 370C to allow 
plaques to form.  
8. To visualize plaques on the third day, 0.5 to 1ml of PBS was added on 
top of the agarose layer to facilitate removal of the agarose overlay and 
a bent needle was used to gently dig out the agarose layer above the 
cells. Care was taken to avoid scratching the bottom of the plate.  
9. The plaques were visualized by adding 0.2ml of 0.5% aqueous crystal 
violet and incubating for at least 5 minutes. Excess stain was removed 
by washing the plate under running tap water. 
10. The plaques were then counted to calculate the total titer/ plaque 
forming units of the viral stock or the lung isolates. 
2.3.4 RBC Hemagglutination assay 	  
1. Fresh guinea pig Red Blood Cells (RBCs) were obtained from NUS 
CARE. 
2. The RBCs were washed twice in Alsever’s solution and stored for up 
to 2 weeks at 40C. 
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3. For the hemagglutination assay, the RBCs in Alsever’s solution were 
washed twice in PBS and pelleted. 
4. A 1% RBC solution was obtained by adding the required volume of the 
pellet to a 1X PBS solution. 
5. The influenza virus was serially diluted two-fold in 25µl volume 
across a 96-well V bottomed plate.  
6. 25µl of the 1% RBC solution was then added to each well using a 
multichannel pipette and left for 2h. 
7. Viral titer was determined by taking the reciprocal of the last virus 
dilution that exhibited hemagglutination activity (e.g. for a dilution of 




2.3.5 Hemagglutination Inhibition assay 	  
1. Mouse serum was treated with receptor destroying enzyme (RDE) II 
(Denka Seiken, Japan; AllEights, Singapore) to remove non-specific 
hemagglutination inhibiting activity by adding 4 parts of RDE to 1 part 
of serum and incubating at 370C overnight.  
2. After digestion, the RDE was destroyed by addition of an equal 
volume (5 parts) of 1.6% sodium citrate and incubating at 56oC for half 
hour. This results in a final 10-fold dilution of serum.  
3. One part of neat guinea pig RBC pellet was added to 10 parts of RDE 
treated serum and incubated for a further half hour at room temperature 
to remove any non-specific binding of RBCs to the serum. The RBCs 
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were spun down and the supernatant containing the serum was 
removed. This does not cause further dilution, as the RBCs do not add 
significantly to the volume of the serum.  
4. Serial 2-fold dilutions of the serum were made in 96-well U-bottom 
plates at 25µl per well following which 25µl of influenza virus 
containing 4 HA units were added. The plate was incubated for half an 
hour to allow the antibodies to bind to the virus.  
5. Finally, 50µl of 1% guinea pig RBC were added and the HAI titer was 
determined 2 hours later, defined as the reciprocal of the maximum 
dilution of serum that resulted in inhibition of virus hemagglutination 
activity. 
 
2.4 Cell Isolation 
2.4.1 Isolation of CD8+ T cells from spleens and lymph nodes of naïve 
mice 	  
1. Spleens and lymph nodes were harvested from euthanized mice and 
mechanically disrupted by pushing through a 61µm cell strainer 
(Fisher Scientific, Singapore) to obtain a single cell suspension. 
2. Single cell suspensions were then washed once with MACS buffer and 
then layered on Ficoll-Paque (GE Healthcare, Scimed, Singapore) and 
centrifuged at 600g for 20 min at room temperature. 
3. Cells accumulating at the interface were collected, washed twice with 
MACS buffer and counted. 
4. The cells were pelleted and the supernatant decanted to remove as 
much liquid as possible. 
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5. The cell pellet so obtained was resuspended and then incubated with 
anti-CD8α conjugated MACS beads (Miltenyi Biotec, Singapore) at a 
concentration of 4µl per million cells. 
6. The cells were incubated at 40C in the dark for 30 min with occasional 
flicking of the tube to prevent the cells from settling down. 
7. The cell pellet was washed with MACS buffer and then re-suspended 
in 1ml of MACS buffer. 
8. The re-suspended cells were then loaded on a pre-equilibrated LS 
MACS column (Miltenyi Biotec, Singapore). 
9. The MACS column was then washed 3-4 times with 3ml of MACS 
buffer each to remove any unbound or loosely bound non-CD8+ T 
cells. 
10. The bound CD8+ T cells were then eluted with 5ml of complete RPMI 
medium. 
2.4.2 CFSE Labeling of CD8+ T cells and adoptive transfer 	  
1. The harvested cells were washed in sterile PBS twice and re-suspended 
in warm (~370C) PBS at a concentration of 20 million cells/ml for 
CFSE labeling. 
2. The CFSE (Invitrogen, Singapore) stock was diluted 5 times to a final 
concentration of 10mM. 
3. The cells were mixed with the CFSE solution at a 1:1 ratio, making the 
final concentration of cells at 10 million cells/ml and concentration of 
CFSE 5mM. 
4. The cells were incubated at 370C in the dark for 15 minutes. 
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5. The reaction was stopped by quenching the cells with complete RPMI 
and incubating on ice for 5 min. 
6. The cells were then centrifuged at 600g for 5min, washed twice with 
PBS and re-suspended in PBS at the required concentration. 
7. Recipient mice were restrained using a mouse restrainer after 
application of lidocaine on the tails and sufficient heating using a heat 
lamp for 2-4 min, until the tail veins become visible.  
8. The required cells were then injecetd into the mouse through the tail 
vein. 
 
2.4.3 Isolation of T cells from the Broncho Alveolar Lavage fluid of 
infected mice 	  
1. Mice were sacrificed using carbon dioxide asphyxiation. 
2. BAL samples were collected by 3 x 0.7ml instillations of PBS into the 
trachea of cannulated mice. 
3. RBCs were lysed using RBC lysis buffer and incubated for 2-3 min 
and then quenched with MACS buffer. 
4. The cells were then centrifuged at 600g for 5 min and the cell pellet 
stained with appropriate antibodies for Flow Cytometry. 
2.4.4 Isolation of T cells from the lungs of infected mice 	  
1. Lungs were harvested from euthanized mice and excised into small 
pieces in 0.5mg/ml Liberase enzyme blend (Roche Diagnostics, 
Singapore) and digested for 45 min at 370C. The suspension was 
homogenized using a Pasteur pipette after 20 min digestion. 
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2. The digested lungs were physically disrupted into a single cell 
suspension by passing through a 61mm-cell strainer (Fisher Scientific, 
Singapore). 
3. Single cell suspensions were washed with FACS/MACS buffer twice. 
4. The washed cell suspensions were then layered on Ficoll-Paque (GE 
Healthcare, Scimed, Singapore) and centrifuged at 600g for 20 min at 
room temperature. 
5. Cells accumulating at the interface were collected, washed twice with 
MACS buffer, suspended in 5ml of MACS buffer and counted. 
6. The cells were then used for further staining with antibodies for flow 
cytometry or for in vitro cell culture. 
 
2.4.5 Isolation of Lung Dendritic cells (DCs) 	  
1. Lungs were finely excised using scissors in 1 × Liberase enzyme blend 
supplemented with 1% v/v FCS to preserve the viability of DCs and 
incubated at 370C for 20 min. The partially digested lung tissue was 
then re-suspended with a Pasteur pipette to break it up further and 
incubated for another 20 min.  
2. The resulting digested cells were then pushed through a 61µm cell 
strainer (Fisher Scientific, Singapore) to obtain a single cell 
suspension. The cells were washed twice in MACS buffer to remove 
any traces of Liberase. 
3. After the second wash, the cell pellet was raked vigorously and re-
suspended in 3ml of OPTIPREP (g=1.064g/ml) (Sigma-Aldrich, 
Singapore) following which 2ml of FCS was gently overlaid on top of 
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the OPTIPREP cell solution. The cells were spun at 1700g for 10 min 
at 40C with brakes and acceleration set to zero.  
4. The low-density cells that accumulated at the interface between 
OPTIPREP and FCS were harvested and transferred into a fresh tube 
and washed twice with MACS buffer to remove any OPTIPREP 
present in the solution. The cell pellet was raked to re-suspend cells. 
5. Fc block (2.4G2) was added at 0.2µg/million cells and incubated for 10 
min at 40C. This is to increase the purity of the cells isolated and 
remove contaminating B-cells, which can otherwise non-specifically 
bind to the MACS beads via the Fc receptor.  
6. Anti-CD11c MACS beads were added to the cells at a volume of 10µl 
per 10 million cells with a minimum of 10µl of beads being used if cell 
numbers were below 10 million. The mixture was incubated at 40C for 
10 min and the cells washed by addition of 3ml of MACS buffer and 
centrifuged at 350g to pellet the cells. As much of the supernatant was 
decanted as possible and the cell pellet resuspended in 1ml of MACS 
buffer before being placed in a LS MACS column that has been pre-
equilibrated with MACS buffer.  
7. Once all the cells have entered, the column was washed with 3ml of 
MACS buffer for 4 times before eluting with 4ml of complete RPMI. 
Note: CD11c is also expressed by lung macrophages, thus for isolating 
CD11c+ cells by positive selection, approximately 50% of the cells will be 
macrophages. Nonetheless, this technique is useful for the enrichment of lung 
DCs for in vitro experiments and facilitates analysis by removing a large 
number of irrelevant cells from the preparation.  
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2.5 Flow cytometry and cell sorting 	  
2.5.1 Staining of cell surface markers for flow cytometry 	  
1. Single cell suspensions were transferred to flow cytometry tubes. 
About 1ml of FACS buffer was added to each of the tubes 
2. The cells were then centrifuged at 600g for 5 min to pellet down the 
cells. 
3. After centrifugation, the supernatant was discarded and the tubes were 
blotted on tissue paper to reduce the amount of liquid left with the cell 
pellet. The tubes were then vigorously raked on the tube racks to re-
suspend the cell pellet. 
4. Fc block (2.4G2) was added at 0.2µg per million cells and incubated 
for 5 min at 40C to prevent non-specific binding of antibodies via Fc 
receptors. 
5. Antibodies directly conjugated to fluorophores were added to the cells 
at 0.02µg per million cells and incubated in the dark at 40C for 30 min.  
6. After incubation, the cells were washed twice with 1ml of FACS buffer 
to remove unbound antibodies. 
7. After the second wash, the cell pellet was re-suspended and fixed with 
350ml of 1% Paraformaldehyde (PFA). To prevent formation of cell 
clumps during fixing, the cell pellet was well disrupted by raking 
several times on the tube racks and then vortexed at 3000 rpm while 
simultaneously adding 1% PFA. 
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2.5.2 Intracellular staining for flow cytometry 	  
1. Intracellular staining of antigens was performed after staining of cell 
surface markers. Cells were stained following the protocol above and 
washed with FACS buffer. 
2. The cell pellet was re-suspended and 1ml of Fix-Perm solution 
(eBioscience, USA; ImmunoCell, Singapore) added while constantly 
vortexing the samples. The samples were then kept in the dark for 30 
min. 
3. After 30 min, 1 ml of permeabilization buffer (eBioscience, USA; 
ImmunoCell, Singapore) was added and the tubes centrifuged at 600g 
for 5 min. The cells were then washed with permeabilization buffer 
and centrifuged 600g for 5 min to obtain a cell pellet and the 
supernatant discarded before raking the tube to re-suspend the cell 
pellet.  
4. Antibodies directly conjugated to fluorophores were added to the cells 
at 0.02µg per million cells and incubated in the dark at 4oC for 30mins, 
while for intra nuclear transcription factors, the incubation was done 
for 1h at 4oC. 
5. After incubation, cells were washed twice with at least 1ml of 
permeablization buffer to remove unbound antibodies. Cells were 
finally re-suspended in 350µl of FACS buffer for analysis. 
Intracellular Cytokine Staining 
For intracellular staining of cytokines in cells, synthesis of cytokines was 
stimulated by addition of the appropriate stimulus. Cytokine secretion from 
the cell was blocked by the addition of Brefeldin A (BD Biosciences, 
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Singapore) and Golgi stop (BD Biosciences, Singapore) containing monensin 
to the culture medium. Both Brefeldin A and Golgi stop was added at 1µl per 
1ml of culture medium. After 4-6 hours, cells were harvested, transferred into 
FACS tubes before proceeding for surface staining of markers, followed by 
intracellular staining for cytokines. 
2.5.3 Sorting of naïve CD8+ T cells by flow cytometry 	  
1. Spleen and lymph node cells were enriched for T cells using Ficoll-
Paque as described earlier. The cells accumulating at the Ficoll-Paque 
and MACS buffer interface were collected, counted and then spun 
down in sterile FACs tubes. Where single stains were required for 
multi-colored cell sorting, small amount of cells were taken for single 
stains at this point.  
2. The concentration of the cells was adjusted to approximately 50 
million cells/ml using MACS buffer.  
3. Fc Block (2.4G2) was added at 0.2µg per million cells and incubated 
for 5 mins at 4oC to prevent non-specific binding of antibodies to Fc 
receptors. Antibodies directly conjugated to fluorophores (B220, CD8, 
CD62L and CD44) were added to the cells at 0.02µg per million cells 
and incubated in the dark at 4oC for 30 min.  
4. After incubation, cells were washed once with 2 to 3ml of MACS 
buffer. Cells were then re-suspended in 2 ml of MACS buffer and 
passed through a 61µm strainer to filter out cell clumps or any tissue 
pieces, which may clog the cell sorter.  
5. The filtered cells were then spun down once more to obtain a cell 
pellet. Cells were finally resuspended to a concentration of between 
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20-50 million cells/ml and NP366+ CD8+ T cells were sorted using the 
MOFLO (Beckman Coulter, USA).  
6. Naive CD8+ T cells were collected in sterile FACS tubes containing 
complete RPMI or neat FCS. 
2.5.4 Sorting of flu-specific lung NP366+ CD8+ T cells by flow cytometry 	  
1. Lung cells were enriched for T cells using Ficoll-Paque as described 
earlier. The cells accumulating at the Ficoll-Paque and MACS buffer 
interface were collected, counted and then pelleted in sterile FACs 
tubes.  
2. The concentration of the cells was adjusted to approximately 50 
million cells/ml using MACS buffer. Where single stains were required 
for multi-colored cell sorting, small amount of cells were taken for 
single stains at this point.  
3. Fc Block (2.4G2) was added at 0.2µg per million cells and incubated 
for 5 min at 4oC to prevent non-specific binding of antibodies to Fc 
receptors. Antibodies directly conjugated to fluorophores (CD11c, Gr1, 
CD8) were added to the cells at 0.02µg per million cells. NP366 
pentamer was added to the cells at 10µl/5 million cells and incubated 
in the dark at 4oC for 30min to 1 hour.  
4. After incubation, cells were washed once with 2 to 3ml of MACS 
buffer. Cells were then re-suspended in 2 ml of MACS buffer and 
passed through a 61µm strainer to filter out cell clumps or any tissue 
pieces, which may clog the cell sorter.  
5. The filtered cells were then spun down once more to obtain a cell 
pellet. Cells were finally re-suspended to a concentration of between 
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20-50 million cells/ml and NP366+ CD8+ T cells were sorted using the 
MOFLO (Beckman Coulter, USA).  
6. NP366+ CD8+ T cells were collected in sterile FACS tubes containing 
complete RPMI or neat FCS. 
 
2.5.4 List of Antibodies used 	  
Primary Antibodies  
Target  
 Host  Clone  Conjugation  Source  
B220  Rat  RA3-6B2  FITC  BD Biosciences, Singapore 




Hamster  500A2  eFluor450  
eBioscience, USA, 
ImmunoCell, 
Singapore  CD3e  




Rat  RM4-5  PB  BD Biosciences, Singapore 
Rat  RM4-5  PE  BD Biosciences, Singapore CD4  




Rat  53-6.7  PB  BD Biosciences, Singapore 
Rat  53-6.7  PE  BD Biosciences, Singapore CD8ჼ  
Rat  53-6.7  PE-Cy7  BD Biosciences, Singapore 
Rat  M1/70  PE  BD Biosciences, Singapore CD11b  
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 Rat  M1/70  APC  BD Biosciences, Singapore 
Hamster  N418  FITC  BD Biosciences, Singapore 
Hamster  HL3  PE  BD Biosciences, Singapore 















CD19  Rat  1D3  PE  BD Biosciences, Singapore 
CD25  Rat  PC61  PCP/Cy5.5  BD Biosciences, Singapore 
CD40  Rat  3/23  FITC  BD Biosciences, Singapore 
CD44  Rat  IM7  APC  BD Biosciences, Singapore 
CD62L  Rat  MEL-14  FITC  BD Biosciences, Singapore 








CD80  Rat  16-10A1  FITC  BD Biosciences, Singapore 
CD86  Rat  GL1  FITC  BD Biosciences, Singapore 
Rat  2E7  PE  
eBioscience, USA, 
ImmunoCell, 
Singapore  CD103  
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IL-2 Rat JES6-5H4 AF488 BD Biosciences, Singapore 
IFN-γ Rat XMG1.2 PE-Cy7 BD Biosciences, Singapore 











Rat  1A8  PE  BD Biosciences, Singapore 




Rat  M5/ 114.15.2  PE  BD Biosciences, Singapore IA/IE  




PD-1  Mouse  25-D1.16  FITC eBioscience, USA, 
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ImmunoCell, 
Singapore  
SiglecF Rat E50-2440 PE BD Biosciences, Singapore 










2.6 Culture and activation of CD8+ T cells  	  
Freshly isolated CD8+ T-cells were cultured at a concentration of 1 × 105 per 
96-well U-bottom well plate. PMA (10mg/ml) (Sigma Aldrich, USA) and 
ionomycin (400mg/ml) (Sigma Aldrich, USA) was added to the CD8+ T cells. 
For experiments requiring addition of IFN-γ, recombinant IFN-γ (Peprotech, 
USA; Gene-Ethics, Singapore) was added at the required concentrations. Cells 
were incubated in a 370C incubator for 48 or 72h and then harvested. 
2.7 Measurement of Cytokines  
 
Levels of cytokines (IL-5, IL-10, IL-13, IL-17, Eotaxin and IFN-γ) were 
detected using the commercially available DuoSet ELISA kits (R&D systems, 
USA; ImmunoCell, Singapore) 
 
Coating of the ELISA plate and blocking 
1.  Capture antibodies were diluted to the working concentration in PBS 
without the carrier protein and a 96-well microplate coated with 100µl 
per well of the diluted capture antibody. The plate was then sealed and 
incubated at room temperature overnight. 
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2.  The next day, each well was aspirated and washed with the wash buffer 
three times. After the last wash, the plate was inverted and blotted it on 
clean paper towels to remove any remaining wash buffer. 
3.  The plate was then blocked by addition of 200µl of blocking buffer and 
incubating for 1h at room temperature. The plate was then washed as in 
step 3. 
Assay procedure 
4.  100µl of sample or standard in the blocking buffer was added to the 
wells, the plate sealed and incubated for 2h at room temperature. 
5.  The plate was then washed as in step 3. 
6.  A working dilution of Streptavidin-HRP (100µl) was then added to each 
well, the plate covered and incubated for 20 min at room temperature in 
the dark. 
7.  The plate was washed as in step 3. 
8.  100µl of substrate solution was added to each well and incubated for 20 
min at room temperature in the dark. 
9.  50µl of the stop solution was added to each well and the plate was 
gently tapped to ensure thorough mixing. 
10.  The Optical Density of each well was then determined using a 
microplate reader set to 450nm.  
 
Note: The readings made directly at 450nm may be less accurate. Hence it is 
recommended that if wavelength correction is available, set it to 540nm or 570 
nm. If wavelength correction is not available, the readings at 540nm or 570nm 
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may be subtracted from the readings at 450nm. This subtraction will correct 
for optical imperfections in the plate. 
2.8 CTL killing assays 	  
2.8.1 51Cr release assay 	  
The chromium release assay was performed under sterile conditions with 
complete RPMI medium. 
1.  Target EL-4 cells were cultured and then centrifuged in a 15ml falcon 
tube at 450g for 5 min at room temperature. 
2.  The supernatant was discarded and 50mCi of 51Cr was added to the cells 
in a BSL2 cabinet. 
3.  The plates were then labeled with hazard tape and then placed in a 370C 
incubator with 5% CO2 for 1h. 
4.  The labeled cells were washed with pre-warmed (~ 370 C) complete 
RPMI and then spun down at 450g for 5min at room temperature. 
5.  The cells were re-suspended in pre-warmed (~ 370 C) complete RPMI 
at 1x106 cells/ml concentration. The cells were then split into two 15ml 
falcon tubes. ASNENMETM peptide at 5mM was added to one of the 
tubes while control peptide GP33-41 was added to the other. Both tubes 
were incubated for 30min at 370C incubator with 5%CO2. 
6.  Effector cells were plated in to a 96-well U-bottomed plate at the 
desired ratios (100:1, 30:1, 10:1, 3:1, 1:1, 1:3etc.) 100mL of pre-
warmed (~ 370 C) complete RPMI was added to the cells without 
effector cells. For total lysis, 80mL of pre-warmed medium was added 
with 20mL of 10% Triton-X. 
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7. The peptide pulsed target cells were washed with 5ml of pre-warmed 
medium at 300g for 5min at room temperature. 
8.  The target cells were counted and then re-suspended at a concentration 
of 4 x 104 cells/ml.  
9.  100mL of the target cells were added to each of the wells (4 x103/ well). 
10.  The plates were incubated at 370C with 5% CO2 for 4-6h, harvested 
from the assay plate using the cell harvester and then transferred to 
appropriate 96-well Luma plate. 
12.  The Luma plate was then dried in an oven at 500C for 2h or O/N at 
room temperature. 
13. The Beckman Top Count was used for the radioactive count. 
Cytotoxic activity was the calculated as follows: 
% Cytotoxic activity = (Sample lysis-spontaneous lysis) / (Total lysis- 
spontaneous lysis) x100. 
% Specific lysis is determined by subtracting the cytotoxic killing of peptide 
pulsed targets versus non-peptide pulsed controls. 
2.8.2 CD107α  de-granulation assay 	  
This assay was performed under sterile conditions with complete RPMI as the 
medium. 
1.  100µl of effector cells (1x106 cells/ml) were plated into a 96-well U-
bottomed plate. 
2.  100µl of medium containing PMA (10mg/ml) (Sigma Aldrich, 
Singapore), ionomycin (400mg/ml) (Sigma Aldrich, USA) Ionomycin, 
Brefeldin (5mg/ml) (BD biosciences, Singapore), Monensin (5mg/ml) 
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(BD biosciences, Singapore) and anti-CD107a- APC (10mg/ml) 
(eBioscience, USA; ) was added to each well. 
3.  The plates were incubated at 370C/5% CO2 for 4-6h, cells harvested and 
surface staining performed for CD3, CD8 and with the NP366 pentamer. 
2.9 Reverse Transcription 	  
2.9.1 Isolation of RNA from the isolated cells  	  
1.  Total RNA was obtained from sorted or harvested cells using the 
RNeasy kit (Qiagen, Singapore). 
2.  Cells were pelleted and then lysed with 350µl of RLT buffer and then 
passed through a QIAshredder column (Qiagen, Singapore) to 
homogenize the lysate. One volume of 70% isopropanol was added to 
precipitate the RNA and then the solution was added to the column. The 
column was then centrifuged at maximum speed for 2 min. 
3.  The column-bound RNA was washed once with 700µl of RW buffer, 
followed by two washes with 500ml of RPE buffer. The column was 
centrifuged again to ensure complete removal of residual ethanol from 
the RPE buffer. 
4.  RNA was eluted by addition of 15µl of RNase-free water and the eluate 
so collected was again put back through the column to enhance the 
yield. 
5.  cDNA was obtained using Quantitect Reverse Transcription kit 
(Qiagen, Singapore) according to manufacturer’s instructions. The 
cDNA was then stored at -800C. 
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2.9.2 Isolation of RNA from the lungs 	  
1. Pieces of lungs were stored in RNAlater® at 40C for up to a week. 
2. The lung pieces were taken from the RNAlater® (Qiagen, Singapore) 
and mashed with the bottom of a syringe in RLTplus® buffer from the 
kit (with beta mercapto-ethanol). 
3. The tissue was then made into a single cell suspension by passing it 
through a needle with a syringe. 
4. The cell suspension was then put through a QIAshredder column 
(Qiagen, Singapore) and the eluate collected. 
5. Total RNA was obtained from whole lungs using the RNeasy Plus Mini 
kit (Qiagen, Singapore). 
 
 2.9.3 Primers 	  
All primers were obtained from AIT Biotech, Singapore. The primer 
sequences are as follows: 
Target Primer sequences 
GAPDH F: AGGCCGGTGCTGAGTATGTCG 
R: GCAGAAGGGGCGGAGATGAT 
M-protein F: GGACTGCAGCGTTAGACGCTT 
R: CATCCTGTTGTATATGAGGCCCAT 
Beta-actin F: AGAGGGAAATCGTGCGTGAC 
R: CAATAGTGATGACCTGGCCGT 
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2.9.4 Real Time PCR 	  
Real time PCR was performed using an ABI7500 Real-time PCR system with 
SYBR Green detection reagent (Applied Biosystems, Singapore). In all 
experiments, the primers were used at 300nM and the reaction volume 
maintained at 25µl. The relative quantities of target gene expression were 
quantified by comparative CT method and normalized to GAPDH or beta-actin 
levels in the cells. 
 
2.10 Lung Histology 	  
2.10.1 Preparation of lung tissue 	  
1. The mice were sacrificed using CO2 asphyxiation and mounted on its 
back on a paraffin block with all the limbs spread apart. 
2. After exposing the abdomen of the mouse, a cut was made at the renal 
artery to drain circulating blood. 
3. The diaphragm was then cut laterally on both sides to expose the heart. 
A cut was made at the left atrium to allow blood and perfusion fluid to 
be released. 
4. Using a pair of forceps, ventral tip of the heart was grasped with the left 
hand while making a small cut at the right ventricle, just enough for the 
cannula tip. 
5. The cannula was then inserted and directed up through the right 
ventricle until the tip of the cannula was visible within the aorta. 
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6. The lung was perfused with PBS using a 50ml syringe until the lung 
turned pale white. 
7. After perfusion, the trachea was cannulated with a needle and plastic 
tubing and 0.7ml of 4%Paraformaldehyde or 1% Formalin to fix the 
lung. 
8. The perfused and fixed lung tissues were then placed in 4% 
Paraformaldehyde or 1% Formalin for 2-5 days before processing. 
2.10.2 Processing of lung tissue 	  
The fixed lung tissues were treated in a Leica tissue processor as follows: 
1. 1h in 75% ethanol 
2. 1h in 80% ethanol 
3. 1h in 90% ethanol 
4. 1.5h in 100% ethanol 
5. 1.5h in 100% ethanol 
6. 1.5h in 100% ethanol (Merck, Sigma Aldrich, Singapore) 
7. 2h in Histoclear (Sigma Aldrich, Singapore) 
8. 2h in Histoclear 
9. 2h in Histoclear 
10. 2.5h in wax 
11. 2.5h in wax 
2.10.3 Mounting the tissue and sectioning 	  
1. The processed tissue was transferred from wax to the embedding mould 
2. The cassette was placed on top of the mould to hold the tissue in place. 
3. The cassette was then topped up with enough hot wax to hold the tissue. 
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4. The mould with the cassette in hot wax was transferred to a cold surface 
and left there until the wax solidified. 
5. The embedded tissue was then removed from the mould using a pair of 
forceps. 
6. The cassette was then mounted in a microtome for sectioning the tissue. 
7. The tissue was cut into 3.5 to 5mM thick sections for staining. 
2.10.4 Deparafinizing the tissues 	  
The sections were then deparaffinized and rehydrated by treating them in the 
following solutions: 
1. 10 min in Histoclear 
2. 10 min in Histoclear 
3. 2 min in 100% ethanol 
4. 2 min in 100% ethanol 
5. 10 dips in 95% ethanol 
6. 10 dips in 70% ethanol 
7. Rinsed in distilled water. 
2.10.5 Hematoxylin and Eosin staining 	  
1. After deparaffinizing and rinsing, the tissue sections were stained in 
Hematoxylin (Sigma-Aldrich, Singapore) for 5 min and then rinsed in 
distilled water. 
2. The sections were differentiated in 0.3% acidic ethanol (0.3% HCl in 
70% ethanol) for 30sec to 1 min and then rinsed in distilled water. 
3. The sections were blued in Scott’s tap water (3.5g Sodium carbonate 
(Na2CO3) and 20g magnesium sulfate (MgSO4 * 7H2O) in 1L distilled 
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water) for 1 min and again rinsed in distilled water. 
4. The slides were checked under the microscope for blue nuclear 
chromatin and blued again in Scott’s tap water if bluing is insufficient. 
5. The slides were stained in alcoholic eosin (Sigma-Aldrich, Singapore) 
for 30 sec and then rinsed in 70% ethanol. 
6. The sections were finally dehydrated and cleared by dipping 10 times in 
95% ethanol and then 10 times in 100% ethanol and finally in 
Histoclear for 10 min. 
7. The slides were then mounted with mounting medium, Histomount 
(Invitrogen, Singapore) 
8. In the resultant slides, nuclear chromatin was visible as blue, the 
nucleoli were visible and the cytoplasm of the cells was stained pinkish 
to pinkish-purple. 
 
2.10.6 Periodic Schiff staining 	  
1. After de-paraffinizing and rinsing, tissue sections were oxidized in 
Periodic acid solution for 5 min and rinsed in distilled water. 
2. The sections were then placed in Schiff’s reagent for 15 min and the 
rinsed under running water for 5 min. 
3. The sections were counterstained in Hematoxylin for 1.5 min and then 
washed in tap water. 
4. The sections were finally dehydrated and cleared by dipping 10 times in 
75 
% ethanol, 10 times in 95% ethanol and then 10 times in 100% ethanol 
and finally in Histoclear for 10 min. 
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5. The slides were then mounted with mounting medium, Histomount 
(Invitrogen, Singapore) 
6. In the resultant slides, the nuclear chromatin in the cells was visible as 
blue, the nucleoli were visible and the mucus was visible as pink to 
pinkish-purple. 
2.11 Statistical Analyses 	  
Unpaired Students t test was used for comparison between two groups with a 
normal distribution and Mann-Whitney test was used for comparison between 
two groups with a skewed distribution. One-way ANOVA was used for 
comparison between multiple groups. Data is expressed as Mean +/- SEM. 
Statistical significance was indicated as p<0.05, p<0.01 and p<0.001. For 
Flow cytometric profiles and histology, plots and pictures are representations 
of repeated experiments. 
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Chapter 3: Mouse model of influenza and characterization of the general 
immune responses. 
3.1 Introduction   	  
Animal models make an important contribution to the study of infectious 
diseases, both for the characteristics of the infection as well as in the 
development of vaccines and therapeutics. Animal models that can accurately 
reflect the human disease characteristics and the protective immune responses 
they induce are indispensable tools for research. Animal models have been 
crucial in the study of immunology to characterize the immune responses in 
general and the behavior of specific immune cells in particular. Several animal 
models have been used for the study of influenza viruses and therapeutics 
targeting the virus. Animals such as mice, ferrets, cotton rats, guinea pigs, 
macaques and hamsters have been used to study influenza infections. Each 
animal model presents several unique advantages and disadvantages. Due to 
their similarity with human disease (ferrets) or the ease with which they can be 
used and the availability of inbred and genetically modified strains (mice) 
some animals are most commonly used.  
Ferrets are naturally susceptible to influenza viruses and hence influenza 
viruses can replicate efficiently in the respiratory tract of these animals 
without prior adaptation. The clinical symptoms of illness are very similar to 
human infection, including fever, sneezing, rhinorrhea and weight loss. 
Neurologic and gastrointestinal symptoms are seen following infection with 
some Highly Pathogenic Avian Influenza (HPAI) viruses. Furthermore the 
receptor distribution is very similar to humans: α 2,6 in the upper respiratory 
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tract and α 2,3 in the alveoli. In spite of these advantages, it is difficult to 
obtain animals that are seronegative for human influenza viruses. In addition, 
the high expense involved, limited immunological reagents available and the 
requirement of special housing requirements for these animals form major 
deterrents against using ferrets to study influenza.  
Although influenza virus is not a natural pathogen of mice, mice have been 
good models of this infection. Human influenza viruses replicate in the 
respiratory tract without prior adaptation but require adaptation for some 
strains to cause disease. The receptor distribution in the respiratory tract of 
mice: α 2,3 in the ciliated airway and type II alveolar epithelial cells are unlike 
those found in humans. In spite of these drawbacks, mice are the most 
commonly used animal models for influenza research. In terms of size of the 
animal, cost involved and husbandry requirements, the murine model is very 
convenient. A wide range of immunological reagents is available for studying 
humoral and cellular immune responses. The availability of species-specific 
reagents and the ability to manipulate mice genetically offers a system in 
which the host response to infection can be studied in depth. Using the mouse 
model is also the most economical way to produce statistically robust data. For 
our study, we use a mouse model of influenza and because all the transgenic 
mice needed for the study were available on the C57BL/6 background, we 
chose to do all our experiments with the C57BL/6 mice. 
Several strains of influenza have been used for experimental studies. The 
influenza viruses A/PR/8/1934 (H1N1) and A/Aichi/2/1968-x31 (a reassortant 
H3N2 virus) are commonly used strains in immunology research. The 
A/PR/8/1934 (H1N1) strain, (abbreviated as PR/8) is an influenza vaccine 
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reference strain that has been extensively passaged in the laboratory and is 
known to grow to very high titers in embryonated chicken eggs (Robertson et 
al. 1992). The PR/8 strain is pathogenic at low doses of the virus as in a 
physiological course of an influenza infection. It is known to have a LD50 
(50% lethal dose) of 200 PFU (Plaque Forming Units) (Quan et al. 2008). The 
A/Aichi/2/1968-x31, (abbreviated as X31) strain of virus is a genetically 
engineered virus such that it has the same internal proteins as that of the PR/8 
strain but surface proteins from the A/Aichi (H3N2) strain (Kilbourne 1969). 
This strain is much less pathogenic compared to the PR/8 strain and has a 
LD50 of 7x105 PFU (Quan et al. 2008). Hence high challenge doses have 
generally been used in previous studies. We had access to both strains of the 
virus and hence we used both strains of the virus.  
In this chapter, we sought to establish a mouse model of influenza. We 
compared the two strains of viruses to choose the appropriate viral strain and 
dose for all the following studies. We also characterized the immune responses 
to this strain at different infectious doses of influenza. We studied weight loss, 
production of pro-inflammatory cytokines in the bronchoalveolar space, the 
kinetics of cellular infiltration into the bronchoalveolar space and the T cell 
responses (both CD4 and CD8) as well as the humoral responses induced in 
response to an influenza infection. 
 
3.2 Choosing the viral strain and dose of virus 
 
We compared viral infections with both strains of viruses: the A/PR/8/H1N1 
and A/HK-X31/H3N2. The PR/8 strain is known to have a LD50 of 200 PFU 
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(Quan et al. 2008). The HK-x31 on the other hand is a much less virulent with 
an LD50 of 7x105 PFU (Quan et al. 2008). We chose to start with a very low 
dose of virus i.e. 5 PFU of PR/8 keeping in view that it is more physiological 
in terms of the levels of virus one is exposed to during an infection but a much 
higher dose of the HK-x31 strain of virus i.e. 105 PFU. 
Both viruses were grown in 9-day old embryonated chicken eggs and the viral 
titers were determined by the plaque assay using MDCK cells. The virus was 
diluted accordingly and C57BL/6 mice infected with 5 plaque-forming units of 
PR/8 or a 105 PFU of HK-x31. 
Signs of clinical sickness include ruffled fur, labored breathing, hunching, 
hypothermia, weight loss and mortality (we avoided the latter by sacrificing 
animals when their weight loss exceeded 25% of body weight). Loss of body 
weight is an excellent indicator of the level of sickness in mice due to an 
influenza infection. The extent of weight loss coincides with other markers of 
sickness. It also provides a non-invasive way to determine the extent of 
influenza infection in the mice so that mice can be sacrificed if they are too 
sick. Mice were weighed at roughly the same time everyday for a better 
representation of their weight loss.  
The C57BL/6 mice were infected intra-nasally with a 5 PFU dose of virus and 
their weights were recorded every day for 14 days until they completely 
returned to their original body weight (Figure 3.1). The PR/8 strain of 
influenza caused significant morbidity in the infected mice at the low dose of 
virus used (5 PFU) but did not lead to the death of the mice. Hence, it is a sub-
lethal dose. The 5 PFU infected C57BL/6 mice infected with PR/8 influenza 
started to show weight loss typically from day 5 after infection. There was a 
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slight decrease in body weight at day 3-post infection (p.i), which may have 
been due to the effects of the anesthetic but this dip was quickly recovered  by 
the next day. The influenza related weight loss started around day 5 p.i. and 
the mice continuously lost weight from then on until about day 8 or 9. Apart 
from the weight loss, the mice also showed signs of morbidity in that they 
were lethargic and were poorly groomed. The weight loss was greatest at day 
8 or day 9. At this point, along with a thin appearance the mice were visibly 
lethargic and their fur was unkempt. After day 9, the mice began to regain 
body weight and completely recovered from the infection by day 14 p.i. 
The C57BL/6 mice infected with HK-x31 influenza started to show weight 
loss immediately and lost a maximum of 12% body weight by day 4 p.i. but 
quickly recovered from there on. This was in contrast with the PR/8 infection, 
but this early loss of weight was probably due to the high dose of virus used 
for this strain. However, these mice quickly recovered from the infection and 
did not show signs of significant morbidity in spite of using such a high dose 
of virus for infection. This finding was in line with earlier studies that this 
viral strain was much less pathogenic than the PR/8 strain of virus. Hence, we 
chose to use the PR/8 strain of influenza with a dose of 5 PFU for all our 
studies with responses to primary infection with influenza.  
For the re-challenge experiments however, using the same virus for both 
infections would mean inducing neutralizing antibodies, which would 
confound the studies of the protective CD8+ T cell responses due to the 
primary infection. Hence, we used both the above-mentioned strains in 
combination. The PR/8 and the HK-x31 strains of virus have the same internal 
proteins but they have different surface glycoproteins (Hemagglutinin and 
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Neuraminidase). The CD8+ T cell responses to influenza are targeted towards 
the internal proteins but the antibody responses are aimed at the surface 
proteins. It is known that the neutralizing antibody response to the surface 
proteins of these two viruses is not cross-reactive (Flynn et al. 1998). Hence 
the protective response of the mice to the secondary challenge is solely 
attributable to the CD8+ T cells and not to the neutralizing antibodies. For 
studying the responses to secondary infections, the HK-x31 strain was used for 
the primary infection and 5 PFU or higher doses of the PR/8 strain were used 
for the re-challenge experiments.  
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Figure 3.1 Percentage weight loss in C57BL/6 mice infected with 
different strains of influenza 
(A) Infection with 5 PFU of PR/8 (n=15)  
(B) 150,000 PFU of X31 (n=5)  
Graphs show mean ± S.E. Data representative of 2-3 experiments  	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3.3 Kinetics of cellular infiltration into the BAL after a 5 PFU influenza 
infection 	  
We studied the progression of 5 PFU influenza infection in WT mice by 
looking at the extent of cellular infiltration into the airways of the lungs at 
different points in time after infection. For this purpose, WT C57BL/6 mice 
were infected with 5 PFU PR/8 and the kinetics of different cell types entering 
the airways were determined by analyzing the BAL fluid of the lungs of the 
infected mice, every day for 10 days after infection. 
The mice were sacrificed on the indicated days post infection and the trachea 
was cannulated and the lung flushed with MACS buffer to harvest the BAL 
fluid. The cells from this extracted BAL fluid were analyzed by flow 
cytometry. The cells were stained with CD11c, CD3, SiglecF and Ly6G to 
identify different cell types (figures 3.2A and 3.3A) by their staining profiles 
as follows: 
Eosinophils: CD11c- SiglecF+ 
Neutrophils: CD11c- Ly6G + 
Macrophages: CD11c+ SiglecF+ 
T cells: CD11c- CD3+ 
We observed that before infection, the number of cells in the BAL fluid of the 
mice was very low. Most of the cells were macrophages. There were no 
neutrophils, eosinophils or T cells in the BAL fluid of uninfected mice. The 
number of macrophages fell by day 2 p.i. and was reduced considerably after 
that and remained lower for the rest of the infection (figure 3.2B). Few 
eosinophils were detected although a small number was seen on day 9 (figure 
3.2C). 
Chapter 3: Mouse model of influenza and characterization of the general 
immune responses 
 
	   80 
The number of neutrophils peaked at day 4 p.i. and then was reduced 
significantly after that (figure 3.3B).Most importantly, the T cells came into 
play only at about day 7 p.i and from then on increased in numbers even as 
long as day 9 p.i. (Figure 3.3 C).
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Figure 3.2 Cellular infiltration in the BAL fluid after influenza 
infection: Kinetics of Eosinophils and Macrophages 
The BAL fluid was harvested from infected mice at different time points after 
infection. The cells from the BAL fluid were counted and stained for flow 
cytometry. (A) Representative plot of Eosinophils (CD11c- SiglecF+) and 
macrophages (CD11c+ SiglecF+) at different time points after infection.  
(B) Kinetics of eosinophil infiltration into the BAL fluid of WT mice after a 5 
PFU influenza infection.  
(C) Kinetics of macrophage infiltration into the BAL fluid of WT mice after a 
5 PFU influenza infection.  
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Figure 3.3 Cellular infiltration in the BAL fluid after influenza 
infection: Kinetics of Neutrophils and T cells 
BAL fluid was harvested from infected mice at different time points after 
infection. The cells from the BAL fluid were counted and stained for flow 
cytometry. 
(A) Representative plot of Neutrophils (CD11c- Ly6G+) and T-cells (CD11c- 
CD3+) at different time points after infection.  
(B) Kinetics of neutrophil infiltration into the BAL fluid of WT mice after 5 
PFU influenza infection.  
(C) Kinetics of T cell infiltration into the BAL fluid of WT mice after 5 PFU 
influenza infection.  
Data are representative of 2 independent experiments with n=3-5 per 
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3.4 Kinetics of pro-inflammatory cytokines Interferon gamma (IFN-γ)  
and Tumor Necrosis Factor alpha (TNF-α) after a 5 PFU influenza 
infection 
To determine the extent of airway inflammation, we looked at the kinetics of 
the cytokine IFN-­‐γ in the infected mice (figure 3.4A). Bronchoalveolar lavage 
fluid was harvested from infected mice every day after infection and the levels 
of IFN-γ and TNF-α were determined by an ELISA based protocol.  
IFN-γ was not detected in the BAL fluids of the infected mice during the early 
days of infection. Although low levels of IFN-γ were recorded on day 4 and 5, 
the levels of IFN-γ peaked at about days 6 and 7 p.i. and remained high for the 
following 2-3 days. The levels again dropped by day 10 p.i. and were not 
detected after day 11 p.i. 
Similar kinetics was also observed for TNF-α. The levels of TNF-α were low 
in the broncho alveolar lavage fluid for the first few days after infection 
(figure 3.4B). The levels started to increase by day 6 p.i. and peaked at day 7 
p.i. In common with IFN-γ, the levels of TNF-α also fell by day 10 p.i. and 
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Figure 3.4 Kinetics of pro-inflammatory cytokines in the BAL fluid of 
C57BL/6 mice infected with 5 PFU of PR/8 influenza 
The BAL fluid was harvested from infected mice at different time points after 
infection. The supernatant from the BAL fluid was used for ELISA to detect 
the respective cytokines. Kinetics of (A) IFN-γ and (B) TNF-α in the BAL 
fluid after infection 
Graphs show mean ± S.E. Data is representative of 2 independent 
experiments.  
n = 3-5 for the set of data shown 
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3.5 Adaptive immune responses to a 5 PFU influenza infection 	  
The adaptive immune response to influenza is established much later in the 
infection, at a time point when the viral titers have already fallen and 
comprises the CD8+ T cells, CD4+ T cells and the antibody responses. 
 
3.5.1 CD8+ T cell responses and antigen specific CD8+ T cells 	  
 The CD8+ T cells form a very important component of the immune protection 
against viral infections, mediating viral clearance (Yap et al. 1978; McMichael 
et al. 1983; Topham et al. 1997) and thereby host recovery. 
Total CD8+ T cell numbers were enumerated in the lung tissue of the mice at 
different time points after infection. The lungs were harvested from the mice 
and digested to harvest the cells from the lungs, which were then stained with 
antibodies anti-CD11c and Gr-1 to gate out the auto fluorescent cells 
(macrophages, neutrophils and some dendritic cells). The cells were also 
stained with antibodies against CD3, CD4 and CD8 to enumerate CD4+ and 
CD8+ T cells. The total number of cells was counted and the numbers of cells 
staining positive for the appropriate markers were then used to calculate the 
absolute numbers of T cells. The cells were gated on live lymphocytes and 
singlets before looking at CD3+ and CD8+ populations (Figure 3.5A). CD8+ T 
cells were readily detectable at day 8 and peaked at day 11 p.i. (Figure 3.5B). 
After the peak, the numbers of CD8+ T cells decreased, marking the 
contraction phase of the response. 
To study the antigen specific CD8+ T cell responses to 5 PFU PR/8 influenza 
infection, we used the MHC I pentamer for NP366-374 ‘ASNENMETM-H-2Kb’, 
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an immunodominant epitope, to detect for influenza-specific CD8+ T-cells 
(Figure 3.5A). NP366-374 specific CD8+ T-cells followed similar kinetics to the 
total CD8+ T cells, although their numbers were smaller. Flu-specific CD8+ T 
cells were readily detectable in the lung tissue from day 8 p.i. with the peak 
response seen at day 11 p.i. (Figure 3.5C). Day 14 had lower numbers, again 
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Figure 3.5 Kinetics of total and antigen-specific CD8+ T cells in the 
lungs of infected mice after 5 PFU PR/8 influenza infection. 
(A) Representative flow cytometry plots to show the gating strategy for the 
total and NP366+ CD8+ T cells,  
(B) kinetics of total CD8+ T cell numbers post influenza infection,  
(C) kinetics of antigen specific NP366+ CD8+ T cells after 5 PFU PR/. Graphs 
show mean +/- SE. Data is representative of 3 independent experiments n=10 
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3.6 CD4+ T cell responses 	  
Although CD4+ T cell responses are not very important in a primary influenza 
infection, they are known to play a crucial role in the memory responses. We 
characterized the CD4+ T cell responses after a 5 PFU influenza infection. Due 
to the lack of CD4+specific tetramers, we only looked at the total CD4+ T cell 
numbers to give us a general idea of the CD4+ T cell response.  
The lungs were harvested from the mice and digested to harvest the cells from 
the lungs, which were then stained with antibodies to CD11c and Gr-1 to gate 
out the auto fluorescent cells (macrophages, neutrophils and some dendritic 
cells). The cells were also stained with antibodies against CD3 and CD4 to 
characterize the CD4+ T cell responses. The gating for the CD4+ T cells was 
done similar to the CD8+ T cells initially and then gated on CD3+ and CD4+ T 
cells (Figure 3.6A). The total number of cells was counted and the numbers of 
cells staining positive for the appropriate markers were then used to calculate 
the numbers of CD4+ T cells. 
The kinetics of the total CD4+ T cell response was similar to what was 
observed with the CD8+ T cells, although the numbers of CD4+ T cells was far 
lower than for CD8+ T cells. The numbers of CD4+ T cells were detectable at 
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Figure 3.6 Kinetics of total CD4+ T cells in the lungs of infected mice 
after 5 PFU PR/8 influenza infection. 
(A) Representative flow cytometry plots to show the gating strategy for the 
total CD4+ T cells, (B) kinetics of total CD4+ T cells post influenza infection. 
Graphs show mean +/- SE. Data is representative of 3 independent 
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3.7 Neutralizing antibody responses 
 
The humoral response is important for an influenza infection for mediating 
viral clearance. Mice deficient in antibodies were found to be incapable of 
clearing the virus after a primary influenza viral challenge (Kris et al. 1985). 
Neutralizing antibodies against influenza virus are generally directed against 
the surface glycoproteins, Hemagglutinin and Neuraminidase of the virus. We 
determined the titers of virus neutralizing antibodies in the serum of mice 
infected with 5 PFU PR/8 influenza by using a hemagglutination inhibition 
(HAI) assay. Serum HAI titers of 40 in human serum are regarded as the 
minimum titers for seroprotection. It was observed that hemagglutination-
inhibiting titers of virus were detected in the sera of infected mice at day 8 p.i. 
and increased by day 11 p.i (Figure 3.7). This indicates that the neutralizing 
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Figure 3.7 Serum Neutralizing antibody titers after 5 PFU PR/8 
influenza infection 
Serum was harvested at different time points after infection from the infected 
mice. The serum was treated with RDE before subjecting the samples to a 
Hemagglutination Inhibition assay with 4HAU of virus. Graph shows mean 
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3.8 Discussion 	  
In this chapter, we have established a mouse model of influenza with the 
C57BL/6 mice using a 5 PFU dose of PR/8 influenza. We have also broadly 
characterized the immune responses to the infection, mainly the T cell 
responses and neutralizing antibody responses. We decided to base our model 
on the 5 PFU dose of influenza, considering that it is presumably similar to the 
dose a person would encounter/ inhale when the virus is transmitted. This dose 
of virus also caused enough morbidity for us to track the infection and monitor 
the engendered immune responses. 
The innate immune responses to influenza infection kick in quite early and the 
neutrophils are found to infiltrate into the airways as early as day 3 p.i. but 
start to go down at later points. The eosinophils do not seem to play such an 
important role here as they are found in very small numbers and although 
there is a peak at day 9 p.i., it was not significant. As innate immune responses 
were not the focus of our study, we did not investigate them in greater detail.  
The adaptive immune response, i.e. the T cells as well as the antibody titers 
come into play much later in the infection, as late as day 8 p.i. We detected 
CD4+ and CD8+ T cells in the lung tissue of the infected mice only at around 
day 7-8. Although this is not the peak of the CD4+ or CD8+ T cell response, 
peak levels of pro-inflammatory cytokines were secreted into the BAL fluid at 
this time-point. These findings also correlated with the fact that the mice were 
sickest at this point, indicated by the maximum loss in body weight. The peak 
in the pro-inflammatory cytokines in the BAL correlated very well with the 
weight loss, indicating that the severe loss in body weight/sickness may be due 
to the cytokine storm, so often linked to an influenza infection. But there is a 
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discrepancy in that, although the levels of cytokines seemed to peak at day 7 
p.i., the levels of CD4+ and CD8+ T cells only seem to peak much later i.e. at 
day 11 p.i. This is not surprising as CD8+ T cells are known to produce 
prominent levels of cytokines during their proliferation and CD8+ T cells are 
known to continue their proliferation even after reaching the lung (Lawrence 
et al. 2005).  
The magnitude of the memory CD8+ T cell response is directly determined by 
the clonal burst of the virus-specific CD8+ T cell response to the infection 
(Hou et al. 1994). The continued proliferation of the virus-specific CD8+ T 
cells in the lung is required to establish a robust memory response. However, 
the levels of cytokines seem to be very low or non-existent during the peak of 
the T cell responses. Recent studies have shown that CD8+ T cells in the lung 
have to interact with lung dendritic cells in order for them to secrete pro-
inflammatory cytokines (Hufford et al. 2011). It is possible the decline in 
numbers of lung dendritic cells at such late points after influenza infection is 
responsible for the reduced pro-inflammatory cytokines. This may indicate an 
efficient way of controlling the inflammatory cytokine environment and 
reducing lung pathology due to cytokine storm even when maintaining high 
numbers of CD8+ T cells to establish a robust memory response. 
Although the influenza-specific CD8+ T cell numbers peak at day 11, there is a 
decline in their numbers by day 14p.i. This marks the contraction phase of the 
CD8+ T cell response during which many of the cells undergo apoptosis. The 
cells that survive the contraction phase of the response go on to form the 
memory population. The factors that determine the contraction phase of the 
influenza-specific CD8+ T cell response are still unknown. Several cytokines 
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such as IL-2, IL-7 and IL-15 play a homeostatic role in maintaining primary 
and memory CD8+ T cells. IL-2 is known to support the generation of terminal 
effector CD8+ T cells as opposed to memory cells (Kalia et al. 2010; Pipkin et 
al. 2010). IL-7 and IL-15 on the other hand support the formation of long-
lived memory T cells(Schluns et al. 2000; Becker et al. 2002). 
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Chapter 4: The role of Interferon gamma in the adaptive immune 
responses to influenza 
4.1 Introduction 	  
Interferon gamma is a well-studied master cytokine, which has effects on 
multiple cell types and hence plays multiple roles in the immune system. 
Some of the pleiotropic roles of IFN-γ have been highlighted in the 
introduction. Our main aim was to study its’ function in the adaptive immune 
response to influenza. Most cells express the IFN-γR and hence can respond to 
IFN-γ. It is because of this fact that it plays important roles in a variety of 
infections, both systemic and local. 
In the previous chapter, we established a mouse model of influenza using the 
PR/8 strain of influenza and demonstrated that infection of mice intra-nasally 
with 5 PFU of PR/8 could induce a robust immune response to influenza in the 
C57BL/6 strain of mice. We used this model for further experiments to study 
the role of IFN-­‐γ signaling in the immune response to a primary influenza 
infection. The availability of mice deficient in IFN-γ and mice deficient for 
IFN-γR make it truly possible to study the immune response in the absence of 
IFN-γ signaling.  IFN-­‐γ is an important cytokine in influenza as it is one of the pro-
inflammatory cytokines produced in very high quantities in an influenza 
infection and adds to the cytokine storm linked to an influenza infection. 
Earlier studies in IFN-­‐γ  deficient mice have had varying results based on viral 
strain and the doses of viruses used for the experiments. The first study of 
influenza infection in the IFN-­‐γ deficient mice used A/Japan/305/57 (H2N2) 
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strain of virus (Graham et al. 1993). In this study, IFN-γ-/- mice showed similar 
susceptibility to C57BL/6 wild type mice to intranasal infection with the 
influenza virus. Another study used the BALB/c model and blocked IFN-γ in 
vivo (Baumgarth and Kelso 1996). These mice showed a significant reduction 
in the titers of virus-specific IgG2a and IgG3 in the serum. Although the 
authors did not observe any change in the viral titers in the lung tissue, they 
observed reduced cellular infiltration in the lungs of the mice with in vivo 
neutralization.  
The roles of IFN-­‐γ have been studied in a wide variety of viral and bacterial 
infections. But most of these studies focus on systemic infections like LCMV 
and Listeria. There are few studies that explore the role of IFN-­‐γ in localized 
infections like influenza. However, most of these studies use re-assortant 
viruses (like HK-x31) and hence use very high doses of virus to elicit a 
response to study the infection. In our study we chose to use a laboratory-
adapted strain PR/8 and a dose of 5 PFU, a physiological dose i.e. the amount 
of virus one would encounter from the environment, from a sneeze etc. Our 
study is comprehensively looking at all the roles IFN-γ might have on the 
adaptive immune response in a localized respiratory infection like influenza. 
One of our main aims for this project was to understand the role of IFN-γ in 
regulating the adaptive immune response and especially the T cell response in 
a mouse model of influenza. For this we made use of mice deficient in IFN-γ 
or in IFN-γ receptor. These tools gave us a better understanding of how IFN-γ 
contributed to the protection and/or pathology after an influenza infection and 
what cell types contributed to this particular phenotype. Our study mainly 
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focused on the CD8+ T cells and the role, played by IFN-γ in the modulation 
of the virus-specific CD8+ T cell responses. 
 
 
4.1.1 Tools for deciphering the role of IFN-γ  in an influenza infection 
 
The main aim of this project was to understand the role of IFN-γ signaling in 
an influenza infection. Hence, we made use of gene knock out mice: 
transgenic mice that were deficient in IFN-γ (IFN-γ-/-) and transgenic mice 
which were deficient in IFN-γR1 (IFN-γR-/-). These mice were obtained from 
Jackson Laboratories with the following stock numbers: IFN-γ-/- mice: 002287 
and IFN-γR-/- mice: 003288. 
The IFN-γ-/- mice were made by the insertion of a neomycin gene into exon 2 
of the IFN-γ gene, which induced a termination codon after the first 30 amino 
acids of the mature protein (Dalton et al. 1993). Mice with this targeted 
mutation were reported to be viable, fertile and normal in a “clean” 
environment but had reduced macrophage function in response to pathogens. 
Their macrophages were shown to have impaired production of antimicrobial 
products and reduced expression of MHC II antigens. They were also 
observed to have reduced resting natural killer cell activity. 
IFN-γR-/- mice were made by insertion of a neomycin cassette into the exon V 
of the IFN-γ receptor 1 gene, which encodes an extracellular membrane-
proximal portion of the receptor (Huang et al. 1993). Mice with this targeted 
mutation were viable and fertile with no overt abnormalities. They were also 
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shown to have normal T cell responses but had increased susceptibility to 
infection by Listeria monocytogenes and vaccinia virus.  
 
4.2 Response to influenza infection in the absence of IFN-γ  signaling 	  
4.2.1 Comparison of weight loss after a 5 PFU influenza infection 	  
To understand the role of IFN-γ signaling in our model of influenza infection, 
WT C57BL/6 mice, IFN-γ-/- mice and IFN-γR-/- mice were infected with 5 PFU 
of PR/8 influenza and their responses to infection were characterized. All the 
mice survived the ensuing infection, irrespective of their ability to make or 
respond to IFN-γ. We measured weight loss in all the infected mice for a 
period of 14 days after the infection. IFN-γ-/- and IFN-γR-/- mice showed 
similar weight loss characteristics to WT mice after infection. They also 
displayed similar symptoms as WT mice, including labored breathing, poor 
grooming, ruffled fur, reduced responses to external stimuli a week p.i. The 
highest weight loss was recorded around day 8-9 p.i at about 20 % of their 
original body weight. They also recovered from the infection regaining their 
original body weight by day 14 p.i. The kinetics as well as the extent of weight 
loss was similar to what was observed in WT mice. This indicated that the loss 
of IFN-γ or its receptor did not increase the susceptibility of the mice to a 5 
PFU dose of PR/8 influenza. Our results are in agreement with previous 
findings with other strains of influenza virus, which show that the IFN-γ-/- 
mice are not more susceptible to an influenza infection (Graham et al. 1993). 
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Figure 4.1 Comparison of loss of body weight in response to a 5 PFU 
PR/8 influenza infection in WT, IFN-γ -/- and IFN-γR-/- mice.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/PR/8/34. Weight loss of mice over a course of 14 days following 
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4.2.2 Comparison of viral load in the lungs of mice after 5 PFU 
influenza infection 
 
We measured viral titers in the lungs of infected mice at different time points 
after infection to determine the kinetics of viral clearance. The lungs of the 
mice were harvested on days 2, 4, 6 and 8 after infection and the lungs 
homogenized. Viral titers in the supernatant were measured by the plaque 
assay. In the C57BL/6 mice, viral titers peaked at day 4 p.i. and no virus could 
be detected in the lungs of WT mice at day 8 p.i. using the plaque assay 
(Figure 4.2). Viral titers in the lungs of IFN-γ-/- and IFN-γR-/- mice were 
similar to WT mice at all times measured. The kinetics of viral clearance from 
the lungs of IFN-γ-/- and IFN-γR-/- mice was similar to what was observed in 
the WT mice (Figure 4.2). This gave us an indication that IFN-γ signaling did 
not play a role in the clearance of the viral antigen and other mechanisms are 
probably able to compensate for its absence. 
We could only detect significant viral titers until day 6 p.i. using the plaque 
assay. As the sensitivity of this assay is limited, we decided to measure the 
viral RNA in the lungs of the infected mice. We compared the levels of viral 
RNA for the M-protein in the lungs of the infected mice by using a qRT-PCR 
assay (Figure 4.3). Although, we could detect viral RNA till about day 10 we 
did not observe any differences in the number of copies of viral RNA between 
the WT, IFN-γ-/- and IFN-γR-/- mice lungs. With this, we confirmed that IFN-γ 
does not have an irreplaceable role in clearance of the influenza virus. 
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Figure 4.2 Kinetics of viral clearance after 5 PFU PR/8 influenza 
infection  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/PR/8/34. The viral loads in the lung tissue of the infected mice 
were measured with a plaque assay over a period of 8 days after infection. 
Data represent mean +/- SEM. n=6-10/group 
 
Figure 4.3 Kinetics of viral RNA after 5 PFU PR/8 influenza infection  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/PR/8/34. The viral RNA in the lung tissue of the infected mice 
was measured over a period of 14 days after infection by qRT-PCR. Graph 
showing relative RNA levels of viral M-protein in the lungs of infected mice. 
Data represent mean +/- SEM n= 5 mice/group. 
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4.3 Th2 responses to influenza in the absence of IFN-γ  signaling 	  
IFN-γ is the hallmark of a Th-1 response. In the absence of IFN-γ, CD4 T cells 
are known to polarize to a Th2 phenotype (Maggi et al. 1992). Influenza elicits 
a strong Th1 response. We wanted to check if there was a tendency to skew 
the response to Th2 in the absence of IFN-γ signaling. Since influenza is a 
respiratory infection, the appearance of a Th2 phenotype can be measured by 
the presence of Th2 cytokines in the BAL fluid as well as the presence of 
eosinophils in the airways. 
4.3.1 Cellular infiltration in the airways of the IFN-γ -/- and IFN-γR-/- 
mice after 5 PFU PR/8 infection 	  
We studied cellular infiltration into the airways of infected mice in the absence 
of IFN-γ signaling. The BAL fluid was harvested from the airways of the 
infected mice with the same protocol as described in Chapter 3.3 and the cells 
in the pellet analyzed by flow cytometry. The supernatant was saved and the 
levels of cytokines measured. 
In the infected WT mice, a very low count of eosinophils was seen in the BAL 
after influenza infection (Figure 3.2). We found that airways of both IFN-γ-/- 
and IFN-γR-/- mice had significantly higher infiltration of eosinophils when 
compared to the WT mice at days 8, 11 and 14 after influenza infection. The 
numbers of eosinophils peaked at day 11 p.i. but reduced only slightly at day 
14 p.i. (Figure 4.4). The presence of significant numbers of eosinophils in the 
IFN-γ-/- and IFN-γR-/- mice indicates that there may be a slight bias towards a 
Th2 phenotype in the absence of IFN-γ signaling. IFN-γ-/- mice also had an 
increased level of macrophages at day 11 and 14 p.i. (Figure 4.4B). The 
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numbers of neutrophils however, were similar to what was observed in the 
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Figure 4.4 Cellular infiltration in the lung airways of WT, IFN-γ -/- and 
IFN-γR-/- mice after 5 PFU influenza infection  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/PR/8/34. BAL fluid was harvested from infected mice at different 
time points after infection. Cells from the BAL fluid were counted and stained 
with anti-CD3, anti-CD11c, anti-Ly6G and anti-SiglecF and then analyzed by 
flow cytometry. Kinetics of (A) Eosinophils (CD11c- SiglecF+)  
(B) Macrophages (CD11c+ SiglecF+ ) and  
(C) Neutrophils (CD11c- Ly6G+) at days 8, 11 and 14 following 5 PFU PR/8 
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4.3.2 Comparison of Th2 cytokine levels in the lung airways of infected 
mice 	  
We compared the various cytokines present in the airways of the infected mice 
by measuring the cytokine levels in the BAL fluid of WT and IFN-γ-/- mice at 
different time-points after 5PFU PR/8 infection. The supernatants from the 
BAL fluid samples were used to measure the cytokines by ELISA.  
Significantly higher levels of IL-5 were found in the IFN-γ-/- mice at day 8 p.i. 
(Figure 4.5A). The levels of IL-13 however did not seem to be different on 
day 8 but were significantly higher in the WT mice at day 11 and day 14 p.i. It 
should be noted that the levels of IL-13 were below 100pg/ml (Figure 4.5B). 
Increased levels of IL-10 were found in the BAL fluid of the IFN-γ-/- mice at 
all times, although the levels of IL-10 were highest at day 8 p.i (Figure 4.5C). 
This indicated that there was a moderate skewing towards a Th2 phenotype in 
the IFN-γ-/- mice. 
We also found that there was a significantly higher level of Eotaxin in the 
IFN-γ-/- mice on day 8 p.i (Figure 4.5D). Eotaxin is a chemotactic factor for 
the migration of eosinophils (Garcia-Zepeda et al. 1996). This could be the 
reason that there is increased infiltration of eosinophils in the airways of IFN-
γ-/- mice. 
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Figure 4.5 Cytokine profiles in the airways of the influenza infected 
mice detected by ELISA 
C57BL/6 WT and IFN-γ-/- mice were infected with 5 PFU of influenza 
A/PR/8/34. The BAL fluid was harvested from infected mice at days 8,11 and 
14 after infection. The levels of different cytokines (A) IL-5, (B) IL-13, (C) 
IL-10 and (D) Eotaxin were measured in the supernatant using ELISA.  
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4.4 Adaptive immune responses to influenza 
 
In order to study the roles of IFN-γ signaling on the adaptive immune response 
to influenza and specifically on the T cell response, we compared the T cell 
responses between the WT, IFN-γ-/- and IFN-γR-/- mice after 5PFU PR/8 
influenza infection. 
4.4.1 CD8+ T cell responses to influenza in the absence of IFN-γ  
signaling 	  
CD8+ T cells respond to an influenza infection by killing virus infected cells 
and hence are important for viral clearance (Bender et al. 1992). CD8+ T cells 
form the majority of the cellular infiltrate in the lung at later time points after 
infection (Lawrence et al. 2005). The CD8+ T cell response affects not only 
viral clearance but also the extent of inflammation in the lungs of the infected 
host as well. Earlier studies in our laboratory have shown that the influenza-
specific CD8+ T cell response is initiated in the posterior mediastinal lymph 
node that drains the lung (Ho et al. 2011). Although CD8+ T cells start to 
proliferate and get activated in the lymph nodes as early as day 5 p.i, they 
reach the lung only slightly later. From the kinetics of cell infiltration in the 
BAL fluid (Figure 3.3), it was evident that the CD3+ T cells start to 
accumulate in the lung tissue only 7-8 days after infection. Hence, we looked 
at days 8, 11 and 14 as suitable time-points to examine the various phases of 
the influenza-specific CD8+ T cell response. We identified influenza-specific 
CD8+ T cells as CD3+CD8+ T cells that bound to the MHC I pentamer NP366 
‘ASNENMETM-H-2Kb’, an immunodominant epitope, (ProImmune, UK). In 
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addition to the lung tissue, we also compared CD8+ T cells in the BAL fluid to 
those in the lung parenchyma.  
 
Kinetics of the antigen specific CD8+ T cell response to influenza 
A small percentage (2-3%) of NP366+ CD8+ T cells started to accumulate in the 
lung tissues of the infected mice on day 8 p.i. (Figure 4.6A). This frequency 
increased greatly by day 11 p.i. This was a result of higher numbers of flu-
specific CD8+ T cells migrating to the lung as well as the proliferation of the 
CD8+ T cells in the lung itself (McGill et al. 2008; McGill and Legge 2009). 
But at day 14 p.i., the frequencies of the flu-specific CD8+ T cells in the lungs 
of the WT mice had started to decline. This decline in frequencies of flu-
specific CD8+ T cells was not seen in the lungs of the IFN-γ-/- and IFN-γR-/- 
mice. 
A similar trend was observed when the total numbers of the antigen-specific 
CD8+ T cells in the BAL fluid (figure 4.6 B) and lung tissue was calculated 
(figure 4.6 C) Although a similar number of NP366+ CD8+ T cells were present 
in the lungs of all the infected mice on day 8 p.i., it was only at day 11 p.i., 
that the cell numbers peaked. There were no differences in the numbers of flu-
specific CD8+ T cells in the lungs of the WT and the IFN-γ signaling-deficient 
animals on days 8 or 11. This showed that the expansion and the peak phases 
of the response were unaffected by the absence of IFN-γ or IFN-γR. On day 14 
p.i., however, the numbers of NP366+ CD8+ T cells in the lungs of the WT mice 
showed a decline, marking the contraction phase of the response. However, 
this phenomenon was not observed in the lungs of the IFN-γ-/- and IFN-γR-/- 
mice and the numbers of NP366+ CD8+ T cells were higher than what was 
Chapter 4: The role of Interferon gamma in the adaptive immune responses to 
influenza 
	   109 
observed in the WT mice, indicating that the absence of IFN-γ signaling might 
have an affect on the contraction phase of the antigen-specific CD8+ T cell 
response to influenza. Although the numbers of NP366+ CD8+ T cells were 
smaller than what was observed in the lung tissue, their kinetics in the BAL 
fluid showed a similar pattern, emulating what was observed in the lung tissue 
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Figure 4.6 Kinetics of antigen specific CD8+ T cells in BAL and lungs 
of IFN-γ -/- and IFN-γR-/- mice after influenza infection 
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/PR/8/34. BAL and lungs were harvested on the indicated days and 
cells stained with anti-CD3, anti-CD8 and H2-Db NP366 pentamer on the 
indicated days. (A) Representative  flow cytometry plots of the proportion of 
CD8+ T cells specific for NP366 (ASNENMETM) in the lung tissue of WT, 
IFN-γ-/- mice and IFN-γR-/- mice. Cells are gated on CD3+CD8+ T cells. 
Numbers represent percentages of CD8+ T cells in the lungs, which are NP366+. 
Total NP366+ CD8+ T cell numbers in the BAL fluids (B) and lung tissues (C) 
across a time-course following influenza infection in the WT, IFN-γ-/- and 
IFN-γR-/- mice. Data are pooled from three independent experiments with 4-5 
mice/group/experiment (*p<0.05 and **p<0.001 determined using Mann-
Whitney test).  
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4.5 Effects of IFN-γ  deficiency on the function of influenza-specific 
CD8+ T cells 	  
The most important effector functions of CD8+ T cells in the context of an 
influenza infection are killing of virus-infected cells and the production of 
cytokines. We wanted to assess the role of IFN-γ in regulating these two 
functions. Hence, we decided to compare the cytotoxic killing ability and the 
cytokine secretion capabilities of the CD8+ T cells in the WT and the IFN-γ-
signaling deficient mice. 
4.5.1 Cytotoxic killing ability of influenza-specific CD8+ T cells 	  
We compared the cytotoxic potential of the NP366+ CD8+ T cells isolated from 
the lungs of infected WT, IFN-γ-/- and IFN-γR-/- mice by the expression of the 
degranulation marker CD107α in these CD8+ T cells at days 7 and 11 after 
influenza infection. A higher percentage of NP366+ CD8+ T cells expressed 
CD107α on day 7 compared to day 11 p.i. This is probably due to the fact that 
higher viral loads are present at day 7 and the cytotoxic ability is more 
relevant at this timepoint. On day 7, all the NP366+ CD8+ T cells had similar 
levels of degranulation, measured by the accumulation of CD107α on the cell 
surface (Figure 4.7A). On day 11 however, we observed that the IFN-γ-/- CD8+ 
T cells had a slightly reduced expression of CD107α (Figure 4.7B). Since this 
was quite variable, this set of experiments was repeated many times. It was 
observed that the levels of CD107a expression was slightly reduced compared 
to the WT, in the IFN-γ-/- mice but not in the IFN-γR-/- mice. Since CD107α is 
only a marker of the potential to kill, we decided to compare the actual killing 
ability by using the chromium (51Cr) release assay. This assay would be more 
relevant and accurate in determining the differences in the cytotoxicities of the 
Chapter 4: The role of Interferon gamma in the adaptive immune responses to 
influenza 
	   112 
cells and hence the role of IFN-γ in influencing the killing ability of the 
influenza -specific CD8+ T cells. 
 
The 51Cr release was measured in the 51Cr labeled peptide pulsed target cells 
after incubation with CD8+ T cells harvested from infected lungs at different 
target to effector ratios. The killing assay revealed that there were no 
differences in the killing ability of the NP366 CD8+ T cells from the WT, IFN-
γ-/- and the IFN-γR-/- mice on day 7 (Figure 4.7 C) or day 11 (Figure 4.7 D). 
These results suggested that although IFN-γ may influence the expression of 
CD107α, IFN-γ signaling does not affect the killing ability of the influenza-
specific CD8+ T cells. This also indicates that although there were higher 
frequencies of antigen-specific CD8+ T cells in the lungs of the infected IFN-γ-
/- and IFN-γR-/- mice, these cells were not deficient in their killing ability. 
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Figure 4.7 IFN-γ  deficiency does not affect the killing ability of 
antigen-specific CD8+ T cells after influenza infection 
 C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/ PR/8/34 and CD107α expression was measured on the NP366 + 
CD8+ T cells on days 7 (A) and 11 p.i. (B) . Graphs representing the 
percentage of NP366 + CD8 T cells expressing CD107α in the lungs of the 
infected mice are shown (A & B). Cytotoxic profiles of CD8+ T cells from the 
lung on day 7 (C) and day 11 p.i (D) determined by 51Cr assay, expressed as 
percentage of specific lysis of target cells. (*p<0.05 and **p<0.001 
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4.5.2 Cytokine secretion by influenza-specific CD8+ T cells 	  
From the cytokines detected by ELISA in the BAL fluid of infected WT mice 
(Figure 3.4), we found that the level of cytokines is at the maximum around 
day 7-8 p.i., when some of the virus is still present. Although there were fewer 
CD8+ T cells in the lung tissue around this time as compared to the peak of the 
response, the levels of cytokines secreted seemed to be quite high indicating 
that the T cells secrete much of their cytokines around this point. In order to 
assess if IFN-γ influenced the secretion of other cytokines by the CD8+ T cells, 
we compared the levels of cytokines IL-2, TNF-α and IFN-γ made by the 
NP366+ CD8+ T cells in the lungs of the WT, IFN-γ-/- and the IFN-γR-/- mice, 
upon ex vivo stimulation with NP366 peptide.  
Both the WT and IFN-γR-/- CD8+ T cells produced IFN-γ at day 8, although 
the levels produced by the IFN-γR-/- CD8+ T cells were slightly higher (Figure 
4.8A). No differences were observed in the production of IL-2 and TNF-α 
(Figure 4.8 B, C).   When we looked at the ability of these cells to produce 
cytokines on day 11 p.i., we could not detect any cytokine production by the 
flu-specific CD8+ T cells. This is in agreement with our earlier data where the 
levels of IFN-γ and TNF-α are very low in the BAL fluids at the later phases 
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Figure 4.8 IFN-γ  deficiency does not affect the ability of antigen-
specific CD8+ T cells to produce cytokines after influenza infection.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU of 
influenza A/ PR/8/34 and cytokine secretion by the NP366 + CD8+ T cells were 
measured on day 8 p.i. Graphs representing the percentages of NP366 + CD8+ T 
cells from the lungs expressing IFN-γ (A), IL-2 (B) and TNF-α (C) after ex 
vivo stimulation with NP366 peptide for 6h are shown (*p<0.05 and **p<0.001 
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4.5.3 Transcription factors in the influenza-specific CD8+ T cells 	  
Transcription factors like T-bet and Eomesodermin (eomes) play an important 
role in regulating the properties of CD4+ and CD8+ T cells. While T-bet is 
associated with Th1 responses, GATA-3 is associated with Th2 responses in 
CD4+ T cells. Since earlier studies show that IFN-γ is known to have a direct 
effect on levels of T-bet in CD4+ T cells, we decided to look at the levels of T-
bet and its paralogue eomes in the NP366+ CD8+ T cells in the lungs of the WT 
and the IFN-γ-/- mice. Since the levels of cytotoxicity as well as cytokine 
secretion were highest at day 7 p.i., we decided to look at the levels of these 
transcription factors at the day 7 p.i. (Figure 4.9) 
At day 7 p.i, almost all the NP366+ CD8+ T cells expressed T-bet and neither 
the number of cells expressing T-bet or the level of expression were affected 
by the absence of IFN-γ signaling (Figure 4.9A, B, D). No significant 
differences were observed in the levels of T-bet between the NP366+ CD8+ T 
cells in the lungs of the WT and IFN-γ-/-, whether in the percentage of cells 
expressing T-bet or in their MFI. However, there was a slight decrease in the 
number of eomes-producing flu-specific CD8+ T cells in the absence of IFN-γ 
(Figure 4.9 A, C). The levels of expression of Eomes were lower as well, as 
measured by the MFI of the cells (Figure 4.9 E). 
This difference may be attributed to the fact that eomes plays a more 
important role in CD8+ T cells than T-bet. Although IFN-γ influences the 
levels of eomes, this difference does not seem to reflect in the functional 
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capabilities of the CD8+ T cells after an influenza infection, since the levels of 
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Figure 4.9 IFN-γ  deficiency affects the transcription factors produced 
by the antigen-specific CD8+ T cells after influenza infection  
C57BL/6 WT and IFN-γ-/-mice were infected with 5 PFU of influenza A/ 
PR/8/34 and levels of transcription factors in the NP366 + CD8+ T cells were 
measured by Intracellular staining on day 7 p.i.  (A) Representative histograms 
showing the expression of transcription factors, T-bet and Eomesodermin on 
the NP366+ CD8+ T cells in the lung.  Graphs comparing the percentages of flu-
specific CD8+ T cells expressing T-bet (B) and eomes (C) on day 7 p.i. Graphs 
comparing the expression in terms of MFI of T-bet (D) and Eomes (E) on the 
flu specific CD8+ T cells on day 7 p.i. Data is representative of three 
independent experiments.  (*p<0.05 and ***p<0.001  using Student’s t test).  
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4.6 CD4+ T cell responses to influenza in the absence of IFN-γ  
signaling 	  
Subsequently we analyzed CD4+ T cell responses in the lungs of the mice after 
infection. Because of the lack of MHC class II tetramers for the identification 
of antigen specific CD4+ T cells, we could only study the total CD4+ T cells in 
the lungs of the mice after different time points after a 5PFU PR8 infection.  
To check whether the lack of IFN-γ has an effect on the CD4+ T cells, we 
compared CD4+ T cell responses to influenza in the WT, IFN-γ-/- and the IFN-
γR-/- mice. We chose similar time-points to measure the total numbers of CD4+ 
T cells as we used for the CD8+ T cells i.e. days 8, 11 and 14 after infection 
(Figure 4.10). We examined CD4+ T cell numbers at the site of infection i.e. in 
the lung tissue. CD4+ T cells also followed similar kinetics to the CD8+ T 
cells, peaking at day 11 p.i. Although the kinetics seems to be similar to the 
CD8+ T cells, the numbers of CD4+ T cells are much lower than total CD8+ T 
cell numbers in the lung tissue after infection.  
CD4+ T cell numbers were similar between the lungs of the WT, IFN-γ-/- and 
the IFN-γR-/- mice at all the time points measured (Figure 4.10). The CD4+ 
response was seen to be contracting on day 14 in both the WT and IFN-γ-/-or 
IFN-γR-/- mice. Although IFN-γ signaling plays a role in the contraction of the 
influenza specific CD8+ T cell response, such an effect seems to be absent 




Chapter 4: The role of Interferon gamma in the adaptive immune responses to 
influenza 
	   120 
 
 
Figure 4.10 IFN-γ  does not affect the total CD4+ T cell responses after a 
5PFU influenza infection.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU of 
influenza A/PR/8/34. Lungs were harvested on the indicated days and cells 
were stained with the anti-CD3 and anti-CD4 antibodies on the indicated days. 
Total CD4+ T cell numbers in the lung tissue across a time-course following 
influenza infection in the WT, IFN-γ-/- and IFN-γR-/- mice. Data are pooled 
from three independent experiments with 4-5 mice/group/experiment (*p<0.05 
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4.7 Role of IFN-γ  in controlling lung damage after an influenza 
infection 
 
Although there were no differences in the number of CD8+ T cells in the lungs 
of the WT, IFN-γ-/- and IFN-γR-/- mice infected with influenza at the expansion 
and peak phases of the response, there was a significant difference in the 
numbers of CD8+ T cells persisting in the lungs of the infected mice at day 14 
p.i. CD8+ T cells can cause severe lung damage during a virus infection due to 
their ability to kill virus-infected cells and to secrete cytokines. Hence, we 
looked at the damage inflicted on the lungs of the infected mice at different 
points in time after influenza infection.  
We studied the lung damage using pulmonary histopathology in lung sections 
of the WT, IFN-γ-/- and IFN-γR-/- mice at different time points after influenza 
infection (Figure 4.11A). Using a four point system we scored lung damage 
blindly and compared the level of inflammatory cell infiltrate in the 3 strains 
(Figure 4.11B). Before the infection, the lung sections of all the mice looked 
normal in all three strains of mice showing that there were no gross 
abnormalities in the lungs in the absence of IFN-γ or IFN-γR1. By day 3 p.i, 
all mice exhibited a similar extent of inflammatory cell infiltration into the 
airways, which increased significantly by day 7 p.i. and partial resolution of 
inflammation was seen by day 14 p.i. The histological findings suggested that 
the absence of IFN-γ signaling does not affect lung damage post influenza 
infection. 
We also examined the leakage of albumin into the BAL fluid as an indicator of 
lung damage (Figure 4.11C). Although we did not observe any changes after 8 
days we observed slightly increased levels of albumin leakage in the BAL 
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fluid of WT mice when compared to the IFN-γ-/- mice on days 11 and 14, 
indicating that there may be decreased inflammation in the absence of IFN-γ 
signaling later in the infection. We concluded that the lack of IFN-γ does not 
grossly affect lung pathology and although there was abnormal contraction of 
CD8+ T cells in the IFN-γ-/- mice, this did not exacerbate the 
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Figure 4.11 IFN-γ  or IFN-γR deficiency does not lead to changes in the 
lung damage due to a 5PFU influenza infection.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/-mice were infected with 5PFU of 
influenza A/ PR/8/34 and the lungs perfused and harvested before infection 
(day 0) or on days 3,7 and 14 p.i. for Hematoxylin and Eosin (H&E) staining. 
Representative images for the H&E sections are shown (A). The lung sections 
scored blind, using a 5-point scoring system as follows 0- no infiltrating cells, 
1-only1-2 airways or vessels have cell infiltration (<3 cell deep), 2- 25-50% of 
the whole section has inflammation (>3 cell deep), 3-50-75% of the whole 
section has inflammation (>3 cell deep), 4- >75% of the whole section has 
inflammation (>3 cell deep). Multiple lung sections were scored per lung and 
3 lungs were scored per group per time point and the means +/- SEM were 
plotted (B). (C) Albumin leakage into the BAL fluid of the infected mice was 
measured using ELISA at days 8, 11 and 14 p.i.. 
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4.8 IFN-γ  influences the contraction phase of the CD8+ T cell response  	  
 We observed from our previous experiments (Figure 4.6) that the levels of 
influenza-specific CD8+ T cells were higher in IFN-γ-/- and IFN-γR-/- mice at 
day 14 p.i., after resolution of the infection. Due to this, we hypothesized that 
IFN-γ played a role in regulating the contraction phase of the flu-specific 
CD8+ T cell response. In order to confirm this, we examined influenza-specific 
CD8+ T cell responses on day 28 p.i. This is a time-point at which all the mice 
have essentially recovered from the infection and the CD8+ T cell response 
should have contracted considerably. In the lungs of the WT mice, we 
observed a much-reduced number of NP366+ CD8+ T cells, than was seen on 
day 14 p.i. But the numbers of NP366+ CD8+ T cells in the BAL of the IFN-γ-/- 
and IFN-γR-/- mice were much higher than what was observed in the WT mice 
(Figure 4.12A). A similar trend was observed in the NP366+ CD8+ T cells in the 
lung tissue (Figure 4.12B) and in the spleens of these mice (Figure 4.12C). 
This confirmed our hypothesis that IFN-γ signaling plays an important role in 
the contraction of the antigen-specific CD8+ T cell response after influenza 
infection and that the absence of IFN-γ signaling leads to a defective 
contraction phase in these mice. 
To further determine the extent of the reduced contraction, we also looked at a 
much later time point i.e. day 120 p.i. At this time point, the numbers of 
antigen-specific CD8+ T cells in the lungs (Figure 4.13A) and spleens (Figure 
4.13B) of the infected mice were higher in the IFN-γ and IFN-γR deficient 
mice, indicating not only a reduced contraction phase in the absence of IFN-γ 
signaling, but also an increased memory CD8+ T cell population in the lungs 
and spleens of the deficient mice. 
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Figure 4.12 Reduced contraction of antigen-specific CD8+ T cell 
responses in IFN-γ -/- and IFN-γR-/- mice after influenza infection.   
C57BL/6 WT, IFN-γ -/- and IFN-γR-/- mice were infected with a 5PFU dose of 
influenza A/PR/8/34. NP366+ CD8+ T cell numbers were examined in the BAL 
fluid (A) and lung tissue (B) and spleens (C) of the mice on day 28 p.i. The 
numbers of CD8+ NP366+ cells (mean+/-SEM) shown are calculated from the 
total counts and the percentages of cells staining positive. (*p<0.05 and 
**p<0.001 determined using Student’s t test). Data are representative of at 
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Figure 4.13 Reduced contraction of antigen-specific CD8+ T cell 
responses and increased memory cells in IFN-γ -/- and IFN-γR-/- mice after 
influenza infection.  
C57BL/6 WT, IFN-γ -/- and IFN-γR-/- mice were infected with a 5PFU dose of 
influenza A/PR/8/34. NP366+ CD8+ T cell numbers were examined in the lung 
tissue (A) and spleens (B) of the mice on day 120 p.i. The numbers of CD8+ 
NP366+ cells (mean+/-SEM) shown are calculated from the total counts and the 
percentages of cells staining positive. (*p<0.05 and **p<0.001 determined 
using Student’s t test). Data are representative of 2 independent experiments 
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4.9 Memory T cell distribution in the absence of IFN-γ  signaling  	  
After the resolution of the infection, the CD8+ T cell response contracts and 
only some of the cells survive to form the memory population. The magnitude 
of the memory cell pool is a function of both the expansion and subsequent 
contraction of the CD8+ T cell response. Memory cells are differentiated into 
central and effector memory cell types based on their expression of CD62L (or 
CCR7). Since the number of influenza specific CD8+ T cells was significantly 
increased in the absence of IFN-γ signaling, we next examined the memory 
distribution of the NP366+ memory CD8+ T cells in the lungs and spleens of the 
WT, IFN-γ-/- and IFN-γR-/- mice.  
At day 28 p.i, higher frequencies of effector memory (CD62Llow) than central 
memory (CD62Lhigh) NP366+ CD8+ T cells were observed in the lung tissue of 
the WT, IFN-γ-/- and IFN-γR-/- mice. However, the increased numbers of 
NP366+ CD8+ T cells in the lungs of IFN-γ-/- and IFN-γR-/- mice were equally 
distributed in both the effector and central memory compartments in the lung 
tissue (Figure 4.14A, B). This trend was observed even at day 120 p.i. (Figure 
4.14D), although a higher frequency of cells showed the central memory 
phenotype (CD62Lhigh) (Figure 4.14C). This clearly indicated that IFN-γ did 
not affect the distribution of NP366+ CD8+ T cells in the different memory cell 
compartments at the site of infection.  
When we looked at the spleens (Figure 4.15), however, we observed that there 
was a higher frequency of effector memory CD8+ T cells in the IFN-γ-/- and 
IFN-γR-/- mice as compared to the WT mice. This was clearly reflected even in 
the total number of effector memory CD8+ T cells in the spleen. This indicated 
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that IFN-γ influenced the expression of CD62L on the antigen specific CD8+ T 
cells, hence causing an accumulation of CD62Llow cells.  
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Figure 4.14 Unaltered distribution NP366+ cells in the different memory 
compartments in the IFN-γ -/- and IFN-γR-/- mice 
NP366+ CD8+ T cells were examined in the lung tissue of mice on day 28(A & 
B) and day 120 p.i. (C & D) for their expression of CD44 and CD62L. 
Representative flow cytometry plots are shown (A and C). The numbers of 
effector memory (CD44hiCD62Llo) and central memory (CD44hiCD62Lhi) 
CD8+ NP366+ cells (mean+/-SEM) shown were calculated from the total counts 
and the percentage of cells staining positive in the lungs of the infected mice 
on day 28 (B) and 120 (D) p.i. The numbers of NP366+ CD8+ cells (mean +/- 
SEM) shown is calculated from the total counts and the percentages of cell 
staining. Data are pooled for two or three independent experiments (n=15). 
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Figure 4.15 Distribution of NP366+ cells in the different memory 
compartments in the spleens of the IFN-γ -/- and IFN-γR-/- mice 
NP366+ CD8+ T cells were examined in the spleens of mice on day 28 for their 
expression of CD44 and CD62L. Representative flow cytometry plots are 
shown (A). The numbers of effector memory (CD44hiCD62Llow) and central 
memory (CD44hiCD62Lhi) CD8+ NP366+ cells (mean +/- SEM) shown were 
calculated from the total counts and the percentages of cells staining positive 
in the lungs of the infected mice on day 28 (B) Data are pooled for two 
independent experiments (n=10). (*p<0.05 and **p<0.01 were determined 
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4.10 Discussion 	  
Understanding the immune response to influenza infection and the specific 
interactions between the influenza virus and the host is fundamental to our 
management of this infection and to the development of better vaccines. This 
is especially true for influenza vaccines in which current vaccine strategies 
lack the ability to elicit lasting CD8+ T cell memory responses. In the present 
study we show that IFN-γ-IFN-γR signaling plays a key role in the modulation 
of antigen-specific CD8+ T cell contraction and memory development in 
response to influenza infection. We have shown that in the absence of IFN-γ 
signaling, the contraction phase of the CD8+ T cell responses is aberrant, 
resulting in the accumulation of antigen-specific CD8+ T cells as far as day 
120 p.i. when the responses in the WT mice declined significantly.  
 Although several recent studies show that IFN-γ may influence the trafficking 
and contraction of the CD8+ T cell response against LCMV and Listeria 
infections (Badovinac et al. 2000; Tewari et al. 2007), other studies have 
reported that IFN-γ does not play a role in the contraction of CD8+ T cell 
responses after CMV and VSV infection (Christensen et al. 2004; Andrews et 
al. 2008). This suggests that the effects of IFN-γ on the magnitude of CD8+ T 
cell contraction may be specific to the particular pathogen. A likely 
explanation is that the inflammatory cytokine milieu induced by the pathogen 
may counter the effect of IFN-γ signaling on the CD8+ T cells to influence 
their survival and contraction. In our influenza model we observed that large 
amounts of IFN-γ are produced during the acute phase of influenza infection 
(Figure 3.4). Hence, we thought that IFN-γ might play a role in programming 
of the CD8+ T cell response during an influenza infection. Although we 
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studied the various aspects of the flu-specific immune response in the IFN-γ-/- 
mice and IFN-γR-/- mice, we observed defects only in the contraction phase of 
the CD8+ T cell response. The other aspects such as the CD4+ T cell response, 
viral clearance, effector function of the CD8+ T cells and lung damage seem 
unchanged in the IFN-γ-/- and IFN-γR-/- mice. Although we observed increased 
levels of Th2 cytokines and eosinophilia in the lungs of the IFN-γ-/- mice, this 
did not lead to more lung damage or exacerbated illness in these mice. 
 
In our model of influenza infection, the viral titers peaked at day 4-6 p.i. The 
CD8+ T cells appeared in the lung at day 8 p.i. and were secreting cytokines 
and displayed cytotoxic potential even in the absence of IFN-γ signaling. 
Although the viral titers peaked so early, the peak of the CD8+ T cell response 
was only seen on day 11 p.i. Although an enhanced cytotoxic ability was still 
present on day 11 p.i.,  we did not observe any cytokine production by the 
CD8+ T cells at this time-point. The IFN-γ-/- and IFN-γR-/- mice in all aspects 
of the CD8+ T cell response studied appeared similar except for the 
contraction phase of the response. The transcription factors T-bet and 
Eomesodermin (eomes) were studied at day 7 p.i. Although, no differences 
were observed in the levels of T-bet, we observed decreased levels of its 
paralogue, eomes. Further study is required to highlight the significance of this 
finding, which was beyond the scope of this thesis. 
The response of the IFN-γ-/- mice to influenza infection was first studied in 
1993 (Graham et al. 1993). In this study the authors noted that the absence of 
IFN-γ led to an increased production of flu-specific IgG1 and that IL-4 and IL-
5 were elevated compared with the WT animals. Furthermore, these authors 
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did not note any differences in the development of an effective CTL response 
in the WT and the IFN-γ-deficient mice. Our findings are in agreement with 
that study and we found no differences in the CTL response in the knock out 
mice. However, we observed differences in the levels of CD107α between the 
WT and IFN-γ-/- CD8+ T cells on day 11 p.i. CD107a (LAMP-1) is a marker 
for degranulation and is an indirect readout of CD8+ T cells cytotoxic function. 
However, since CD8+ T cells kill target cells by Fas-FasL (Topham et al. 
1997) and TRAIL (Brincks et al. 2008) in addition to the release of granzyme 
and perforin during degranulation, we realized that CD107α staining may not 
be give a complete picture of actual CD8+ T cell  cytotoxic function. As we 
have already assessed the true ability of the flu-specific CD8+ T cells to kill in 
a chromium release-killing assay, we concluded that IFN-γ does not affect the 
cytotoxic function of the CD8+ T cells. 
 Several studies have also shown that IFN-γ influences the CD4+ T cell 
responses to a variety of infections and especially the contraction phase of the 
response (Haring and Harty 2006). Hence we looked at total CD4+ T cell 
numbers in our model throughout the infection. Although, we did not track the 
antigen-specific CD4+ T cell response, we did not observe any differences in 
the total CD4+ T cell numbers throughout the 5 PFU PR/8 influenza infection. 
However, as we focused more on the CD8+ T cell response, we did not 
examine in detail, the properties or the functions of the CD4+ T cells during 
the infection. 
The reduced contraction of the flu-specific CD8+ T cell response found in the 
IFN-γ-/- and IFN-γR-/- mice consequently lead to an increase in the memory 
population in these mice. When we looked at their CD62L expression in the 
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lungs, we observed equal levels of CD62L expression on the NP366+ CD8+ T 
cells in the IFN-γ-/- and IFN-γR-/- mice as compared to the WT mice. However, 
in the spleens, a higher number of CD62Llow cells were present in the IFN-γ-/- 
and IFN-γR-/- mice as compared to the WT mice. This anomaly can be 
explained by the fact that CD62L is a lymph node homing receptor and its 
expression decides the location of the CD8+ T cells. Cells expressing high 
CD62L migrate into the spleens and lymph nodes (Kaech et al. 2002). Hence, 
although there is no difference in the CD62L expression on the NP366+ cells in 
the lung tissue, this difference is manifested in the spleens. Since there are a 
higher number of memory cells in the IFN-γ-/- and IFN-γR-/- mice as compared 
to the WT mice, this differences in CD62L could be a division-linked 
differentiation (Schlub et al. 2010), where it was described that there was a 
link between CD62L expression and cell division. It is evident that IFN-γ 
regulates CD62L expression but it is still unclear whether this leads to faulty T 
cell trafficking after influenza infection. Since the differences between TCM 
and TEM is present only in the spleens, it could be possible that the trafficking 
back to the spleen after contact with antigen in the lung is dependent on the 
up-regulation of CD62L, which is in turn regulated by IFN-γ. The role of 
CD62L in lymph node homing has been well studied but it has also been 
shown that equal numbers of effector and central memory CD8+ T cells can 
develop in the absence of CD62L mediated lymph node trafficking (Wirth et 
al. 2009).  
In summary, we found that the contraction of the influenza specific CD8+ T 
cell response is influenced by IFN-γ and hence increased numbers of antigen 
specific CD8+ T cells were present in the IFN-γ-/- and IFN-γR-/- mice even at 
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day 120 p.i., leading to increased memory cells in these mice. However, the 
effector function of the CD8+ T cells and the viral clearance were not affected 
by the absence of IFN-γ signaling.  
In the next chapters, we investigate the possible causes and mechanisms of the 
reduced contraction of the CD8+ T cell response to an influenza infection. 
Further, we also study the effects the reduced contraction phase has during a 
recall response to a re-challenge with a heterologous strain of influenza. 
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Chapter 5: Identifying the mechanisms by which IFN-γ  regulates the 
contraction of influenza-specific CD8+ T cell response 
5.1 Introduction 	  
IFN-γ has long known to be important in the regulation of immune responses. 
Our aim was to study specifically, the roles it plays in the regulation of CD8+ 
T cell responses to an influenza infection. In Chapter 4, we have shown that 
IFN-γ regulates the contraction phase of the CD8+ T cell response to influenza. 
In this chapter, we set out to identify the underlying mechanism/s by which 
IFN-γ modulates the influenza-specific CD8+ T cell response. 
Several studies have looked at the roles of IFN-γ in regulating Th1 responses 
by suppressing Th2 responses (Gajewski and Fitch 1988). It has also been 
contemplated that IFN-γ can slow/arrest the proliferation of T cells (Novelli et 
al. 1996). There have been studies that show that IFN-γ causes apoptosis of T 
cells in vitro (Refaeli et al. 2002). The role of IFN-γ in the activation induced 
cell death of T cells has been well studied (Liu and Janeway 1990; Gorak-
Stolinska et al. 2002). Our initial efforts concentrated on identifying whether 
increased proliferation or reduced survival was the reason for the reduced 
CD8+ T cell contraction phase in the absence of IFN-γ signaling. We also 
studied the role of IFN-γ regulated PD-1, a marker for cell exhaustion on the 
contraction phase of the response. 
Furthermore, we looked at the downstream effectors of IFN-γ signaling by 
which this regulation of contraction could be brought about. Since we 
identified increased survival as the reason for increased cell numbers in the 
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IFN-γ-/- and IFN-γR-/- mice, we studied the receptors on the NP366+ CD8+ T 
cells, for the cytokines involved in providing survival signals.  
In this chapter, we show with in vitro and in vivo experiments that IFN-γ does 
not control the rates of proliferation of CD8+ T cells during an influenza 
infection. We also show that IFN-γ is responsible for inducing the cell death of 
antigen specific CD8+ T cells in the lungs of influenza-infected mice. We also 
identify some of the downstream effectors by using a PCR array of molecules 
involved in pathways of cell death. Further, we found that the expression of 
IL-7R on the NP366+ CD8+ T cells and hence the survival signals received by 
these cells during an influenza infection are controlled by IFN-γ. Finally, we 
show that the reduced contraction in the IFN-γ-/- mice comes back to WT 
levels when IL-7 is blocked in the lung during the peak of the CD8+ T cell 
response to the influenza infection. 
 
5.2 Determination of precursor frequencies of NP366+ CD8+ T cells in 
the IFN-γ -/- and IFN-γR-/- mice 	  
The extent of CD8+ T cell clonal expansion is a function of the initial 
endogenous precursor frequency of the CD8+ T cells in the immune system. 
We compared the precursor frequencies of NP366+ CD8+ T cells in naïve 
uninfected WT, IFN-γ-/- and IFN-γR-/- mice (Figure 5.1). The spleen, inguinal, 
cervical, axial and brachial lymph nodes were pooled from individual 
uninfected healthy mice in an attempt to collect all the naïve T cell population. 
CD8+ T cells were purified by MACS separation and stained with NP366 
Pentamer and the entire sample was analyzed by flow cytometry. 
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We found that there were about 300-600 NP366+ CD8+ T cell precursors in a 
naive uninfected WT mouse. Similar numbers of NP366+ CD8+ T cells were 
also found in IFN-γ-/- and IFN-γR-/- mice. This showed that IFN-γ does not 
influence the naïve CD8+ T cell frequencies and the reduced contraction was 
not due to an increase in the naïve influenza-specific CD8+ T cell frequency in 
the IFN-γ-/- and IFN-γR-/- mice. 
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Figure 5.1 Precursor frequency of NP366+ CD8+ T cells is not different 
in uninfected WT, IFN-γ -/- and IFN-γR-/- mice 
NP366+ CD8+ T cells were examined in the spleens and pooled lymph nodes of 
naïve-uninfected mice by flow cytometry. The numbers of CD44lowCD62LHi 
CD8+ NP366+ cells (mean +/- SEM) shown were counted per animal. Data are 
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5.3 Rates of proliferation of CD8+ T cells in the absence of IFN-γ  
signaling 	  
Earlier studies have shown that IFN-γ can regulate the rate of proliferation of 
CD8+ T cells. We wanted to examine if this was true in our model. First of all, 
we compared the rates of proliferation of naïve WT and IFN-γ-/- CD8+ T cells 
after activation in vitro. Naïve CD8+ T cells were isolated from the spleens 
and lymph nodes of naïve WT and IFN-γ-/- mice and purified. The cells were 
then labeled with CFSE and stimulated with PMA and Ionomycin for 48 
hours. The IFN-γ-/- CD8+ T cells were also cultured in the presence of rIFN-γ 
to observe its effects on the deficient cells. After 48h, the cells were stained 
with CD3 and CD8 and a live/dead stain. The extent of proliferation in these 
cells after 48h of culture was compared between the two cell-types (Figure 
5.2). Similar results were also seen when antibodies to CD3 and CD28 were 
used for in vitro stimulation of the CD8+ T cells. 
Both the WT and IFN-γ-/- cell cultures had undergone equal numbers of cell 
divisions. We examined the proliferation statistics using FlowJo software. We 
compared the proliferation index of the cells. Proliferation Index is the total 
number of divisions undergone by the number of cells that went into division. 
We observed that both cell types had similar proliferation indices indicating 
that the rates of proliferation were not different in the absence of IFN-γ. We 
also did not observe any difference in the culture with IFN-γ-/- CD8+ T cells 
cultured in the presence of IFN-γ. This indicated that IFN-γ did not influence 
the rates of proliferation of CD8+ T cells when stimulated in vitro. 
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Figure 5.2 Comparison of proliferation rates of naïve WT and IFN-γ -/- 
CD8+ T cells after in vitro stimulation.  
CD8+ T cells were purified from WT and IFN-γ-/- mouse spleens and lymph 
nodes, labeled with CFSE and stimulated in vitro with PMA and ionomycin 
and stained with antibodies after 48 hours. IFN-γ-/- CD8+ T cells were also 
cultured in the presence of rIFN-γ. (A) Representative flow plots of the 
proliferation of CD8+ T cells in culture after stimulation for 48h (B) 
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We also examined the rates of proliferation of antigen specific CD8+ T cells in 
vivo during an influenza infection. For this set of experiments, we used CD8+ 
T cells isolated from OT-1 and OT-1 x IFN-γ-/- mice. Naïve CD8+ T cells were 
isolated from the spleens and lymph nodes of these mice, purified, CFSE-
labeled and transferred into WT and IFN-γ-/-- mice respectively. Recipient 
mice were infected with PR8-OT1 (PR/8 virus with SIINFEKL expressed on 
the surface NA stalk) after 24h. The mice were sacrificed at day 4 after 
infection and the lymph nodes harvested and the labeled cells were examined 
for their extent of proliferation. 
Both sets of mice showed similar numbers of transferred CD8+ T cells. When 
we looked at the dilution of the CFSE labeling, we observed that both groups 
of cells had undergone similar numbers of divisions (Figure 5.3A). Both cell 
types had undergone 8 divisions with similar kinetics. When we compared the 
proliferation statistics using proliferation indices, we did not observe a 
difference in their rates of proliferation (Figure 5.3B). We concluded that the 
IFN-γ does not influence the rates of proliferation of naive CD8+ T cells while 
responding to an influenza infection. 
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Figure 5.3 Comparison of proliferation rates of antigen specific OT-1 
and OT-1 x IFN-γ -/- CD8+ T cells in vivo after infection with PR8-OT1 
Naïve CD8+ T cells were purified from the spleens and lymph nodes of OT-1 
and OT-1 x IFN-γ-/- mice, labeled with CFSE, transferred into WT or IFN-γ-/- 
mice respectively, and infected with 50 PFU of PR8-OT1 strain of influenza. 
Lung draining lymph nodes were harvested on day 4 p.i. and stained for CD3 
and CD8.  
(A) Representative flow plots of proliferation of labeled CD8+ T cells 
determined using FlowJo software. (B) Proliferation indices of the transferred 
CD8+ T cells in A. Data are pooled from 3 independent experiments with n=3-
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The differences between the numbers of NP366+ CD8+ T cells in the WT, IFN-
γ-/- and IFN-γR-/- during an influenza infection is non-existent on day 11 but is 
evident only on day 14 p.i.. To determine the contribution of cell proliferation 
to this phenomenon, we compared proliferation of WT, IFN-γ-/- and IFN-γR-/- 
NP366+ CD8+ T cells at these time-points by their expression of Ki-67. The 
antigen Ki-67 is a nuclear protein that is associated with cellular proliferation 
and is generally used as a marker of proliferation. It is associated with 
ribosomal RNA transcription and inactivation of Ki-67 leads to inhibition of 
ribosomal RNA synthesis and hence blocks cell proliferation. 
Cells were harvested from the lungs of the WT, IFN-γ-/- and IFN-γR-/- mice on 
days 11 and 14 p.i. and the intracellular levels of Ki-67 were measured on the 
NP366+ CD8+ T cells (Figure 5.4). We observed that most NP366+ CD8+ cells in 
the lungs of the WT mice expressed Ki-67. This was also true for NP366+ CD8+ 
cells from the lungs of IFN-γ-/- and IFN-γR-/- mice. No differences were 
observed in the proportion of NP366+ cells expressing Ki-67 or in the levels of 
Ki-67 they expressed. More cells were found to express Ki-67 on day 11 than 
on day 14 p.i.  
We considered that all cells were undergoing some degree of basal 
proliferation and hence expressed high levels of intra-nuclear Ki-67. However, 
with this experiment we could absolutely conclude that cellular proliferation is 
not a contributing factor to the reduced contraction that is seen in the absence 
of IFN-γ signaling. 
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Figure 5.4 Comparison of nuclear antigen Ki67 to determine extent of 
cellular proliferation in the NP366+ CD8+ T cells after influenza infection 
WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU of influenza A/ 
PR/8/34 and the lungs were harvested on day 11 and day 14 p.i.. The CD8+ T 
cells from the lungs were isolated and surface stained with anti-CD3, anti-CD8 
and NP366 pentamer and after fixation and permeabilization with anti-
intracellular Ki67 nuclear antigen. The percentage of NP366+ CD8+ T cells 
positive for Ki67 on day 11 (B) and day 14 p.i (C) were plotted.	  Data are 
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5.4 Interferon gamma and cell death 	  
5.4.1 Rate of survival of CD8+ T cells in the absence of IFN-γ  signaling 
 
From our earlier experiments, we could establish that the rates of proliferation 
are not regulated by IFN-γ and hence do not contribute to the reduced 
contraction phase of the CD8+ T cells in its absence. Next we assessed 
whether IFN-γ controls the rates of death or survival of the CD8+ T cells. The 
first set of experiments look at the rates of survival of naïve CD8+ T cells after 
stimulation in vitro. We purified CD8+ T cells from the spleens and lymph 
nodes of WT and IFN-γ-/- mice and cultured them in the presence of PMA and 
ionomycin for 72h. After 3 days, we determined the percentages of live cells 
in the WT and IFN-γ-/- CD8+ T cell cultures. We observed that there were 
fewer living cells in the WT than in the IFN-γ-/- CD8+ T cell cultures (Figure 
5.5A).  
We hypothesized that IFN-γ induced cell death in the WT CD8+ T cell cultures 
and hence the higher percentage of cells in the IFN-γ-/- cultures was due to the 
absence of IFN-γ induced cell death. We examined if we could induce death in 
the IFN-γ-/- CD8+ T cells by adding in recombinant rIFN-γ into the cell culture 
and observed a dose dependent decrease in the percentage and number of 
living cells upon addition of increasing amounts of IFN-γ  (Figure 5.5B & C). 
We tried the same experiment using a different approach by blocking IFN-γ 
signaling on WT CD8+ T cell cultures by using blocking antibodies to IFN-γ 
and IFN-γR1 (Figure 5.5D) and found that a higher percentage of CD8+ T cells 
survived after IFN-γ signaling was blocked as compared to the cultures 
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without the blocking antibodies. We inferred that IFN-γ induces cell death in 
CD8+ T cell cultures upon in vitro stimulation.  
Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   148 
 
 
Figure 5.5 Interferon gamma induces death of activated CD8+ T cells 
in vitro 
CD8+ T cells were purified from the spleens and lymph nodes of WT and IFN-
γ-/- mice. (A) WT and IFN-γ-/- CD8+ T cells were stimulated in vitro with PMA 
and ionomycin and cultured cells were stained with anti-CD3 and anti-CD8 
antibodies and 7-AAD. Live cells (7-AAD negative) were counted in all 
cultures and plotted. (B and C) IFN-γ-/- CD8+ T cells were stimulated in vitro 
with PMA and ionomycin and cultured in the presence of increasing amounts 
of rIFN-γ and percentages (B) and numbers (C) of live cells after 48h were 
plotted. (D) WT CD8+ T cells were stimulated in the presence or absence of 
blocking antibodies to IFN-γ and IFN-γR1 for 48h. Live cells were counted 
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5.4.2 Increased survival of influenza-specific CD8+ T cells in the lungs of    
IFN-γ -/- mice 	  
We concluded from the previous experiments that IFN-γ induces cell death in 
activated CD8+ T cells. Next we wanted to examine if IFN-γ regulated the 
contraction of CD8+ T cells by inducing cell death in the antigen specific 
CD8+ T cells in the lungs of influenza infected mice. We hypothesized that if 
this was the case, then antigen specific CD8+ T cells in the lungs of IFN-γ-/- 
mice would undergo lower levels of death than those in the WT mice. To 
verify this hypothesis, we harvested the lungs of influenza infected WT and 
IFN-γ-/- mice, at day 12 p.i. and compared levels of apoptosis in the CD8+ T 
cells. This time-point was chosen because it was after the peak of the response 
and the time point at which contraction of the CD8+ T cell response should 
have begun. To determine whether the CD8+ T cells from the influenza 
infected IFN-γ-/- mice had decreased apoptosis, we stained freshly isolated 
CD8+ T cells from the lungs of WT and IFN-γ-/- mice for CD8, NP366 
pentamer, Annexin-V and 7-AAD and gated on the antigen specific NP366+ 
CD8+ T cells. We observed that an increased percentage of NP366+ cells 
stained positive for Annexin-V and 7-AAD in the WT mice as compared to 
the IFN-γ-/- mice (figure 5.4.2). This was true of late apoptotic (Annexin-V+ 7-
AAD+) (Figure 5.6B) and all Annexin-V+ NP366+cells  (Figure 5.6C). We 
concluded that the antigen specific CD8+ T cells from IFN-γ-/- mice are 
refractory to apoptosis after an influenza infection, which supports our theory 
that IFN-γ induces apoptosis in the antigen specific CD8+ T cells in the lungs 
after an influenza infection. 	  
Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   150 
	  
 
Figure 5.6 Decreased apoptosis in flu-specific CD8+ T cells in the IFN-
γ -/- mice  
WT or IFN-γ-/- mice were infected with 5PFU of influenza A/ PR/8/34 and the 
lungs were harvested on day 12 p.i.- The CD8+ T cells from the lungs were 
isolated and stained with Annexin-V and 7-AAD. (A) Representative flow 
cytometry plots of Annexin-V and 7-AAD staining of WT and IFN-γ-/- mice. 
(B and C) The percentage of cells positive for Annexin-V and 7-AAD (B) and 
all Annexin-V+ (C) were plotted.  
Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   151 
5.5 Addition of rIFN-γ  increases cell death in ex vivo cultures of lungs 
from influenza-infected IFN-γ -/- mice as well as in vivo 
 
From the previous experiments, we concluded that antigen specific CD8+ T 
cells from IFN-γ-/- mice are refractory to apoptosis. We next investigated 
whether we could induce or enhance cell death in the flu-specific CD8+ T cells 
from the IFN-γ-/- mice by the addition of exogenous IFN-γ ex vivo. IFN-γ-/- 
mice were infected with 5PFU of PR/8 influenza and the lungs harvested on 
day 14 p.i. (Figure 5.7). Single cell suspensions of these lungs were enriched 
for lymphocytes and cultured for 24h in the presence or absence of 
recombinant IFN-γ. After 24h the cells were stained with antibodies against 
CD3, CD8 and NP366 pentamer and the numbers of live CD3+CD8+NP366+ 
cells that were 7-AAD-ve (live) enumerated (Figure 5.7A). Addition of IFN-γ 
to the cell cultures resulted in a decrease in the percentage of live NP366+ CD8+ 
T cells from the IFN-γ-/- cultures compared to the cultures without rIFN-γ 
(Figure 5.7B). This confirmed that IFN-γ regulates cell survival and induces 
cell death in the antigen specific CD8+ T cells.  	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Figure 5.7 Addition of rIFN-γ  increases cell death in ex vivo cultures of 
lungs from influenza-infected IFN-γ -/- mice  
IFN-γ-/- mice were infected with 5 PFU of influenza A/ PR/8/34 and CD8+ T 
cells were harvested on day 14 p.i. The Ficoll-enriched cells were cultured in 
the presence or absence of rIFN-γ for 24h. Live NP366+ CD8+ T cell 
proportions were examined in the culture according to the gating strategy (A). 
The NP366+ CD8+ T cells in the cultures without IFN-γ were considered as 
100% and the percentage of live NP366+ CD8+ T cells in the cultures with IFN-
γ were calculated accordingly (B). Mean+/-SEM shown is calculated from the 
percentage of cells staining positive. Data are representative of two 
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We have shown so far that IFN-γ induces cell death of the antigen specific 
CD8+ T cells in vitro and ex vivo. The next logical step was to see if 
administration of exogenous IFN-γ into IFN-γ-/- mice during an ongoing 
influenza infection would reverse the abnormal contraction phase of the flu-
specific CD8+ T cell response in these mice. We decided to administer rIFN-γ  
into the lungs of the flu-infected     IFN-γ-/- mice at various time points after 
infection. We chose time points where the local concentration of IFN-γ would 
be high in the lungs of WT mice. As per our previous observation, we had 
seen that the levels of IFN-γ in the BAL fluid of flu-infected mice were 
highest at days 5, 6 and 7 after infection. Hence, we chose to administer rIFN-
γ or PBS (as control) into the lungs of IFN-γ-/- mice at day 5 and 7 p.i. via the 
intra tracheal route. We chose not to do this multiple time points as this would 
lead to added stress in the lungs of the flu-infected animals. The mice were 
allowed to rest for the next week and the animals were sacrificed at day 14 p.i, 
their lungs were harvested and the NP366+ CD8+ T cells were enumerated.  
The influenza infected mice which received rIFN-γ had lower numbers of 
NP366+ CD8+ T cells in the lungs when compared to the mice that got PBS 
(Figure 5.8). This indicated that the presence of IFN-γ in the lung environment 
programs antigen specific CD8+ T cells to undergo cell death in influenza 
infected mice and hence regulates the contraction phase of the influenza 
specific CD8+ T cell response. 
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Figure 5.8 In vivo administration of rIFN-γ  into the IFN-γ -/- mice 
reduces the CD8+ T cell accumulation in the lungs after influenza 
infection 
 IFN-γ-/- mice were infected with 5 PFU influenza infection and PBS or rIFN-γ 
was administered i.t. to the lungs of these mice at days 5 and 7 p.i. The mice 
were sacrificed on day 14 p.i, the lungs were harvested and the antigen 
specific NP366+ CD8+ T cells were enumerated. Mean+/-SEM shown is 
calculated from the number of cells staining positive. Data are representative 
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5.6 PCR array to look at the molecules associated with cell death 
(apoptosis, autophagy and necrosis) 
 
Various pathways can induce cell death. Apoptosis (programmed cell death) 
and necrosis are the two major types of cell death. Autophagy has been 
proposed as a third kind of cell death in which cells digest their own 
organelles. All these three forms of cell death can be induced by programmed 
control mechanisms involving several players. Some of these key players may 
have a role to play in more than one pathway. In order to identify the pathways 
activated by IFN-γ, we used the mouse cell death pathway finder from SA 
Biosciences. This array profiles the expression of 84 key genes important for 
all the three mechanisms of cell death. The mechanisms behind the cell death 
pathways overlap and more than one form of cell death can occur 
simultaneously. The array uses real-time PCR to analyze the expression of a 
focused panel of genes involved in cellular death pathways. The genes profiled 










Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   156 
 
 
Apoptosis: Pro-Apoptotic: Abl1, Apaf1, Atp6v1g2, Bax, Bcl2l11, Birc2 (c-
IAP2), Casp1 (ICE), Casp3, Casp6, Casp7, Casp9, Cd40 (Tnfrsf5), Cd40lg 
(Tnfsf5), Cflar (Casper), Cyld, Dffa, Fas (Tnfrsf6), Fasl (Tnfsf6), Gadd45a, 
Nol3, Spata2, Sycp2, Tnf, Tnfrsf1a, Tnfrsf10b, Trp53. Anti-Apoptotic: Akt1, 
Bcl2, Bcl2a1a (Bfl-1/A1), Bcl2l1 (Bcl-x), Birc3 (c-IAP1), Casp2, Igf1r, Mcl1, 
Tnfrsf11b, Traf2, Xiap. 
 
Autophagy: Akt1, App, Atg12, Atg16l1, Atg3, Atg5, Atg7, Bax, Bcl2, Bcl2l1 
(Bcl-x), Becn1, Casp3, Ctsb, Ctss, Esr1 (ERa), Fas (Tnfrsf6), Gaa, Htt, Ifng, 
Igf1, Ins2, Irgm1, Map1lc3a, Mapk8 (Jnk1), Nfkb1, Pik3c3 (Vps34), 
Rps6kb1, Snca, Sqstm1, Tnf, Trp53, Ulk1. 
 
Necrosis: 9430015G10Rik, Atp6v1g2, Bmf, Ccdc103, Commd4, Cyld, Defb1, 
Dennd4a, Dpysl4, Eif5b, Foxi1, Galnt5, Grb2, Hspbap1, Jph3, Kcnip1, Mag, 
Olfr1404, Parp1 (Adprt1), Parp2, Pvr, Rab25, S100a7a, Spata2, Sycp2, 
Tmem57, Tnfrsf1a, Txnl4b. 
 
Housekeeping genes: beta-2-microglobulin, beta-actin, GAPDH, Ribosomal 
protein L3a, HPRT1 
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IFN-γ  induced death in the NP366+ CD8+ T cells in the lungs of infected 
mice.  
We have already stained for Annexin V (Figure 5.9) and have hence 
confirmed that IFN-γ induces the apoptotic program to induce cell death in the 
NP366+ CD8+ T cells. We wanted to confirm if apoptosis was the only pathway 
induced by IFN-γ or if other death pathways were also activated by IFN-γ. 
We purified NP366+ CD8+ T cells from the lungs of WT and IFN-γ-/- mice by 
Fluorescence-Activated Cell Sorting (FACS) after staining with antibodies to 
CD8 and NP366 pentamer. The RNA was isolated from these cells and then 
subjected to the above-mentioned PCR-array. 
The IFN-γ-/- NP366+ CD8+ T cells had up-regulated anti-apoptotic molecules 
like Birc3 and Bcl-2 but had down regulated several genes involved in 
apoptosis (Akt1 and Casp3), necrosis (Mcl-1, Pvr and Tnfrsf1a) and 
autophagy (Atg16l1, App, Esr1, Gaa and Irgm1). Since the array also included 
the IFN-γ gene, this was down regulated several fold in the IFN-γ-/- cells, 
which worked as an excellent internal control. Surprisingly, certain apoptotic 
genes like Casp6, ApaF1 and Fasl were also up regulated in these cells. This 
showed that the pathways induced by IFN-γ were not dependent on a single 
pathway or a single set of molecules. IFN-γ influenced more than one type of 
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Figure 5.9 PCR array of molecules involved in different cell death 
pathways  
NP366+ CD8+ T cells were sorted from the lungs of influenza infected WT and 
IFN-γ-/- mice on day 14 p.i. and the RNA was subjected to the Cell death 
pathway finder PCR array, the details of which are described above and the 
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5.7 The absence of IFN-γ  does not alter levels of exhaustion marker 
PD-1 on NP366+ CD8+ T cells 
 
The inhibitory receptor PD-1 contains a classic immunoreceptor tyrosine-
based inhibitory motif (ITIM) and its engagement has been shown to induce T 
cell apoptosis and inhibit proliferative responses in response to TCR 
engagement (Freeman et al. 2000). It is an inhibitory receptor expressed on 
activated CD8+ T cells for immune regulation and to reduce immunopathology 
during infection. The primary function of PD-1 is to attenuate the immune 
response. Hence, the expression of PD-1 is associated with cell exhaustion and 
immune suppression. 
IFN-γ is known to influence the levels of PD-1 expression on CD8+ T cells 
(Bos et al. 2012). Hence, we determined the levels of expression of PD-1 on 
the NP366+ CD8+ T cells at the peak of the CD8+ T cell response i.e. at day 11 
p.i. (Figure 5.10). A high percentage of NP366+ CD8+ cells was found to 
express PD-1 at this time-point in the WT mouse lungs. A similar proportion 
of NP366+ CD8+ cells in the IFN-γ-/- and IFN-γR-/- mice also expressed such 
high levels of PD-1, indicating that the levels of CD8+ T cell exhaustion and 
immune suppression were similar in the absence of IFN-γ signaling, indicating 
that levels of PD-1 did not play a role in the reduced contraction observed in 
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Figure 5.10 The absence of IFN-γ  does not alter levels of exhaustion 
marker PD-1 on the NP366+ CD8+ T cells.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU of 
influenza A/ PR/8/34 and PD-1 expression was measured on the NP366 + CD8+ 
T cells on day 11 p.i. Representative flow plots showing the percentage of 
NP366 + CD8+ T cells expressing PD-1 in the lungs of the infected mice (A). 
Graph representing the percentages of NP366 + CD8+ T cells from the lungs 
expressing PD-1 (B). Data are pooled from 3 independent experiments with 
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5.8 Contribution of DCs to the abnormal contraction in the absence of 
IFN-γ  signaling after influenza infection 
 
DCs are the sentinels of the lung airway and play a very important role in the 
initiation of the immune response to an influenza infection. They are the first 
group of cells that interact with the virus, acquire viral antigen and migrate to 
the draining lymph node to present this to naive CD8+ T cells (Belz et al. 
2004). Studies in our lab have shown that lung DCs migrate to the lung 
draining lymph node (Ho et al. 2011). These cells play an important role in 
programming the CD8+ immune response to the influenza infection. In order 
to see how IFN-γ signaling regulates the characteristics of the DCs, we first 
characterized the dendritic cell population in the draining lymph node i.e. the 
posterior pMLN at day 5 p.i. (Figure 5.11).  
There were no differences in the proportions of total CD11c+ DCs in the lungs 
of the infected WT, IFN-γ-/- and IFN-γR-/- mice. When the levels of Class I and 
Class II MHC molecules were measured on the surface of the CD11c+ DCs, 
we did not see any down regulation in the absence of IFN-γ signaling. We 
observed a slight decrease in the MFI of expression of Class II on IFN-γ-/- DCs 
but not in their class I expression (figure 5.11B). No differences were 
observed in the expression of the co-stimulatory molecules measured CD40, 
CD70, CD80 and CD86 (figure 5.11C). This showed that the DCs do not 
depend on IFN-γ for their expression of co-stimulatory molecules or their 
expression of MHC class I or class II molecules during the initiation of the 
response to influenza in the lung draining lymph nodes. 
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Figure 5.11 No differences in the dendritic cell characteristics at the 
initiation of the immune response to influenza in the lung draining lymph 
node.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/ PR/8/34 and DCs were harvested from the lung draining lymph 
nodes on day 5 p.i . (A) Gating strategy for lymph node dendritic cells. Graph 
representing the percentages of DCs from the lymph nodes (B), their 
expression of Class I and Class II MHC molecules (C) and co-stimulatory 
molecules (D). Data are representative from 2 independent experiments with 
n=4-5 per group. 
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DCs are also important mediators of CD8+ T cell survival in the lung tissue 
after influenza infection (Dolfi et al. 2008; Peperzak et al. 2010). Since there 
were higher numbers of antigen specific CD8+ T cells in the lungs of the mice 
deficient in IFN-γ signaling, we thought that the survival signals from the DCs 
might be different in these mice. Hence, we also characterized the DC 
population in the lungs of the infected mice on day 14 p.i. (Figure 5.12) 
We harvested the lungs from infected mice on day 14 p.i, isolated the CD11c+ 
DCs and compared their characteristics between the WT, IFN-γ-/- and IFN-γR-
/- mice. We observed that the proportion of DCs was significantly lesser in WT 
lungs as compared to those from IFN-γ-/- and IFN-γR-/- mice. But we figured 
that the reason for this could be the high numbers of influenza-specific CD8+ 
T cells in the lungs of the IFN-γ-/- and IFN-γR-/- mice. Since we did not 
compare the total cell counts of the DCs, we could not conclusively decide 
whether this was affecting the lung CD8+ response.  
Furthermore, we looked at the levels of expression of MHC class I and MHC 
class II on the DCs and we observed significantly lower expression of MHC I 
on the DCs from the IFN-γ-/- and IFN-γR-/- mice. When the levels of co-
stimulatory molecules were compared however, we did not see any significant 
differences in the levels of CD40 and CD86 but slightly lower levels of CD80 
was observed on the DCs in the lungs of the IFN-γ-/- mice but not in the IFN-
γR-/- mice. 
We also studied the DCs at steady state in the lungs of naïve mice. We found 
that in the steady state, the percentage of DCs was comparable in the lung in 
the presence or absence of IFN-γ signaling (Figure 5.13). 
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Figure 5.12 Comparison of the dendritic cell characteristics in the lungs 
of infected mice on day 14 p.i.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU of 
influenza A/ PR/8/34 and DCs were harvested from the lungs on day 14 p.i. 
(A) Gating strategy for lung DCs. Graph representing the percentages of DCs 
from the lung tissues (B), their expression of Class I and Class II MHC 
molecules (C) and co-stimulatory molecules (D). Data are representative from 
2 independent experiments with n=4-5 per group. 
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Figure 5.13 Comparison of the dendritic cell characteristics in the lungs 
of  mice at steady state.  
Naïve C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were sacrificed and DCs were 
harvested from the lungs. (A) Gating strategy for lung DCs. (B) Graph 
representing the percentages of DCs from the lung tissues. Data are 
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Furthermore we wanted to confirm that there was no extended duration of 
antigen presentation in the IFN-γ-/- and IFN-γR-/- mice. Although, we have 
confirmed that the viral titers and the kinetics of viral clearance were similar 
in the lungs of the WT, IFN-γ-/- and IFN-γR-/- mice, we wanted to know if 
clearance of virus coincides with antigen disappearance. To assess this, we 
infected WT, IFN-γ-/- and IFN-γR-/- mice with the PR8-OT1 virus and then 
harvested the APCs (antigen presenting cells) from the lung draining lymph 
node on day 5 p.i (as controls) and from the lungs on day 11 p.i. to measure 
their antigen presentation. These APCs were then cultured with naïve CFSE-
labeled OT-1 cells for 72h. We chose the day 11 time-point as this is when the 
virus was totally cleared and viral RNA was very low. The extent of CFSE 
dilution measured the cell proliferation and indirectly the extent of antigen 
presentation by the isolated APCs (Figure 5.14). 
We observed that there was a very high dilution of CFSE in the OT-1 cells 
cultured with all the day 5 APCs, indicating high cell proliferation and hence 
high levels of antigen presentation. However, we did not observe any cell 
proliferation in any of the cultures with APCs isolated from the day 14 p.i. 
lungs. This trend was maintained in the WT, IFN-γ-/- and IFN-γR-/- mice, 
indicating that there is no extended antigen presentation in the absence of IFN-
γ signaling. 
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Figure 5.14 No persistence of viral antigen presentation in the absence 
of IFN-γ  signaling.  
DCs were harvested from the lung draining lymph nodes (pMLNs) and lungs 
of mice infected with SIINFEKL-PR/8 influenza and cultured with CFSE-
labelled naïve OT-1 cells for 3 days. After 3 days the CFSE dilution was 
analyzed. Representative flow plots of proliferation of labeled CD8+ T cells 
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5.9 IFN-γ  regulates number of memory precursors as determined by 
the expression of IL-7Rα  (CD127) on the antigen specific CD8+ T cells in 
the lungs of influenza infected mice 
 
Memory T cells display enhanced survival when exposed to certain cytokines 
that are known to boost rates of survival and proliferation in responding cells. 
The gamma chain cytokines are particularly known for this function. T cells 
can only respond to these cytokines provided they express the relevant 
receptors for these cytokines. As antigen specific CD8+ T cells in the lungs of 
IFN-γ-/- and IFN-γR-/- mice displayed enhanced survival during the contraction 
phase, we hypothesized that these cells may be memory precursors. In order to 
confirm this and to assess whether these cells could respond better to the 
cytokine milieu, we measured the levels of expression of receptors for key 
cytokines that can regulate survival and differentiation into memory cells (viz. 
IL-2, IL-7, IL-15). We examined levels of all subunits for IL-2R (α CD25, β 
CD122 and γ CD132), IL-7R (α CD127 and γ CD132) and IL-15R (α CD215, 
β CD122 and γ CD132) on the surface of the NP366+ CD8+ T cells at the peak 
of the infection i.e. at day 11 p.i. (Figure 5.15). Although we noted a slight 
increase in the level of CD122 on the flu-specific cells of the IFN-γR-/- mice, 
this was not seen in the IFN-γ-/- mice. We did not observe any differences in 
the levels of expression of CD25, CD132 and CD215. However, we observed 
significant differences in the levels of CD127 (IL-7Rα) expression in both the 
IFN-γ-/- and IFN-γR-/- mice.  
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Figure 5.15 Expression of cytokine receptors on antigen specific CD8+ T 
cells in the lungs of WT, IFN-γ -/- and IFN-γR-/- mice.  
WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU PR/8 influenza. 
NP366+ CD8+ T cell proportions were examined in the lung tissue for 
expression of different receptors on day 11 p.i. (A) Graphs showing the 
percentages of NP366+ CD8+ T cells in the lung expressing the receptor sub-
units for IL-2 (CD25, CD122 and CD132), IL-7 (CD127, CD132) and IL-15 
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The increased expression of IL-7Rα on CD8+ T cells at the peak of the 
response is thought to identify those effector CD8+ T cells that will eventually 
differentiate into memory cells (Kaech et al. 2003). When we examined the 
levels of IL-7Rα expression on the antigen specific CD8+ T cells at the peak 
of the influenza infection, we found that only about 3-7 % of the NP366+ CD8+ 
T cells from WT mice expressed IL-7Rα. This is consistent with the 
percentage of cells that survive to become long-lived memory cells in WT 
mice. However, in the IFN-γ-/- and IFN-γR-/- mice, we observed that a 
significantly higher percentage (~10-15%) of antigen specific CD8+ T cells 
expressed IL-7Rα at this point (Figure 5.16A and B). This observation is 
consistent with our previous results that more antigen specific CD8+ T cells 
survive in these mice. We concluded that in the absence of IFN-γ signaling, a 
higher number of memory precursor cells are formed. We further examined 
the kinetics of the IL-7Rα expression on these cells on day 14 after infection 
(Figure 5.16 A and C). Although the percentage of cells expressing IL-7Rα at 
this time point showed an increase compared to day 11 p.i, the expression of 
IL-7Rα was still higher in both IFN-γ-/- and IFN-γR-/- mice. These data suggest 
that one mechanism that IFN-γ may use to control the survival of antigen-
specific CD8+ T-cells is to regulate the expression of IL-7Rα during the 
contraction phase to promote death of effector CD8+ T cells.  
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Figure 5.16 Expression of IL-7Rα  on antigen specific CD8+ T cells in 
the lungs of WT, IFN-γ -/- and IFN-γR-/- mice 
WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU PR/8 influenza. 
NP366+ CD8+ T cell proportions were examined in the lung tissue for 
expression of IL-7Rα (CD127) on day 11 p.i. (A) Representative flow 
cytometry plots and (B and C) graphs showing the percentage of cells 
expressing IL-7Rα in the WT, IFN-γ-/- and IFN-γR-/- mice on day 11 p.i. (A & 
B) and day 14 p.i. (A & C). Data were pooled from two or three independent 
experiments with 4-5mice/group/experiment. (*p<0.05 and **p<0.001 




Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   172 
 
 
Next we co-stained for the T cell degranulation marker CD107α as well as 
CD127 (IL-7Rα) at day 11 p.i. We observed that at the peak of the response, 
the NP366+ CD8+ T cells that were IL-7Rαlow expressed CD107α whereas the 
IL-7Rαhigh cells did not Figure 5.17). This could be an indication that the IL-
7Rαlo cells may be the short-lived effector cells whereas the IL-7Rαhigh cells 
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Figure 5.17 Differential expression of degranulation marker CD107α  
on the IL-7Rαhi and IL-7Rα low antigen specific CD8+ T cells.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5PFU of 
influenza A/ PR/8/34 and the percentage CD107α expression measured on the 
NP366 + CD8+ T cells on day 11 p.i. (A) Representative flow cytometry plots 
showing the relative expression of CD107α and IL-7Rα(CD127) on the 
NP366+ CD8+ T cells in the lungs of mice on Day 11 p.i. Data are 
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5.10 Increased IL-7R expression in the CD8+ T cells increases their 
survival by increasing the levels of anti-apoptotic molecule Bcl-2 inside 
the cell 
 
We also examined the levels of intracellular Bcl-2 expressed by the antigen 
specific IL-7Rhi and IL-7Rlo cells (Figure 5.18A). We observed that the IL-
7Rhi cells express higher levels of the anti-apoptotic molecule Bcl-2, 
indicating that these are refractive to apoptosis and hence may be long-lived 
memory precursors (Figure 5.18 B). 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   175 
	  	  	  
	  
Figure 5.18 Levels of expression of intracellular Bcl-2 on the IL-7Rαhi 
and IL-7Rα low antigen specific CD8+ T cells.  
(A and B) Representative flow cytometry plots showing the level of Bcl-2 in 
the IL-7Rhi and IL-7Rlo population of antigen specific CD8+ T cells. (C) Graph 
showing percentages of IL-7Rlow and IL-7Rhi NP366 CD8+ T cells expressing 
Bcl-2. Representative plots are shown from three independent experiments. 
(*p<0.05 and **p<0.001 determined using Student’s t test).  
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5.11 Blocking IL-7 in the lungs of infected IFN-γ -/- mice returns the 
contraction phase to normal WT levels 
 
To confirm whether IL-7R expression was indeed key to the survival of the 
influenza-specific CD8+ T cells in vivo, we blocked IL-7 in the lungs of 
infected mice. We delivered IL-7 neutralizing antibody or control isotype IgG 
to the lungs of infected WT and IFN-γ-/- mice on day 11 p.i. by the intranasal 
route and quantified NP366+ CD8+ T cells in the lung tissues of the treated mice 
on day 14 p.i. Blocking IL-7 enhanced the death of the NP366+ CD8+ T cells 
and significantly fewer cells survived in the lungs of the IFN-γ-/- mice, 
compared to the control treated IFN-γ-/- mice (Figure 5.19).  
When IL-7 was blocked in the lungs of WT mice, a similar induction of cell 
death was observed. Even fewer NP366+ CD8+ T cells survived in the lungs of 
WT mice treated with anti-IL-7. This finding demonstrates that IL-7R 
expression on the NP366+ CD8+ T cells is functionally important in their 
survival during the contraction phase of the response.  
This experiment confirmed that the expression of IL-7R is functionally 
important for receiving survival signals. Hence, the increased frequency of IL-
7Rα (CD127) on the NP366+ CD8+ T cells in the absence of IFN-γ signaling 
enhances their survival and consequently their ability to develop into memory 
cells.  	  	  	  	  
Chapter 5: Identifying the mechanisms by which IFN-γ regulates the 
contraction of influenza-specific CD8+ T cell response 
	   177 
	  	  
	  
Figure 5.19 Administering IL-7 neutralizing antibodies to the lungs of 
infected mice leads to reduced survival of NP366+ CD8+ T cells  
Infected WT and IFN-γ-/- mice were treated with intranasal 0.05mg of anti-IL-
7 pAb (aIL-7) or control isotype Goat IgG (Iso) on D11 p.i. and NP366+ CD8+ 
T cells were enumerated in the lungs of these mice on D14 p.i. Representative 
plots are shown from three independent experiments. (*p<0.05 and **p<0.001 
determined using Student’s t test).  	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There is increasing evidence that IFN-γ regulates the contraction of CD8+ T 
cell responses in systemic infections although our study is the first to examine 
its role in localized infections. Although these studies show that IFN-γ 
regulates the contraction of the CD8+ T cell response, they fail to identify the 
mechanism/s for this. In the present study we demonstrate that IFN-γ-IFN-γR 
signaling regulates the reduction of CD8+ T cells even in localized mucosal 
infections like influenza. We have shown in chapter 4 that in the absence of 
IFN-γ signaling the contraction phase of the CD8+ T cell response is aberrant, 
resulting in the accumulation of antigen specific CD8+ T cells as far as day 
120 p.i. Our data also suggests that IFN-γ can act directly on antigen specific 
CD8+ T cells to induce cell death during an influenza infection as we observed 
when we cultured IFN-γ-/- effector cells in the presence of IFN-γ. We postulate 
that IFN-γ can act on the influenza-specific CD8+ T cells by multiple 
mechanisms activating several downstream effectors including the receptor for 
Interleukin 7. We showed that the IL-7R expression was functionally 
important for the survival of effector cells during the contraction phase. We 
have also identified some of the other molecules that IFN-γ can activate which 
may be involved in inducing CD8+ T cell death in an influenza-infected lung. 
IFN-γ is known to influence the rates of proliferation and apoptosis in 
activated T cells (Gajewski and Fitch 1988; Liu and Janeway 1990; Refaeli et 
al. 2002). Therefore, we thought that the increased accumulation of antigen 
specific CD8+ T cells in the lungs of influenza infected IFN-γ-/- and IFN-γR-/- 
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mice could be a result of either the rates of cell proliferation and/or death. 
However, analysis of in vitro and in vivo proliferation indirectly, indicated that 
IFN-γ deficiency did not alter the rates of proliferation of CD8+ T cells. 
Expression of Ki67, a nuclear marker for cellular proliferation (Scholzen and 
Gerdes 2000), on flu-specific CD8+ T cells in the lung was not affected by 
IFN-γ. Indeed, we observed decreased rates of cell death in antigen specific 
CD8+ T cells in the IFN-γ-/- mice. We could also induce cell death in antigen 
specific CD8+ T cells by the addition of recombinant IFN-γ to ex-vivo cultures. 
This mechanism is consistent with findings from other studies which show 
that IFN-γ contributes to activation-induced-cell death of in vitro activated T 
cells (Vukmanovic-Stejic et al. 2000; Refaeli et al. 2002). We further 
identified several molecules acting downstream of IFN-γ that induce cell 
death, in a cell death pathway finder PCR array.  
The levels of homeostatic cytokine receptors may be differentially expressed 
in the absence of IFN-γ signaling and hence responsible for increased rates of 
survival of CD8+ T cells in the IFN-γ and IFN-γR deficient mice. Studies in 
LCMV showed that IFN-γ had an effect on expression of IL-7R (Tewari et al. 
2007). Also, expression of IL-7Rα (CD127) on antigen specific CD8+ T cells 
at the peak of the response is known to identify cells that will survive to 
become memory precursor populations (Kaech et al. 2003). We observed that 
IFN-γ could influence levels of IL-7Rα expression on the effector CD8+ T 
cells in an influenza infection. IL-7 is one of the homeostatic cytokines, which 
delivers survival signals to the CD8+ T cells by increasing expression of anti-
apoptotic molecules such as Bcl-2 (Kaech et al. 2003). We found that this was 
also true for influenza and observed increased frequencies of cells expressing 
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IL-7Rα at the peak of the response in the absence of IFN-γ signaling and 
showed that these cells also expressed higher levels of Bcl-2. This agreed with 
our initial finding that increased numbers of cells survived the contraction 
phase in the absence of IFN-γ signaling. We could confirm that expression of 
IL-7Rα was functionally significant by IL-7 blocking in vivo. Neutralizing IL-
7 in the IFN-γ-deficient mice reduced the numbers of flu-specific CD8+ T cells 
to WT levels. Hence, the higher expression of IL-7Rα is one reason that more 
cells in these mice are resistant to cell death and hence survive the contraction 
phase to form a higher percentage of memory cells. In addition to IL-7Ra, 
other molecules may also regulate the survival of these cells and further 
studies will be needed to identify the factors responsible. 
Antigen specific CD8+ T cells in IFN-γ-/- and IFN-γR-/- mice exhibited higher 
IL-7Rα expression at the peak of expansion and their numbers did not contract 
compared with antigen specific CD8+ T cells in WT mice. However, it 
remains to be determined if early IFN-γ signals in T cells directly regulate 
which effector cells will or will not up regulate IL-7Rα. Thus, determining 
how antigen-specific CD8+ T cells directly respond to IFN-γ signals during 
infection may provide important clues to how the immune system regulates 
the survival of only a small proportion of effector CD8+ T cells for memory 
cell generation. T-bet is a transcription factor that regulates the levels of IL-
7Rα and T-bet deficiency leading to increased levels of IL-7Rα expressing 
CD8+ T cells at the peak of the response (Intlekofer et al. 2007). Inhibition of 
T-bet expression due to IFN-γ deficiency could lead to the increased levels of 
IL-7Rα on the virus-specific CD8+ T cells. 
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There is evidence to suggest that memory CD8+ T cells may derive from 
effector cells (Joshi et al. 2007; Sarkar et al. 2008; Bannard et al. 2009). 
However, it is also possible that memory CD8+ T cells represent a separate 
lineage that is resistant to contraction. We show here that the memory CD8+ T 
cells are formed from a population of effector cells which are IL-7Rα+ but do 
not express cytotoxic molecules like CD107α and that only the IL-7Rαlo/neg 
cells express CD107α but not the IL-7Rαhi/pos cells. This indicates that the IL-
7Rαhi/pos cells may be memory precursors and is in agreement with the finding 
that CD127+(IL-7Rαhi/pos) CD8+ T cells display low levels of cytotoxicity and 
effector function and progressively differentiate into memory cells (Bachmann 
et al. 2005). 
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Chapter 6: Role of IFN-γ  in CD8+ T cell response to a heterologous re-
challenge 	  
6.1 Introduction 	  
The essential hallmark of the adaptive immune system is its ability to 
engender antigen-specific memory, which can protect against repeated 
infections with the same or a similar pathogen (Pulendran and Ahmed 2006; 
Sallusto et al. 2010; Pulendran and Ahmed 2011). This ability is termed 
immunological memory and is based on the induction of long-lived T and B 
cells after infection or vaccination (Ahmed and Gray 1996; Gourley et al. 
2004). Memory cells are highly responsive to antigenic stimulation and 
proliferate swiftly to differentiate into effector cells to confer protection 
against the invading pathogen (Veiga-Fernandes et al. 2000; Whitmire et al. 
2008). The extent to which the host is protected from a re-challenge is 
dependent on the quality and quantity of memory T cells formed (Swain et al. 
2004; Hand and Kaech 2009). Understanding the mechanisms that regulate the 
formation of efficient T cell memory is important for the development of 
effective vaccines. 
CD8+ T cells are important contributors to immunity against viral infections, 
such as influenza, by promoting viral clearance (Yap et al. 1978; McMichael 
et al. 1983; Topham et al. 1997). During a CD8+ T cell response, naïve CD8+ 
T cells proliferate and differentiate into effectors. In the case of an influenza 
infection, the peak of the CD8+ T cell expansion is reached at around day 11 
p.i after which most of the cells are fated to die, leaving only a small pool of 
long-lived antigen-specific memory CD8+ T cells. The number of memory 
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cells depends on the magnitude of expansion and contraction of the CD8+ T 
cell response. The molecules that control the differentiation of effector cells 
into memory cells during the contraction of the response and the mechanisms 
behind this conversion are not yet fully understood. 
In earlier chapters, we have shown that IFN-γ regulates the contraction of the 
antigen-specific CD8+ T cell response to an influenza infection and hence 
contributes to increased numbers of antigen specific CD8+ T cells persisting in 
the lungs and other tissues (eg. spleen) of infected mice in the absence of IFN-
γ signaling long after the infection has been resolved. We have also shown that 
the expression of IL-7R by the influenza-specific CD8+ T cells is important for 
their survival through the contraction phase and that this expression of IL-7R 
is also regulated by IFN-γ signaling. Furthermore, we wanted to assess if the 
large numbers of memory CD8+ T cells generated in the absence of IFN-γ, can 
respond to a re-infection and if they are efficient in eliminating the second 
viral infection.  
It has been shown that memory CD8+ T cells isolated from the lungs can 
participate in recall responses (Ely et al. 2003). In this chapter, we set out to 
establish a re-infection model for influenza by using two different viruses 
differing only in their surface proteins. Using this model, our main aim was to 
determine whether the increased numbers of antigen-specific CD8+ T cell 
generated in the IFN-γ-/- and IFN-γR-/- mice could respond to a re-challenge 
and if whether they offered any advantage over CD8+ T cells from WT mice. 
We hypothesized that if the increased memory generated in the absence of 
IFN-γ signaling confers an advantage over WT animals, then it would be a 
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potential avenue to pursue for establishing better immune CD8+ T cell memory 
with vaccinations. 
 
6.2 Model for secondary challenge 
 
It is generally believed that memory CD8+ T cells recognize epitopes in the 
conserved internal proteins of influenza and hence contribute to 
heterosubtypic immunity to a secondary challenge. To evaluate the role of 
IFN-γ to a recall CD8+ T cell response, we decided to use a well-established 
mouse model that has been previously used for the detection of heterosubytpic 
immunity. We used a pair of influenza strains, A/HK-X31 (X31) and 
A/PR/8/34 (PR8), that express different HA and NA subtypes. Since X31 
expresses the H3N2 subtypes of HA and NA coat proteins and PR8 expresses 
the H1N1 subtypes of HA and NA, antibodies generated to X31 do not 
neutralize PR8 and vice versa. However, the internal proteins of both viruses 
are the same and hence contain epitopes that stimulate CD8+ T cell responses 
to both viruses. These cross-reactive CD8+ T cells are thought to mediate the 
effects of heterosubtypic immunity. These two viruses provided us with a 
model to study the recall CD8+ T cell responses without any interference from 
their B-cell counterparts. 
Our study compared the recall CD8+ T cell responses in the presence and 
absence of IFN-γ signaling. Protective immunity following challenge was 
assessed by determining weight loss in infected mice, their rates of survival, 
and lung viral titers. Given the reduced CD8+ T cell contraction phase in the 
absence of IFN-γ signaling, we were mainly interested to see how this would 
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influence the recall response. Furthermore, we wanted to ascertain whether the 
increased numbers of memory CD8+ T cells in the absence of IFN-γ signaling, 
could actually respond to a re-challenge and if they could afford better 
protection in a secondary infection. 
 
6.3 Primary infection with PR8 followed by a re-challenge with X31 
 
Considering that we had used the PR8 virus for all the primary infection 
experiments, we first chose to use the same strain for primary infection for the 
re-challenge experiments. Mice that were infected with a 5PFU of PR8 virus 
were then re-infected with 1000 PFU of X31 virus. The mice were monitored 
for morbidity and mortality for 8 days p.i (Figure 6.1). We found that the mice 
did not lose any weight in response to a re-challenge with 1000 PFU of X31. 
The only slight weight loss that was observed early in the infection was 
probably a result of the innate immunity or could be an effect of the anesthetic 
drugs. But this slight weight loss was quickly followed by a steady weight 
gain until day 8 p.i. None of the mice showed any signs of sickness. 
Further, to look at the CD8+ T cell responses to this re-challenge, we measured 
the antigen specific CD8+ T cells in the lung using the NP366 pentamer (Figure 
6.2). We found that there were higher numbers of NP366+ CD8+ T cells 
responding to the re-challenge at day 8 p.i than was observed at day 8 p.i after 
a primary infection. Our data is in agreement with earlier studies that 
established T cell memory confers at best a 2-3 day advantage in the rate of 
effector T cell development and localization to the influenza virus infected 
respiratory tract (Bennink et al. 1978). 
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We also found that there were a significantly larger number of NP366+ CD8+ T 
cells in the lungs of IFN-γ-/- and IFN-γR-/- mice. This meant that the cells that 
were present in the IFN-γ-/- and IFN-γR-/- mice after the primary infection 
could respond to a re-challenge and higher numbers of influenza-specific 
CD8+ T cells that survive the contraction phase translated to enhanced CD8+ T 
cell responses to a re-infection. 
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Figure 6.1 Weight loss in response to a 1000 PFU X31 influenza re-
infection after a primary infection with 5 PFU PR8.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 PFU PR/8 and 
30 days later with a 1000 PFU of influenza A/HKx31/(H3N2). Weight loss of 
mice over a course of 12 days following infection. Data represents mean+/- 
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Figure 6.2 Antigen specific CD8+ T cell response to an X31 rechallenge 
after a PR8 primary infection 
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a sub-lethal dose 
of influenza A/ PR/8/34 (H1N1) and after 30 days, mice were infected with a 
second virus HK/X31 (H3N2) and monitored for 8 days after infection. Total 
NP366+ CD8+ T cell numbers in the lung tissue at day 8 after re-infection. The 
numbers of NP366+ CD8+ cells (mean+/-SEM) shown is calculated from the 
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 However, with this model of re-infection, we could not see any weight loss 
after re-infection even with 1000 PFU of X31. And although we could see 
enhanced numbers of antigen-specific CD8+ T cells in the IFN-γ-/- and IFN-γR-
/- mice, we could not determine if they could afforded better protection against 
a re-challenge. Hence, we decided to alter the model for re-challenge: primary 
infection with X31 followed by re-challenge with PR8, as we could increase 
the doses of PR8 much higher (5PFU to 500PFU) than we could with X31. 
But to use the new model, we first had to confirm if we saw the same 
phenotype of reduced contraction in the IFN-γ-/- and IFN-γR-/- mice after 
primary infection with X31.  
6.4 Comparing the primary CD8+ T cell response to an X31 infection 
 
The A/HK/X31 (X31) virus is a recombinant strain that expresses the surface 
Hemagglutinin (HA) and Neuraminidase (NA) proteins of A/Aichi (H3N2) 
and the internal components of PR/8 (Kilbourne 1969). Neutralizing antibody 
responses to the surface HA and NA glycoproteins of these two viruses are not 
cross-reactive, so protection and recall responses seen are restricted to CD8+ T 
cells. 
The X31 strain of virus is much less pathogenic when compared to PR/8. The 
extent of weight loss in the infected mice is also very low and about 15-20% 
which can be only achieved after using very high doses of the X31 virus (i.e. 
1000 PFU). This weight loss is comparable to what can be seen with only 5 
PFU of the PR/8 strain of virus. The kinetics of weight loss with X31 virus 
was somewhat different to PR8. Animals started losing weight earlier, which 
may reflect the higher dose of virus given. Maximum weight loss and recovery 
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were comparable. To compare the responses to X31 virus, WT C57BL/6 mice, 
IFN-γ-/- mice and IFN-γR-/- mice were infected with 1000 PFU of X31 
influenza and their responses to the infection determined. All infected mice 
survived the ensuing infection, irrespective of their ability to make or respond 
to IFN-γ. We measured weight loss in all the infected mice for a period of 14 
days after the infection (Figure 6.3). IFN-γ-/- and IFN-γR-/- mice showed 
similar weight loss to WT mice after infection. All X31 infected mice 
exhibited reduced symptoms compared with mice infected with PR/8 
including: poor grooming, ruffled fur, reduced responses to external stimuli 
after a week p.i. The highest weight loss was recorded around day 8-9 p.i, i.e. 
about 20 % of their original body weight. They also recovered from the 
infection regaining their original body weight by day 12 p.i. This indicated 
that the loss of IFN-γ or its receptor does not increase the susceptibility of the 
mice to a 1000 PFU dose of X31 influenza. Our results are in agreement with 
previous findings with our earlier studies with the PR8 strain of influenza 
virus. 
Further, we compared the antigen-specific CD8+ T cell responses to the X31 
infection (Figure 6.4) by enumerating CD3+CD8+ T cells that bound to the 
MHC I pentamer NP366 ‘ASNENMETM-H-2Kb’, an immunodominant 
epitope, similar to the approach used earlier with the PR8 strain. Since we 
were only interested in checking if the reduced contraction phase that is seen 
with the PR8 strain is also evident with the X31, we looked examined later 
time points in the infection i.e. day 28 p.i. We found an increase in the 
numbers of NP366+ CD8+ T cells in the BAL fluid and lung tissue of IFN-γ-/- 
and IFN-γR-/- mice even after X31 infection. This was even true in the spleens 
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of these mice, indicating a reduced contraction phase and hence an increased 
memory population in the absence of IFN-γ signaling. To confirm the 
findings, we even looked at a later time point i.e. day 120 p.i, at which all 
mice have returned to a state of normalcy (Figure 6.5). The WT mice had very 
low numbers of flu-specific CD8+ T cells but there were higher numbers 
present in the IFN-γ-/- and IFN-γR-/- mice. This provided the confirmation we 
needed to use X31 as the strain for primary infection and then re-challenge 
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Figure 6.3 Comparison of loss of body weight in response to a 1000 
PFU X31 influenza infection in WT, IFN-γ -/- and IFN-γR-/- mice 
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 1000 PFU of 
influenza A/HKx31/ (H3N2). Weight loss of mice over a course of 12 days 
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 Figure 6.4 Increased numbers of antigen-specific CD8+ T cells in the 
IFN-γ -/- and IFN-γR-/- mice after X31 infection on day 28 p.i.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a 1000 PFU dose 
of influenza A/HK/X-31. NP366+ CD8+ T cell numbers were examined in the 
BAL fluid (A), lung tissue (B) and spleens (C) of the mice on day 28 p.i. The 
numbers of CD8+ NP366+ cells (mean+/-SEM) shown are calculated from the 
total counts and the percentages of cells staining positive. (***p<0.001 
determined using Student’s t test). Data are representative of at least 2 
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Figure 6.5 Increased numbers of antigen-specific CD8+ T cells in the 
IFN-γ -/- and IFN-γR-/- mice after X31 infection on day 120 p.i. 
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a 1000 PFU dose 
of influenza A/HK/X-31. NP366+ CD8+ T cell numbers were examined in the 
lung tissue (A and spleens (B) of the mice on day 120 p.i. The numbers of 
CD8+ NP366+ cells (mean+/-SEM) shown are calculated from the total counts 
and the percentages of cells staining positive. (***p<0.001 determined using 
Student’s t test). Data are representative of at least 2 independent experiments 
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6.5 Model for re-challenge: Primary infection with X31 followed by 
re-challenge with PR8 
  
We decided to use X31 as the strain for the primary infection but we still 
needed to decide on the dose of PR8 to be used for the re-challenge 
experiments. Hence, we infected mice with a series of doses of PR8 virus 
(Figure 6.6). C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with 5 
PFU PR8 as a primary infection (Figure 6.6A) or as a re-infection 35 days 
after X31 infection and monitored for a period of 8 days. Naïve mice that were 
infected with 5PFU PR8 behaved similarly to primary PR8 infections shown 
in chapter 4. They lost about 15-20% of their body weight but regained it by 
day 14 p.i. Mice that received 5 PFU PR8 as a re-challenge, however did not 
lose any weight. All the re-infected mice showed no signs of sickness and 
although did not gain weight in the initial days as uninfected mice would, but 
started to gain weight after day 5 p.i.  
When a higher dose of 50 PFU was used (Figure 6.6B), naïve mice with the 
primary infection showed signs of sickness and severe weight loss and lost 
about 20-25% of their body weight and hence had to be euthanized by day 8. 
These mice would have succumbed to the infection if they had not been 
sacrificed. Mice that received 50 PFU as a re-infection after an initial infection 
of X31 showed some weight loss in the initial days of infection but recovered 
quickly by day 8 p.i. There were no severe signs of sickness observed in these 
mice and none died. But all three groups of mice infected behaved in a similar 
manner and hence showed that increasing the virus dose did not have an effect 
on the mice in the absence of IFN-γ signaling. 
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When a lethal dose of 500 PFU was used (Figure 6.6C), naïve mice that 
received this dose as a primary infection lost weight quickly and showed 
severe signs of infection: lethargy, poor grooming with ruffled fur, hunched 
backs and lack of response to external stimuli. These mice lost 20-30% of their 
original body weight and were euthanized. Mice that received this high dose 
as a reinfection lost about 7-12% of their body weight by day 4 but quickly 
regained their original weight by day 8 p.i. The mice did not show any signs of 
sickness. Although the WT mice seemed to lose slightly less weight than the 
IFN-γ-/- and IFN-γR-/- mice, these differences were not statistically significant. 
Since 500 PFU of PR8 seemed to be the dose of virus with which mice 
showed weight loss even during a re-infection, we decided to use this dose of 
virus for our re-infection model. For all experiments carried out after this, we 
used 1000 PFU of X31 as the primary infection and 500 PFU of PR8 for the 
second infection. Mice were allowed to recover and generate memory 
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Figure 6.6 Weight loss curves with Primary infection with X31 
followed by re challenge with PR8.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were either infected with a primary 
infection of 5 PFU (A), 50 PFU (B) or 500 PFU(C) of PR/8 virus or first 
infected with X31 and then re-infected with the same doses of PR8 after 35 
days. Mice infected with a primary infection are shown in open squares and 
mice with the re-infection are shown as closed squares. (#) indicates mice 
which were euthanized for loss of excessive weight. Data are pooled from at 
least 3 independent experiments with n=20 per group. 
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6.6 Influenza specific CD8+ T cell responses after re-challenge 	  
In order to confirm that the increased frequencies of IL-7Rα expressing cells 
resulting from the reduced contraction in the absence of IFN-γ signaling were 
indeed memory precursor cells, we compared recall CD8+ T cell responses in 
these mice after a secondary challenge with a heterologous strain of influenza. 
For this set of experiments, mice were infected with X31 (H3N2), and then re-
infected after 35 days with 500 PFU of PR/8. As expected for a recall 
response, we observed an earlier CD8+ T cell response and higher frequencies 
of antigen specific CD8+ T cells in the lungs of the infected mice, when 
compared to a primary infection. However, the differences between the CD8+ 
responses of WT, IFN-γ-/- and IFN-γR-/- mice were greatly enhanced after the 
secondary challenge, as the NP366+ CD8+ T cells accounted for ~30% of the 
CD8+ T cells in the WT mice but in the IFN-γ and IFN-γR deficient mice, 
these cells accounted for >50% of the CD8+ T cells (Figure 6.7A).  
There was a sharp increase in the numbers of antigen specific CD8+ T cells in 
the lungs and BAL fluid of infected mice when compared to that seen after a 
primary infection. There was also a dramatic difference in the total numbers of 
NP366+ CD8+ T cells in the BAL of IFN-γ-/- and IFN-γR-/- compared to WT 
mice (Figure 6.7B) and in the lungs as well (Figure 6.7C). The re-infection 
was done after a period of 120 days after the primary infection with similar 
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Figure 6.7 Enhanced Antigen-specific CD8+ T cell responses to a re-
infection with 500 PFU PR8.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a sub-lethal dose 
of influenza HK/X31 (H3N2) and after 30 days, mice were infected with a 
second virus A/ PR/8/34 (H1N1) and monitored for 8 days after infection. (A) 
Representative flow cytometry plots of the proportion of NP366+ CD8+ T cells 
in the BAL fluid and lung tissue of mice re-infected with 500 PFU of PR/8. 
Cells are gated on the CD3+CD8+ T cells. Numbers represent percentage of 
CD8+ T cells, which are NP366+. Total NP366+ CD8+ T cell numbers in the BAL 
fluid (B) lung tissue (C) at day 8 after re-infection. The numbers of NP366+ 
CD8+ cells (mean+/-SEM) shown are calculated from the total counts and the 
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6.7 Cytotoxic potential of CD8+ T cells responding to re-infection with 
500 PFU PR8 
 
To determine whether the enhanced numbers of CD8+ T cells generated in 
response to PR8 re-infection were functional, we wanted to assess their ability 
to kill influenza-infected cells. We decided to study their expression of 
CD107α as a surrogate marker of their cytotoxic potential. Lung tissues were 
enriched for T cells and the resulting cells were cultured in the presence of 
PMA-Ionomycin and anti-CD107α antibodies for 6h in the presence of 
Brefeldin A and Monensin. The cells were then stained for other cell surface 
markers and with the NP366 tetramer and then analyzed by flow cytometry. The 
levels of CD107α indicate the potential of the cells to degranulate and hence 
act as an indirect marker for measuring cytotoxic potential. All the NP366+ 
CD8+ T cells expressed high levels of CD107α at day 4 p.i. (Figure 6.8A) but 
the percentage of cells expressing CD107α decreased by day 8 p.i (Figure 
6.8B). This is probably because the virus is cleared by day 8, since this is a re-
infection and higher CD8+ T cell numbers are already present in the lung 
tissue to NP366+ CD8+ T cell expressing CD107α in the WT, IFN-γ-/- and IFN-
γR-/- mice. This indicated that the CD8+ T cells generated in the recall 
response were comparable in their ability to kill infected cells and maintained 
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Figure 6.8 Cytotoxic potential of flu-specific CD8+ T cells after 500 
PFU re-infection. 
 C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a sub-lethal 
dose of influenza HK/X31 (H3N2) and after 35 days, mice were infected with 
a second virus A/ PR/8/34 (H1N1) and monitored for 8 days after infection. 
The CD8+ T cells were enriched from the lung tissues and their CD107a levels 
were measured on day 4 p.i (A) and day 8 p.i (B). Data are pooled for two-
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6.8 Lung damage after re-infection with 500 PFU PR8 
 
Next we wanted to measure the extent of lung damage due to the re-infection 
with 500 PFU of PR8. In our earlier experiments with the primary infection, 
we did not see any differences in the extent of lung damage in the WT and 
IFN-γ-/- mice. We measured the albumin leakage in to the airways as an 
indirect measure of the lung damage as higher albumin leakage into the 
airways translates to increased lung damage. We collected the BAL fluid from 
the infected mice at day 4 and 8 p.i. and the supernatant was used to measure 
the albumin using an ELISA protocol (Figure 6.9). 
We found that there were similar levels of albumin leakage in to the BAL fluid 
on both days 4 (Figure 6.8A) and day 8 p.i. (Figure 6.9B)  The extent of 
albumin leakage was similar in the WT, IFN-γ-/- and IFN-γR-/- mice, both on 
days 4 and 8 p.i. This indicated that in spite of having higher numbers of flu-
specific CD8+ T cells in the lungs of the IFN-γ-/- and IFN-γR-/- mice, this did 
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Figure 6.9 Albumin leakage in the lungs as a measure of lung damage 
after re-infection with 500 PFU of PR8.  
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a sub-lethal dose 
of influenza HK/X31 (H3N2) and after 35 days, mice were infected with a 
second virus A/ PR/8/34 (H1N1) and monitored for 8 days after infection. The 
BAL fluid was collected from the mice and albumin was measured by an 
ELISA based assay. Albumin leakage into the airway (BAL fluid) on day 4 p.i 
(A) and day 8 p.i (B). Data are pooled for two- three independent experiments 
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6.9 CD4+ T cell response after re-infection with 500 PFU PR8 
 
Influenza-specific CD8+ T cell responses were enhanced in the absence of 
IFN-γ signaling. Hence, we could ascertain that the increased NP366+ CD8+ T 
cells generated in the IFN-γ-/- and IFN-γR-/- mice could respond to a recall 
response and hence confirmed that increased memory precursors were 
generated in the absence of IFN-γ signaling. CD4+ T cells are known to play a 
role in the memory responses to influenza infection (Belz et al. 2002). Since 
the primary CD4+ T cell responses were not different in the absence of IFN-γ 
signaling, we studied the CD4+ T cell responses after a re-challenge with 500 
PFU PR8 infection. 
We studied the CD4+ T cell response to get a general idea if IFN-γ is involved 
in regulating the CD4+ T cell responses. Since, tetramers are not yet available 
to study the antigen specific CD4+ T cells; we chose to look at total CD4+ T 
cell numbers during influenza infection instead. The total CD4+ T cell 
numbers in the lung tissue were measured at days 4 (Figure 6.10A) and 8 p.i. 
(Figure 6.10B). The numbers of CD4+ T cells increased from day 4 to day 8 in 
all the mice. However, no differences were observed between the WT, IFN-γ-/- 
and IFN-γR-/- mice. Although we did not study the properties of the CD4+ T 
cells in greater detail, we could confirm that IFN-γ did not play a role in 
regulating the CD4+ T cell responses to influenza and this did not influence the 
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Figure 6.10 Total CD4+ T cell response after 500 PFU PR8 re-infection 
C57BL/6 WT, IFN-γ-/- and IFN-γR-/- mice were infected with a sub-lethal dose 
of influenza HK/X31 (H3N2) and after 35 days, mice were infected with a 
second virus A/ PR/8/34 (H1N1) and monitored for 8 days after infection. 
Total lung cells were harvested and cells were stained for CD3 and CD4. Total 
CD4+ T cells were calculated by the total number of cells and frequency of 
cells staining positive on day 4 (A) and day 8 p.i. (B). Data are pooled for two- 
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6.10 Viral clearance after re-infection with 500 PFU of PR8 
 
Finally, we examined the kinetics of lung viral RNA by qRT-PCR (Figure 
6.11). We observed high viral titers in the lungs of mice with a primary 
infection of 500PFU PR/8 whereas all the re-infected mice showed much 
lower titers. The high titer of virus was maintained until day 8 after the 
primary infection. However, as with the primary infection with a low dose of 5 
PFU PR/8, there was no difference in viral loads in the WT, IFN-γ-/- and IFN-
γR-/- mice after a primary infection with a high dose of 500 PFU.  
In the re-infected mice however, we saw that the levels of viral RNA peaked 
at day 2 but from then on decreased steadily and were much lower by day 8 
p.i. We also observed that levels of viral RNA in the lungs of the IFN-γ-/- and 
IFN-γR-/- were significantly reduced compared to WT mice on day 8 after re-
infection. This demonstrates that persisting antigen-specific CD8+ T cells in 
IFN-γ-/- and IFN-γR-/- mice after resolution of the primary infection indeed 
lead to higher frequencies of memory precursors and hence produced better 
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Figure 6.11 Viral clearance after primary infection or re-infection with 
500 PFU PR8 
Graph showing relative RNA levels of viral M-protein in the lungs of infected 
mice after primary infection and re-infection with 500 PFU PR/8. (*p<0.05 
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6.11 Discussion 
 
Heterosubtypic immunity is defined as cross-protection against a virus of a 
different subtype to a virus previously encountered. This is mediated by 
antigen-specific CD8+ T cells which are generally targeted against the internal 
proteins of the influenza virus, such as the nucleoprotein (NP). We were 
interested to determine if the increased memory precursor cells generated in 
the absence of IFN-γ signaling could provide heterosubtypic immunity and if 
the higher numbers of memory CD8+ T cells would translate to better 
protection from a re-challenge. 
We have shown in the earlier chapters that IFN-γ directly regulates effector 
CD8+ T-cell survival by controlling the proportion of antigen specific CD8+ T 
cells that expressed IL-7Rα, which was functionally important for survival of 
effector cells during the contraction phase of the response. In the current 
chapter, we show that in a recall response to a secondary challenge with a 
heterologous strain of influenza, higher numbers of influenza specific CD8+ T 
cells were found in the IFN-γ-/- and IFN-γR-/- compared with WT mice, 
confirming that higher frequencies of memory precursors are indeed formed in 
the absence of IFN-γ signaling which subsequently conferred the ability to 
clear virus faster than WT mice.  
Our findings with IFN-γ-/- mice infected with a primary infection of both PR/8 
or HK-x31 strains of influenza differ from the previously published data using 
IFN-γ-/- mice (Turner et al. 2007), wherein a defect in migration of the antigen 
specific CD8+ T cells to the lung and concomitant accumulation in the spleen 
was reported. However, our results are consistent with their observations in 
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terms of lung viral load and resolution of infection (no difference seen in the 
absence of IFN-γ signaling), an aspect controlled by the CD8+ T cell response 
in the lung. Furthermore, it is important to note that evaluation of the BAL 
does not provide a comprehensive evaluation of the CD8+ T cell response in 
the lung and could explain differences observed between the studies. 
Furthermore the emergence of Norovirus as a pathogen in mice around the 
world may have changed the background status of the animals. 
Our studies using the re-infection model are in agreement with previous 
studies (Bot et al. 1998), which show that IFN-γ is not required for the 
induction of secondary influenza-specific CD8+ T cell responses and the 
absence of IFN-γ signaling does not affect the cross-reactive virus-specific 
immune responses. Although our study is in accordance with most of the 
findings of the second study (Bot et al. 1998) that IFN-γ does not influence the 
cytotoxicity of CD8+ T cells, numbers of CD4+ T cells and viral titers, this 
study showed that the IFN-γ-/- mice displayed reduced survival rates 
subsequent to a re-challenge. This may have to do with the fact that in that 
study the primary virus was delivered intraperitoneally, which may not have 
had the same effect on the memory CD8+ T cell generation in the absence of 
IFN-γ. Our findings further add to the previous studies by utilizing varying 
doses of the re-challenge virus, that IFN-γ limits the numbers of memory 
CD8+ T cells formed against the influenza virus. The higher numbers of 
antigen-specific memory CD8+ T cells formed in the absence of IFN-γ 
signaling could lead to slightly faster clearance of the second virus.  
Our results suggest that modulation of IFN-γ levels to increase IL-7Rα 
expression on effector CD8+ T cells represents a potential strategy to increase 
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the numbers of CD8+ T cell memory precursors, thus permitting the 
development of an effective memory response to influenza. Our studies 
provide strong evidence supporting a T cell intrinsic role for IFN-γ in limiting 
the magnitude of the memory CD8+ T cell pool against influenza. These 
findings advance our understanding of CD8+ T cell homeostasis and have 
implications for the development of more effective vaccines against influenza. 
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Chapter 7: Final discussion and future direction 
7.1 Brief Summary of Main Findings 
 
In this thesis, we show that IFN-γ-IFN-γR signaling plays a key role in the 
modulation of antigen-specific CD8+ T cell contraction and memory 
development in response to influenza infection. We have shown that in the 
absence of IFN-γ signaling, the contraction phase of the CD8+ T cell response 
is aberrant, resulting in the accumulation of antigen-specific CD8+ T cells that 
is evident as long as 120 days p.i. when the response in WT mice has declined 
significantly. We could confirm that this was not due to persisting viral loads 
or extended antigen presentation in the absence of IFN-γ signaling. IFN-γ 
directly regulates effector CD8+ T-cell survival as we could induce cell death 
in IFN-γ-/- effector cells by culturing them in the presence of IFN-γ. We also 
identified some of the molecules that are likely to be responsible for IFN-γ 
induced CD8+ T cell death with a PCR-array. In addition, a larger proportion 
of antigen specific CD8+ T cells in IFN-γ-/- and IFN-γR-/- mice expressed IL-
7Rα, which was functionally important for survival of effector cells during the 
contraction phase of the response. We showed that blocking IL-7 signals in the 
lungs of the IFN-γ-/- mice lead to a reduction in the numbers of antigen 
specific CD8+ T cells surviving the contraction phase. This was true even in 
the WT mice, which indicates that IL-7 signals in the lung are indeed 
important for the survival of influenza-specific CD8+ T cells after the 
contraction phase. Our studies also show that IFN-γ controls the survival 
signals received through IL-7 by regulating the expression of IL-7Rα on the 
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CD8+ T cells. Furthermore, in a recall response to a secondary challenge with 
a heterologous strain of influenza, higher numbers of influenza specific CD8+ 
T cells were found in the IFN-γ-/- and IFN-γR-/- compared with WT mice, 
confirming that higher frequencies of memory precursors are indeed formed in 
the absence of IFN-γ signaling, which can respond to a re-challenge with 
influenza. Finally, we show that the increased numbers of influenza-specific 
CD8+ T cells in the IFN-γ-/- and IFN-γR-/- mice confer a greater ability to clear 
virus than WT mice. Collectively, our findings indicate that IFN-γ plays a 
critical role in regulating antiviral CD8+ T cell responses and memory and 
hence represents a potential target for improving vaccines aiming to engender 
protective CD8+ T cell responses. 
7.2 Limitations of the study 
 
Exact mechanism of IFN-γ  induced cell death 
Although in this study we show that IFN-γ induces cell death in influenza 
specific CD8+ T cells during the contraction phase of the response to infection, 
we have not identified the exact mechanisms by which this occurs. We used 
the cell death identifier PCR array to narrow down the molecules whose 
expression may be controlled by IFN-γ. The IFN-γ-/- NP366+ CD8+ T cells had 
up-regulated expression of anti-apoptotic molecules Birc3 and Bcl-2 but had 
down regulated several genes involved in apoptosis (Akt1 and Casp3), 
necrosis (Mcl-1, Pvr and Tnfrsf1a) and autophagy (Atg16l1, App, Esr1, Gaa 
and Irgm1). It is possible that IFN-γ acts on several molecules to activate 
pathways leading to cell death. Due to redundancy of the molecules involved 
it is difficult to identify the exact pathway involved using such an array. 
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Further studies will be required to confirm and assess the exact roles played by 
these molecules in the cell death induced by IFN-γ. 
 
Physiological significance of the findings 
One of the main limitations of this study is the physiological relevance of this 
finding with respect to human influenza infections. As our model is in mice, it 
remains to be seen if this is true of humans and if IFN-γ plays a similar role in 
the contraction of CD8+ T cell responses in individuals after influenza 
infection. Although there are some IFN-γ deficient humans and indeed there 
are many who have lesser IFN-γ signaling (Jouanguy et al. 2000; Bogunovic et 
al. 2012), either due to a pre-existing Th2 phenotype or polymorphisms in the 
ifn-γ gene (Chong et al. 2006). 
Another limitation is the fact that we look at naïve mice and since there are no 
“naïve” human beings per sse, it is difficult to evaluate the responses in the 
absence of other micro flora. Also, the presence of other infections, whether 
bacterial or viral will definitely affect the responses of CD8+ T cells. Further, 
the presence of a pre-existing Th2 phenotype due to asthma or the 
aforementioned conditions could have an effect on the immune response 
influenza infections. In our studies, we noticed an increased eosinophilia in the 
IFN-γ-signaling deficient mice (chapter 4). Although this did not translate to 
increased lung damage in the mice in our system, the presence of eosinophilia 
in humans could lead to increased exacerbation of the infection due to 
increased allergic airway inflammation after an influenza infection. 
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7.3 Future direction 
7.3.1 Understanding the mechanism behind IFN-γ-induced cell death 
 
Although our study has identified that IFN-γ induces cell death in the activated 
effector CD8+ T cells after an influenza infection, we are yet to find the exact 
pathway/mechanism by which this is brought about. Some of the molecules 
likely to be responsible were identified using a PCR array but further studies 
will be needed to confirm their roles in the IFN-γ-induced cell death. It will be 
interesting to study the downstream effectors of IFN-γ, which participate in 
inducing CD8+ T cell death during the contraction of the immune response 
after an influenza infection. 
7.3.2 Finding how IFN-γ  affects the expression of IL-7R 
 
In our study we observed that in the absence of IFN-γ signaling, higher 
frequencies of influenza-specific CD8+ T cells express IL-7Ra, as a result of 
which these cells receive signals that lead to increased survival to form 
memory T cells. But we haven’t identified how IFN-γ down-regulates IL-7Ra 
expression. It also remains to be determined if early IFN-γ signals in T cells 
directly regulate which effector cells will or will not up regulate IL-7Ra. Thus, 
determining how antigen-specific CD8+ T cells directly respond to IFN-γ 
signals during infection may provide important clues as to how the immune 
system regulates the survival of only a small proportion of effector CD8+ T 
cells for memory cell generation. T-bet is a transcription factor that was found 
to regulate the levels of IL-7Ra and T-bet deficiency leads to increased levels 
of IL-7Ra expressing CD8+ T cells at the peak of the response (Intlekofer et al. 
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2007). Inhibition of T-bet expression due to IFN-γ deficiency could lead to 
increased levels of IL-7Ra on the virus-specific CD8+ T cells. But we did not 
see any differences in the levels of T-bet in the absence of IFN-γ. However, 
we did observe differences in the levels of its paralog eomesodermin. It 
remains to be determined if eomes or some other transcription factor affects 
the expression of IL-7Ra. 
 
 
7.3.3 Identifying the cells that make IL-7 in the lung tissue 	  
IL-7 is known to be a hematopoietic growth factor that is important for the 
growth and survival of B and T cells. Stromal cells in the bone marrow and 
thymus secrete IL-7. It is also produced by keratinocytes (Heufler et al. 1993), 
dendritic cells (Kroncke et al. 1996), hepatocytes (Sawa et al. 2009) and 
epithelial cells (Watanabe, M. et al. 1995) but not by T lymphocytes. In our 
study, we showed that IL-7 provided crucial survival signals that permit 
antigen specific CD8+ T cells to survive to form memory cells in the lung after 
influenza infection. Blocking IL-7 in the lung lead to decreased survival of 
influenza-specific memory CD8+ T cells. However, the cells that make the 
cytokine in the lung tissue still need to be identified. It remains to be 
determined whether non-lymphoid cells or the lymphoid cells make IL-7 in 
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7.3.4 Looking at effect of other infections after a primary infection of 
influenza 
 
In our study we examined the role of IFN-γ in a primary and then a re-
infection model, both with influenza infection. Although this helped to 
delineate and simplify the study, the roles of other infections still need to be 
studied. It will be interesting to see how the absence of IFN-γ affects a 
secondary infection with another virus or bacteria, after a primary infection 
with influenza. It has been shown in one study (Sun, K. and Metzger 2008) 
that IFN-γ produced during influenza infection in mice inhibits initial bacterial 
clearance from the lung by alveolar macrophages during a secondary bacterial 
infection. The effect of having increased influenza-specific memory CD8+ T 
cell responses on other subsequent infections will need to be studied. 
 
7.3.5 Understanding whether IFN-γ  signaling can be blocked to increase 
memory cell populations 
 
Current vaccination strategies have failed to elicit a strong and lasting CD8+ T 
cell response against influenza that provides heterosubtypic immunity. One 
study has shown that limiting the inflammation phase during the infection can 
reduce the contraction phase thereby increasing the number of memory 
precursors, also keeping the tissue damage in check (Badovinac et al. 2004). 
Another study has shown that neutralization of IFN-γ in the lungs of mice 
during an influenza infection leads to decreased susceptibility to a secondary 
pneumococcal infection (Sun, K. and Metzger 2008).  Our studies provide 
strong evidence supporting a T cell intrinsic role for IFN-γ in limiting the 
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magnitude of the memory CD8+ T cell pool against influenza. If the levels of 
IFN-γ can be controlled during a primary influenza infection by IFN-γ 
neutralization, this would lead to increased memory influenza-specific CD8+ T 
cells, which may initiate better protection against subsequent infections with 
both similar and dissimilar stains of influenza. However, these studies have to 
be carried out and interpreted with caution as the negative effects of blocking 
such an important molecule during viral infection may have other negative 
implications, which have to be weighed against the benefits. It will also be 
interesting to observe the effect of IFN-γ neutralization during vaccinations for 
influenza and the effects it has on the memory CD8+ T cell response 
generated. These findings will advance our understanding of CD8+ T cell 
homeostasis and will have implications on the development of more effective 
vaccines against influenza. 
References 
	   218 
References 
 
(2000). "Update: influenza activity--United States and worldwide, 1999-2000 
season, and composition of the 2000-01 influenza vaccine." MMWR 
Morb Mortal Wkly Rep 49(17): 375-381. 
Acosta-Rodriguez, E. V., et al. (2007). "Interleukins 1beta and 6 but not 
transforming growth factor-beta are essential for the differentiation of 
interleukin 17-producing human T helper cells." Nat Immunol 8(9): 
942-949. 
Ada, G. L. and P. D. Jones (1986). "The immune response to influenza 
infection." Curr Top Microbiol Immunol 128: 1-54. 
Adachi, M., et al. (1997). "Expression of cytokines on human bronchial 
epithelial cells induced by influenza virus A." Int Arch Allergy 
Immunol 113(1-3): 307-311. 
Ahmed, R. and D. Gray (1996). "Immunological memory and protective 
immunity: understanding their relation." Science 272(5258): 54-60. 
Akashi, K., et al. (1997). "Bcl-2 rescues T lymphopoiesis in interleukin-7 
receptor-deficient mice." Cell 89(7): 1033-1041. 
Andrews, D. M., et al. (2008). "The early kinetics of cytomegalovirus-specific 
CD8+ T-cell responses are not affected by antigen load or the absence 
of perforin or gamma interferon." J Virol 82(10): 4931-4937. 
Arnon, T. I., et al. (2001). "Recognition of viral hemagglutinins by NKp44 but 
not by NKp30." Eur J Immunol 31(9): 2680-2689. 
Bachmann, M. F., et al. (2005). "Functional properties and lineage relationship 
of CD8+ T cell subsets identified by expression of IL-7 receptor alpha 
and CD62L." J Immunol 175(7): 4686-4696. 
References 
	   219 
Badovinac, V. P., et al. (2002). "Programmed contraction of CD8(+) T cells 
after infection." Nat Immunol 3(7): 619-626. 
Badovinac, V. P., et al. (2004). "CD8+ T cell contraction is controlled by early 
inflammation." Nat Immunol 5(8): 809-817. 
Badovinac, V. P., et al. (2000). "Regulation of antigen-specific CD8+ T cell 
homeostasis by perforin and interferon-gamma." Science 290(5495): 
1354-1358. 
Bannard, O., et al. (2009). "Secondary replicative function of CD8+ T cells 
that had developed an effector phenotype." Science 323(5913): 505-
509. 
Bateman, E. D., et al. (2008). "Global strategy for asthma management and 
prevention: GINA executive summary." Eur Respir J 31(1): 143-178. 
Baumgarth, N. and A. Kelso (1996). "In vivo blockade of gamma interferon 
affects the influenza virus-induced humoral and the local cellular 
immune response in lung tissue." J Virol 70(7): 4411-4418. 
Becker, T. C., et al. (2002). "Interleukin 15 is required for proliferative 
renewal of virus-specific memory CD8 T cells." J Exp Med 195(12): 
1541-1548. 
Belz, G. T., et al. (1998). "Characteristics of virus-specific CD8(+) T cells in 
the liver during the control and resolution phases of influenza 
pneumonia." Proc Natl Acad Sci U S A 95(23): 13812-13817. 
Belz, G. T., et al. (2004). "Distinct migrating and nonmigrating dendritic cell 
populations are involved in MHC class I-restricted antigen presentation 
after lung infection with virus." Proc Natl Acad Sci U S A 101(23): 
8670-8675. 
Belz, G. T., et al. (2002). "Compromised influenza virus-specific CD8(+)-T-
cell memory in CD4(+)-T-cell-deficient mice." J Virol 76(23): 12388-
12393. 
References 
	   220 
Ben-Sasson, S. Z., et al. (2009). "IL-1 acts directly on CD4 T cells to enhance 
their antigen-driven expansion and differentiation." Proc Natl Acad Sci 
U S A 106(17): 7119-7124. 
Bender, B. S., et al. (1992). "Transgenic mice lacking class I major 
histocompatibility complex-restricted T cells have delayed viral 
clearance and increased mortality after influenza virus challenge." J 
Exp Med 175(4): 1143-1145. 
Bender, B. S. and P. A. Small, Jr. (1992). "Influenza: pathogenesis and host 
defense." Semin Respir Infect 7(1): 38-45. 
Bennink, J., et al. (1978). "Influenzal pneumonia: early appearance of cross-
reactive T cells in lungs of mice primed with heterologous type A 
viruses." Immunology 35(3): 503-509. 
Beyer, M., et al. (2004). "Sustained increases in numbers of pulmonary 
dendritic cells after respiratory syncytial virus infection." J Allergy 
Clin Immunol 113(1): 127-133. 
Bogunovic, D., et al. (2012). "Mycobacterial disease and impaired IFN-
gamma immunity in humans with inherited ISG15 deficiency." Science 
337(6102): 1684-1688. 
Bos, R., et al. (2012). "Functional differences between low- and high-affinity 
CD8(+) T cells in the tumor environment." Oncoimmunology 1(8): 
1239-1247. 
Bot, A., et al. (1998). "Protective role of gamma interferon during the recall 
response to influenza virus." J Virol 72(8): 6637-6645. 
Brincks, E. L., et al. (2008). "CD8 T cells utilize TRAIL to control influenza 
virus infection." J Immunol 181(7): 4918-4925. 
Bruder, D., et al. (2006). "Cellular immunity and lung injury in respiratory 
virus infection." Viral Immunol 19(2): 147-155. 
References 
	   221 
Bullough, P. A., et al. (1994). "Structure of influenza haemagglutinin at the pH 
of membrane fusion." Nature 371(6492): 37-43. 
Cerwenka, A., et al. (1999). "Naive, effector, and memory CD8 T cells in 
protection against pulmonary influenza virus infection: homing 
properties rather than initial frequencies are crucial." J Immunol 
163(10): 5535-5543. 
Chan, M. C., et al. (2005). "Proinflammatory cytokine responses induced by 
influenza A (H5N1) viruses in primary human alveolar and bronchial 
epithelial cells." Respir Res 6: 135. 
Chong, W. P., et al. (2006). "The interferon gamma gene polymorphism +874 
A/T is associated with severe acute respiratory syndrome." BMC Infect 
Dis 6: 82. 
Chowell, G., et al. (2009). "Severe respiratory disease concurrent with the 
circulation of H1N1 influenza." N Engl J Med 361(7): 674-679. 
Christensen, J. E., et al. (2004). "Perforin and IFN-gamma do not significantly 
regulate the virus-specific CD8+ T cell response in the absence of 
antiviral effector activity." Eur J Immunol 34(5): 1389-1394. 
Chu, C. Q., et al. (2000). "Failure to suppress the expansion of the activated 
CD4 T cell population in interferon gamma-deficient mice leads to 
exacerbation of experimental autoimmune encephalomyelitis." J Exp 
Med 192(1): 123-128. 
Cooper, A. M., et al. (1993). "Disseminated tuberculosis in interferon gamma 
gene-disrupted mice." J Exp Med 178(6): 2243-2247. 
Crowe, S. R., et al. (2006). "Uneven distribution of MHC class II epitopes 
within the influenza virus." Vaccine 24(4): 457-467. 
Cruz, A., et al. (2006). "Cutting edge: IFN-gamma regulates the induction and 
expansion of IL-17-producing CD4 T cells during mycobacterial 
infection." J Immunol 177(3): 1416-1420. 
References 
	   222 
Dalton, D. K., et al. (2000). "Interferon gamma eliminates responding CD4 T 
cells during mycobacterial infection by inducing apoptosis of activated 
CD4 T cells." J Exp Med 192(1): 117-122. 
Dalton, D. K., et al. (1993). "Multiple defects of immune cell function in mice 
with disrupted interferon-gamma genes." Science 259(5102): 1739-
1742. 
Davies, E. G., et al. (1982). "Defective immune interferon production and 
natural killer activity associated with poor neutrophil mobility and 
delayed umbilical cord separation." Clin Exp Immunol 50(2): 454-460. 
Decker, T. and P. Kovarik (2000). "Serine phosphorylation of STATs." 
Oncogene 19(21): 2628-2637. 
Derynck, R., et al. (1982). "Human interferon gamma is encoded by a single 
class of mRNA." Nucleic Acids Res 10(12): 3605-3615. 
Diebold, S. S., et al. (2004). "Innate antiviral responses by means of TLR7-
mediated recognition of single-stranded RNA." Science 303(5663): 
1529-1531. 
Doffinger, R., et al. (2004). "Autoantibodies to interferon-gamma in a patient 
with selective susceptibility to mycobacterial infection and organ-
specific autoimmunity." Clin Infect Dis 38(1): e10-14. 
Doherty, P. C., et al. (2006). "Influenza and the challenge for immunology." 
Nat Immunol 7(5): 449-455. 
Dolfi, D. V., et al. (2008). "Late signals from CD27 prevent Fas-dependent 
apoptosis of primary CD8+ T cells." J Immunol 180(5): 2912-2921. 
Dupuis, S., et al. (2001). "Impairment of mycobacterial but not viral immunity 
by a germline human STAT1 mutation." Science 293(5528): 300-303. 
References 
	   223 
Durbin, J. E., et al. (1996). "Targeted disruption of the mouse Stat1 gene 
results in compromised innate immunity to viral disease." Cell 84(3): 
443-450. 
Ealick, S. E., et al. (1991). "Three-dimensional structure of recombinant 
human interferon-gamma." Science 252(5006): 698-702. 
Ege, M. J., et al. (2011). "Exposure to environmental microorganisms and 
childhood asthma." N Engl J Med 364(8): 701-709. 
Ekiert, D. C., et al. (2009). "Antibody recognition of a highly conserved 
influenza virus epitope." Science 324(5924): 246-251. 
Ely, K. H., et al. (2003). "Cutting edge: effector memory CD8+ T cells in the 
lung airways retain the potential to mediate recall responses." J 
Immunol 171(7): 3338-3342. 
Farrar, M. A. and R. D. Schreiber (1993). "The molecular cell biology of 
interferon-gamma and its receptor." Annu Rev Immunol 11: 571-611. 
Feng, C. G., et al. (2008). "The immunity-related GTPase Irgm1 promotes the 
expansion of activated CD4+ T cell populations by preventing 
interferon-gamma-induced cell death." Nat Immunol 9(11): 1279-1287. 
Fesq, H., et al. (1994). "Programmed cell death (apoptosis) in human 
monocytes infected by influenza A virus." Immunobiology 190(1-2): 
175-182. 
Flynn, K. J., et al. (1998). "Virus-specific CD8+ T cells in primary and 
secondary influenza pneumonia." Immunity 8(6): 683-691. 
Flynn, K. J., et al. (1999). "In vivo proliferation of naive and memory 
influenza-specific CD8(+) T cells." Proc Natl Acad Sci U S A 96(15): 
8597-8602. 
Fountoulakis, M., et al. (1992). "Stoichiometry of interaction between 
interferon gamma and its receptor." Eur J Biochem 208(3): 781-787. 
References 
	   224 
Freeman, G. J., et al. (2000). "Engagement of the PD-1 immunoinhibitory 
receptor by a novel B7 family member leads to negative regulation of 
lymphocyte activation." J Exp Med 192(7): 1027-1034. 
Gajewski, T. F. and F. W. Fitch (1988). "Anti-proliferative effect of IFN-
gamma in immune regulation. I. IFN-gamma inhibits the proliferation 
of Th2 but not Th1 murine helper T lymphocyte clones." J Immunol 
140(12): 4245-4252. 
Garcia-Zepeda, E. A., et al. (1996). "Human eotaxin is a specific 
chemoattractant for eosinophil cells and provides a new mechanism to 
explain tissue eosinophilia." Nat Med 2(4): 449-456. 
Garten, R. J., et al. (2009). "Antigenic and genetic characteristics of swine-
origin 2009 A(H1N1) influenza viruses circulating in humans." 
Science 325(5937): 197-201. 
Gerhard, W. (2001). "The role of the antibody response in influenza virus 
infection." Curr Top Microbiol Immunol 260: 171-190. 
Gern, J. E. and W. W. Busse (2002). "Relationship of viral infections to 
wheezing illnesses and asthma." Nat Rev Immunol 2(2): 132-138. 
GeurtsvanKessel, C. H., et al. (2008). "Clearance of influenza virus from the 
lung depends on migratory langerin+CD11b- but not plasmacytoid 
dendritic cells." J Exp Med 205(7): 1621-1634. 
Goldrath, A. W., et al. (2002). "Cytokine requirements for acute and Basal 
homeostatic proliferation of naive and memory CD8+ T cells." J Exp 
Med 195(12): 1515-1522. 
Gomez-Puertas, P., et al. (2000). "Influenza virus matrix protein is the major 
driving force in virus budding." J Virol 74(24): 11538-11547. 
Gorak-Stolinska, P., et al. (2002). "Activation-induced cell death in human T 
cells is a suicidal process regulated by cell density but superantigen 
induces T cell fratricide." Cell Immunol 219(2): 98-107. 
References 
	   225 
Gorak-Stolinska, P., et al. (2001). "Activation-induced cell death of human T-
cell subsets is mediated by Fas and granzyme B but is independent of 
TNF-alpha." J Leukoc Biol 70(5): 756-766. 
Gourley, T. S., et al. (2004). "Generation and maintenance of immunological 
memory." Semin Immunol 16(5): 323-333. 
Graham, M. B. and T. J. Braciale (1997). "Resistance to and recovery from 
lethal influenza virus infection in B lymphocyte-deficient mice." J Exp 
Med 186(12): 2063-2068. 
Graham, M. B., et al. (1994). "Influenza virus-specific CD4+ T helper type 2 
T lymphocytes do not promote recovery from experimental virus 
infection." J Exp Med 180(4): 1273-1282. 
Graham, M. B., et al. (1993). "Response to influenza infection in mice with a 
targeted disruption in the interferon gamma gene." J Exp Med 178(5): 
1725-1732. 
Hamada, H., et al. (2009). "Tc17, a unique subset of CD8 T cells that can 
protect against lethal influenza challenge." J Immunol 182(6): 3469-
3481. 
Hand, T. W. and S. M. Kaech (2009). "Intrinsic and extrinsic control of 
effector T cell survival and memory T cell development." Immunol 
Res 45(1): 46-61. 
Haring, J. S., et al. (2005). "Dynamic regulation of IFN-gamma signaling in 
antigen-specific CD8+ T cells responding to infection." J Immunol 
174(11): 6791-6802. 
Haring, J. S. and J. T. Harty (2006). "Aberrant contraction of antigen-specific 
CD4 T cells after infection in the absence of gamma interferon or its 
receptor." Infect Immun 74(11): 6252-6263. 
Harty, J. T. and V. P. Badovinac (2008). "Shaping and reshaping CD8+ T-cell 
memory." Nat Rev Immunol 8(2): 107-119. 
References 
	   226 
Hassantoufighi, A., et al. (2007). "Respiratory syncytial virus replication is 
prolonged by a concomitant allergic response." Clin Exp Immunol 
148(2): 218-229. 
Hayden, F. G. (1997). "Antivirals for pandemic influenza." J Infect Dis 176 
Suppl 1: S56-61. 
Hayden, F. G., et al. (1999). "Use of the selective oral neuraminidase inhibitor 
oseltamivir to prevent influenza." N Engl J Med 341(18): 1336-1343. 
Herold, S., et al. (2006). "Alveolar epithelial cells direct monocyte 
transepithelial migration upon influenza virus infection: impact of 
chemokines and adhesion molecules." J Immunol 177(3): 1817-1824. 
Heufler, C., et al. (1993). "Interleukin 7 is produced by murine and human 
keratinocytes." J Exp Med 178(3): 1109-1114. 
Ho, A. W., et al. (2011). "Lung CD103+ dendritic cells efficiently transport 
influenza virus to the lymph node and load viral antigen onto MHC 
class I for presentation to CD8 T cells." J Immunol 187(11): 6011-
6021. 
Hofmann, P., et al. (1997). "Susceptibility of mononuclear phagocytes to 
influenza A virus infection and possible role in the antiviral response." 
J Leukoc Biol 61(4): 408-414. 
Holzinger, D., et al. (2007). "Induction of MxA gene expression by influenza 
A virus requires type I or type III interferon signaling." J Virol 81(14): 
7776-7785. 
Horimoto, T. and Y. Kawaoka (2005). "Influenza: lessons from past 
pandemics, warnings from current incidents." Nat Rev Microbiol 3(8): 
591-600. 
Hou, S., et al. (1994). "Virus-specific CD8+ T-cell memory determined by 
clonal burst size." Nature 369(6482): 652-654. 
References 
	   227 
Huang, S., et al. (1993). "Immune response in mice that lack the interferon-
gamma receptor." Science 259(5102): 1742-1745. 
Hufford, M. M., et al. (2011). "Antiviral CD8+ T cell effector activities in situ 
are regulated by target cell type." J Exp Med 208(1): 167-180. 
Hussell, T., et al. (2001). "Inhibition of tumor necrosis factor reduces the 
severity of virus-specific lung immunopathology." Eur J Immunol 
31(9): 2566-2573. 
Igarashi, K., et al. (1994). "Interferon-gamma induces tyrosine 
phosphorylation of interferon-gamma receptor and regulated 
association of protein tyrosine kinases, Jak1 and Jak2, with its 
receptor." J Biol Chem 269(20): 14333-14336. 
Intlekofer, A. M., et al. (2007). "Requirement for T-bet in the aberrant 
differentiation of unhelped memory CD8+ T cells." J Exp Med 204(9): 
2015-2021. 
Jayasekera, J. P., et al. (2007). "Natural antibody and complement mediate 
neutralization of influenza virus in the absence of prior immunity." J 
Virol 81(7): 3487-3494. 
Jayasekera, J. P., et al. (2006). "Enhanced antiviral antibody secretion and 
attenuated immunopathology during influenza virus infection in nitric 
oxide synthase-2-deficient mice." J Gen Virol 87(Pt 11): 3361-3371. 
Joshi, N. S., et al. (2007). "Inflammation directs memory precursor and short-
lived effector CD8(+) T cell fates via the graded expression of T-bet 
transcription factor." Immunity 27(2): 281-295. 
Jouanguy, E., et al. (1996). "Interferon-gamma-receptor deficiency in an infant 
with fatal bacille Calmette-Guerin infection." N Engl J Med 335(26): 
1956-1961. 
References 
	   228 
Jouanguy, E., et al. (2000). "In a novel form of IFN-gamma receptor 1 
deficiency, cell surface receptors fail to bind IFN-gamma." J Clin 
Invest 105(10): 1429-1436. 
Jouanguy, E., et al. (1997). "Partial interferon-gamma receptor 1 deficiency in 
a child with tuberculoid bacillus Calmette-Guerin infection and a 
sibling with clinical tuberculosis." J Clin Invest 100(11): 2658-2664. 
Julkunen, I., et al. (2000). "Inflammatory responses in influenza A virus 
infection." Vaccine 19 Suppl 1: S32-37. 
Julkunen, I., et al. (2001). "Molecular pathogenesis of influenza A virus 
infection and virus-induced regulation of cytokine gene expression." 
Cytokine Growth Factor Rev 12(2-3): 171-180. 
Kaech, S. M., et al. (2003). "Selective expression of the interleukin 7 receptor 
identifies effector CD8 T cells that give rise to long-lived memory 
cells." Nat Immunol 4(12): 1191-1198. 
Kaech, S. M. and E. J. Wherry (2007). "Heterogeneity and cell-fate decisions 
in effector and memory CD8+ T cell differentiation during viral 
infection." Immunity 27(3): 393-405. 
Kaech, S. M., et al. (2002). "Effector and memory T-cell differentiation: 
implications for vaccine development." Nat Rev Immunol 2(4): 251-
262. 
Kalia, V., et al. (2010). "Prolonged interleukin-2Ralpha expression on virus-
specific CD8+ T cells favors terminal-effector differentiation in vivo." 
Immunity 32(1): 91-103. 
Kelchtermans, H., et al. (2005). "Defective CD4+CD25+ regulatory T cell 
functioning in collagen-induced arthritis: an important factor in 
pathogenesis, counter-regulated by endogenous IFN-gamma." Arthritis 
Res Ther 7(2): R402-415. 
References 
	   229 
Kemler, I., et al. (1994). "Nuclear import of microinjected influenza virus 
ribonucleoproteins." Virology 202(2): 1028-1033. 
Kennedy, M. K., et al. (2000). "Reversible defects in natural killer and 
memory CD8 T cell lineages in interleukin 15-deficient mice." J Exp 
Med 191(5): 771-780. 
Kilbourne, E. D. (1969). "Future influenza vaccines and the use of genetic 
recombinants." Bull World Health Organ 41(3): 643-645. 
Kim, E. Y., et al. (2008a). "Persistent activation of an innate immune response 
translates respiratory viral infection into chronic lung disease." Nat 
Med 14(6): 633-640. 
Kim, H. M., et al. (2008b). "Alveolar macrophages are indispensable for 
controlling influenza viruses in lungs of pigs." J Virol 82(9): 4265-
4274. 
Kim, T. S. and T. J. Braciale (2009). "Respiratory dendritic cell subsets differ 
in their capacity to support the induction of virus-specific cytotoxic 
CD8+ T cell responses." PLoS One 4(1): e4204. 
Klenk, H. D., et al. (1975). "Activation of influenza A viruses by trypsin 
treatment." Virology 68(2): 426-439. 
Kobasa, D., et al. (2004). "Enhanced virulence of influenza A viruses with the 
haemagglutinin of the 1918 pandemic virus." Nature 431(7009): 703-
707. 
Kris, R. M., et al. (1985). "Protection and recovery in influenza virus-infected 
mice immunosuppressed with anti-IgM." J Immunol 134(2): 1230-
1235. 
Kroncke, R., et al. (1996). "Human follicular dendritic cells and vascular cells 
produce interleukin-7: a potential role for interleukin-7 in the germinal 
center reaction." Eur J Immunol 26(10): 2541-2544. 
References 
	   230 
Ku, C. C., et al. (2000). "Control of homeostasis of CD8+ memory T cells by 
opposing cytokines." Science 288(5466): 675-678. 
Kumagai, Y., et al. (2008). "Pathogen recognition by innate receptors." J 
Infect Chemother 14(2): 86-92. 
Kuo, C., et al. (2011). "Rhinovirus infection induces expression of airway 
remodelling factors in vitro and in vivo." Respirology 16(2): 367-377. 
La Gruta, N. L., et al. (2007). "A question of self-preservation: 
immunopathology in influenza virus infection." Immunol Cell Biol 
85(2): 85-92. 
Lamb, R. A., et al. (1985). "Influenza virus M2 protein is an integral 
membrane protein expressed on the infected-cell surface." Cell 40(3): 
627-633. 
Langrish, C. L., et al. (2005). "IL-23 drives a pathogenic T cell population that 
induces autoimmune inflammation." J Exp Med 201(2): 233-240. 
Lawrence, C. W., et al. (2005). "Frequency, specificity, and sites of expansion 
of CD8+ T cells during primary pulmonary influenza virus infection." 
J Immunol 174(9): 5332-5340. 
Li, C., et al. (2006). "Autophagy is induced in CD4+ T cells and important for 
the growth factor-withdrawal cell death." J Immunol 177(8): 5163-
5168. 
Li, X., et al. (2007). "IFN-gamma acts directly on activated CD4+ T cells 
during mycobacterial infection to promote apoptosis by inducing 
components of the intracellular apoptosis machinery and by inducing 
extracellular proapoptotic signals." J Immunol 179(2): 939-949. 
Liu, Y. and C. A. Janeway, Jr. (1990). "Interferon gamma plays a critical role 
in induced cell death of effector T cell: a possible third mechanism of 
self-tolerance." J Exp Med 172(6): 1735-1739. 
References 
	   231 
Lodolce, J. P., et al. (1998). "IL-15 receptor maintains lymphoid homeostasis 
by supporting lymphocyte homing and proliferation." Immunity 9(5): 
669-676. 
Maggi, E., et al. (1992). "Reciprocal regulatory effects of IFN-gamma and IL-
4 on the in vitro development of human Th1 and Th2 clones." J 
Immunol 148(7): 2142-2147. 
Mandelboim, O., et al. (2001). "Recognition of haemagglutinins on virus-
infected cells by NKp46 activates lysis by human NK cells." Nature 
409(6823): 1055-1060. 
Maraskovsky, E., et al. (1997). "Bcl-2 can rescue T lymphocyte development 
in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- 
mice." Cell 89(7): 1011-1019. 
Maraskovsky, E., et al. (1996). "Impaired survival and proliferation in IL-7 
receptor-deficient peripheral T cells." J Immunol 157(12): 5315-5323. 
Masopust, D., et al. (2001). "Preferential localization of effector memory cells 
in nonlymphoid tissue." Science 291(5512): 2413-2417. 
Matrosovich, M. N., et al. (2004). "Human and avian influenza viruses target 
different cell types in cultures of human airway epithelium." Proc Natl 
Acad Sci U S A 101(13): 4620-4624. 
Mazanec, M. B., et al. (1995). "Intracellular neutralization of influenza virus 
by immunoglobulin A anti-hemagglutinin monoclonal antibodies." J 
Virol 69(2): 1339-1343. 
McGeoch, D., et al. (1976). "Influenza virus genome consists of eight distinct 
RNA species." Proc Natl Acad Sci U S A 73(9): 3045-3049. 
McGill, J. and K. L. Legge (2009). "Cutting edge: contribution of lung-
resident T cell proliferation to the overall magnitude of the antigen-
specific CD8 T cell response in the lungs following murine influenza 
virus infection." J Immunol 183(7): 4177-4181. 
References 
	   232 
McGill, J., et al. (2008). "Protective influenza-specific CD8 T cell responses 
require interactions with dendritic cells in the lungs." J Exp Med 
205(7): 1635-1646. 
McMichael, A. J., et al. (1983). "Cytotoxic T-cell immunity to influenza." N 
Engl J Med 309(1): 13-17. 
Meraz, M. A., et al. (1996). "Targeted disruption of the Stat1 gene in mice 
reveals unexpected physiologic specificity in the JAK-STAT signaling 
pathway." Cell 84(3): 431-442. 
Message, S. D., et al. (2008). "Rhinovirus-induced lower respiratory illness is 
increased in asthma and related to virus load and Th1/2 cytokine and 
IL-10 production." Proc Natl Acad Sci U S A 105(36): 13562-13567. 
Miller, E. K., et al. (2008). "Influenza burden for children with asthma." 
Pediatrics 121(1): 1-8. 
Morens, D. M., et al. (2008). "Predominant role of bacterial pneumonia as a 
cause of death in pandemic influenza: implications for pandemic 
influenza preparedness." J Infect Dis 198(7): 962-970. 
Moskophidis, D. and D. Kioussis (1998). "Contribution of virus-specific 
CD8+ cytotoxic T cells to virus clearance or pathologic manifestations 
of influenza virus infection in a T cell receptor transgenic mouse 
model." J Exp Med 188(2): 223-232. 
Mosmann, T. R. and R. L. Coffman (1989). "TH1 and TH2 cells: different 
patterns of lymphokine secretion lead to different functional 
properties." Annu Rev Immunol 7: 145-173. 
Mozdzanowska, K., et al. (1999). "Treatment of influenza virus-infected SCID 
mice with nonneutralizing antibodies specific for the transmembrane 
proteins matrix 2 and neuraminidase reduces the pulmonary virus titer 
but fails to clear the infection." Virology 254(1): 138-146. 
References 
	   233 
Muller, I., et al. (1994). "Expansion of gamma interferon-producing CD8+ T 
cells following secondary infection of mice immune to Leishmania 
major." Infect Immun 62(6): 2575-2581. 
Mullooly, J. P., et al. (2007). "Influenza- and RSV-associated hospitalizations 
among adults." Vaccine 25(5): 846-855. 
Murphy, B. R., et al. (1982). "Secretory and systemic immunological response 
in children infected with live attenuated influenza A virus vaccines." 
Infect Immun 36(3): 1102-1108. 
Murphy, C. A., et al. (2003). "Divergent pro- and antiinflammatory roles for 
IL-23 and IL-12 in joint autoimmune inflammation." J Exp Med 
198(12): 1951-1957. 
Nguyen, H. H., et al. (2000). "Gamma interferon is not required for mucosal 
cytotoxic T-lymphocyte responses or heterosubtypic immunity to 
influenza A virus infection in mice." J Virol 74(12): 5495-5501. 
Novelli, F., et al. (1996). "Switching on of the proliferation or apoptosis of 
activated human T lymphocytes by IFN-gamma is correlated with the 
differential expression of the alpha- and beta-chains of its receptor." J 
Immunol 157(5): 1935-1943. 
O'Neill, R. E., et al. (1995). "Nuclear import of influenza virus RNA can be 
mediated by viral nucleoprotein and transport factors required for 
protein import." J Biol Chem 270(39): 22701-22704. 
Paget, C., et al. (2011). "Potential role of invariant NKT cells in the control of 
pulmonary inflammation and CD8+ T cell response during acute 
influenza A virus H3N2 pneumonia." J Immunol 186(10): 5590-5602. 
Pang, I. K. and A. Iwasaki (2011). "Inflammasomes as mediators of immunity 
against influenza virus." Trends Immunol 32(1): 34-41. 
References 
	   234 
Peper, R. L. and H. Van Campen (1995). "Tumor necrosis factor as a mediator 
of inflammation in influenza A viral pneumonia." Microb Pathog 
19(3): 175-183. 
Peperzak, V., et al. (2010). "CD27 sustains survival of CTLs in virus-infected 
nonlymphoid tissue in mice by inducing autocrine IL-2 production." J 
Clin Invest 120(1): 168-178. 
Perrone, L. A., et al. (2008). "H5N1 and 1918 pandemic influenza virus 
infection results in early and excessive infiltration of macrophages and 
neutrophils in the lungs of mice." PLoS Pathog 4(8): e1000115. 
Perussia, B. (1991). "Lymphokine-activated killer cells, natural killer cells and 
cytokines." Curr Opin Immunol 3(1): 49-55. 
Picard, C. and J. L. Casanova (2004). "Inherited disorders of cytokines." Curr 
Opin Pediatr 16(6): 648-658. 
Pichlmair, A., et al. (2006). "RIG-I-mediated antiviral responses to single-
stranded RNA bearing 5'-phosphates." Science 314(5801): 997-1001. 
Pipkin, M. E., et al. (2010). "Interleukin-2 and inflammation induce distinct 
transcriptional programs that promote the differentiation of effector 
cytolytic T cells." Immunity 32(1): 79-90. 
Potter, C. W. and J. S. Oxford (1979). "Determinants of immunity to influenza 
infection in man." Br Med Bull 35(1): 69-75. 
Prabhu, N., et al. (2009). "Monoclonal antibodies against the fusion peptide of 
hemagglutinin protect mice from lethal influenza A virus H5N1 
infection." J Virol 83(6): 2553-2562. 
Pulendran, B. and R. Ahmed (2006). "Translating innate immunity into 
immunological memory: implications for vaccine development." Cell 
124(4): 849-863. 
References 
	   235 
Pulendran, B. and R. Ahmed (2011). "Immunological mechanisms of 
vaccination." Nat Immunol 12(6): 509-517. 
Quan, F. S., et al. (2008). "A bivalent influenza VLP vaccine confers complete 
inhibition of virus replication in lungs." Vaccine 26(26): 3352-3361. 
Reading, P. C., et al. (1997). "Collectin-mediated antiviral host defense of the 
lung: evidence from influenza virus infection of mice." J Virol 71(11): 
8204-8212. 
Refaeli, Y., et al. (2002). "Interferon gamma is required for activation-induced 
death of T lymphocytes." J Exp Med 196(7): 999-1005. 
Reid, A. H., et al. (2001). "The 1918 Spanish influenza: integrating history and 
biology." Microbes Infect 3(1): 81-87. 
Rinderknecht, E., et al. (1984). "Natural human interferon-gamma. Complete 
amino acid sequence and determination of sites of glycosylation." J 
Biol Chem 259(11): 6790-6797. 
Robertson, J. S., et al. (1992). "High growth reassortant influenza vaccine 
viruses: new approaches to their control." Biologicals 20(3): 213-220. 
Rothbarth, P. H., et al. (1999). "Influenza virus serology--a comparative 
study." J Virol Methods 78(1-2): 163-169. 
Sad, S., et al. (1995). "Cytokine-induced differentiation of precursor mouse 
CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 
cytokines." Immunity 2(3): 271-279. 
Sallusto, F., et al. (2010). "From vaccines to memory and back." Immunity 
33(4): 451-463. 
Sallusto, F., et al. (1999). "Two subsets of memory T lymphocytes with 
distinct homing potentials and effector functions." Nature 401(6754): 
708-712. 
References 
	   236 
Sarawar, S. R., et al. (1994). "Administration of anti-IFN-gamma antibody to 
beta 2-microglobulin-deficient mice delays influenza virus clearance 
but does not switch the response to a T helper cell 2 phenotype." J 
Immunol 153(3): 1246-1253. 
Sarkar, S., et al. (2008). "Functional and genomic profiling of effector CD8 T 
cell subsets with distinct memory fates." J Exp Med 205(3): 625-640. 
Sawa, Y., et al. (2009). "Hepatic interleukin-7 expression regulates T cell 
responses." Immunity 30(3): 447-457. 
Schlub, T. E., et al. (2010). "Predicting CD62L expression during the CD8+ 
T-cell response in vivo." Immunol Cell Biol 88(2): 157-164. 
Schluns, K. S., et al. (2000). "Interleukin-7 mediates the homeostasis of naive 
and memory CD8 T cells in vivo." Nat Immunol 1(5): 426-432. 
Schluns, K. S., et al. (2002). "Cutting edge: requirement for IL-15 in the 
generation of primary and memory antigen-specific CD8 T cells." J 
Immunol 168(10): 4827-4831. 
Schnell, J. R. and J. J. Chou (2008). "Structure and mechanism of the M2 
proton channel of influenza A virus." Nature 451(7178): 591-595. 
Scholzen, T. and J. Gerdes (2000). "The Ki-67 protein: from the known and 
the unknown." J Cell Physiol 182(3): 311-322. 
Schroder, K., et al. (2004). "Interferon-gamma: an overview of signals, 
mechanisms and functions." J Leukoc Biol 75(2): 163-189. 
Shope, R. E. (1931). "Swine Influenza : I. Experimental Transmission and 
Pathology." J Exp Med 54(3): 349-359. 
Shope, R. E. (1934). "The Infection of Ferrets with Swine Influenza Virus." J 
Exp Med 60(1): 49-61. 
Shope, R. E. (1935). "The Infection of Mice with Swine Influenza Virus." J 
Exp Med 62(4): 561-572. 
References 
	   237 
Sprenger, H., et al. (1996). "Selective induction of monocyte and not 
neutrophil-attracting chemokines after influenza A virus infection." J 
Exp Med 184(3): 1191-1196. 
Stegmann, T., et al. (1991). "The HA2 subunit of influenza hemagglutinin 
inserts into the target membrane prior to fusion." J Biol Chem 266(27): 
18404-18410. 
Subrata, L. S., et al. (2009). "Interactions between innate antiviral and atopic 
immunoinflammatory pathways precipitate and sustain asthma 
exacerbations in children." J Immunol 183(4): 2793-2800. 
Sun, J., et al. (2009). "Effector T cells control lung inflammation during acute 
influenza virus infection by producing IL-10." Nat Med 15(3): 277-
284. 
Sun, K. and D. W. Metzger (2008). "Inhibition of pulmonary antibacterial 
defense by interferon-gamma during recovery from influenza 
infection." Nat Med 14(5): 558-564. 
Suptawiwat, O., et al. (2010). "Enhanced susceptibility of nasal polyp tissues 
to avian and human influenza viruses." PLoS One 5(9): e12973. 
Swain, S. L., et al. (2004). "T cell responses to influenza virus infection: 
effector and memory cells." Viral Immunol 17(2): 197-209. 
Tacon, C. E., et al. (2010). "Human rhinovirus infection up-regulates MMP-9 
production in airway epithelial cells via NF-{kappa}B." Am J Respir 
Cell Mol Biol 43(2): 201-209. 
Tanchot, C., et al. (1997). "Differential requirements for survival and 
proliferation of CD8 naive or memory T cells." Science 276(5321): 
2057-2062. 
Taubenberger, J. K. and S. P. Layne (2001). "Diagnosis of influenza virus: 
coming to grips with the molecular era." Mol Diagn 6(4): 291-305. 
References 
	   238 
Taubenberger, J. K. and D. M. Morens (2008). "The pathology of influenza 
virus infections." Annu Rev Pathol 3: 499-522. 
Taubenberger, J. K., et al. (1997). "Initial genetic characterization of the 1918 
"Spanish" influenza virus." Science 275(5307): 1793-1796. 
Tewari, K., et al. (2007). "Role of direct effects of IFN-gamma on T cells in 
the regulation of CD8 T cell homeostasis." J Immunol 179(4): 2115-
2125. 
Topham, D. J., et al. (1997). "CD8+ T cells clear influenza virus by perforin or 
Fas-dependent processes." J Immunol 159(11): 5197-5200. 
Tumpey, T. M., et al. (2005). "Pathogenicity of influenza viruses with genes 
from the 1918 pandemic virus: functional roles of alveolar 
macrophages and neutrophils in limiting virus replication and mortality 
in mice." J Virol 79(23): 14933-14944. 
Turner, S. J., et al. (2007). "Disregulated influenza A virus-specific CD8+ T 
cell homeostasis in the absence of IFN-gamma signaling." J Immunol 
178(12): 7616-7622. 
Valente, G., et al. (1992). "Distribution of interferon-gamma receptor in 
human tissues." Eur J Immunol 22(9): 2403-2412. 
Veiga-Fernandes, H., et al. (2000). "Response of naive and memory CD8+ T 
cells to antigen stimulation in vivo." Nat Immunol 1(1): 47-53. 
Vella, A. T., et al. (1998). "Cytokine-induced survival of activated T cells in 
vitro and in vivo." Proc Natl Acad Sci U S A 95(7): 3810-3815. 
Verbist, K. C., et al. (2011). "Cutting edge: IL-15-independent maintenance of 
mucosally generated memory CD8 T cells." J Immunol 186(12): 6667-
6671. 
References 
	   239 
Vukmanovic-Stejic, M., et al. (2000). "Human Tc1 and Tc2/Tc0 CD8 T-cell 
clones display distinct cell surface and functional phenotypes." Blood 
95(1): 231-240. 
Walsh, J. J., et al. (1961). "Bronchotracheal response in human influenza. 
Type A, Asian strain, as studied by light and electron microscopic 
examination of bronchoscopic biopsies." Arch Intern Med 108: 376-
388. 
Wang, Z., et al. (2006). "Role of IFN-gamma in induction of Foxp3 and 
conversion of CD4+ CD25- T cells to CD4+ Tregs." J Clin Invest 
116(9): 2434-2441. 
Wang, Z. E., et al. (1994). "CD4+ effector cells default to the Th2 pathway in 
interferon gamma-deficient mice infected with Leishmania major." J 
Exp Med 179(4): 1367-1371. 
Watanabe, M., et al. (1995). "Interleukin 7 is produced by human intestinal 
epithelial cells and regulates the proliferation of intestinal mucosal 
lymphocytes." J Clin Invest 95(6): 2945-2953. 
Watanabe, T., et al. (2013). "Characterization of H7N9 influenza A viruses 
isolated from humans." Nature. 
Watanabe, Y., et al. (2005). "Augmentation of fatality of influenza in mice by 
inhibition of phagocytosis." Biochem Biophys Res Commun 337(3): 
881-886. 
Wheelock, E. F. (1965). "Interferon-like virus-inhibitor induced in human 
leukocytes by phytohemagglutinin." Science 149(3681): 310-311. 
Whitmire, J. K., et al. (2008). "Tentative T cells: memory cells are quick to 
respond, but slow to divide." PLoS Pathog 4(4): e1000041. 
Wiley, J. A., et al. (2001). "Production of interferon-gamma by influenza 
hemagglutinin-specific CD8 effector T cells influences the 
References 
	   240 
development of pulmonary immunopathology." Am J Pathol 158(1): 
119-130. 
Williams, M. A. and M. J. Bevan (2007). "Effector and memory CTL 
differentiation." Annu Rev Immunol 25: 171-192. 
Wirth, T. C., et al. (2009). "Differentiation of central memory CD8 T cells is 
independent of CD62L-mediated trafficking to lymph nodes." J 
Immunol 182(10): 6195-6206. 
Yap, K. L., et al. (1978). "Transfer of specific cytotoxic T lymphocytes 
protects mice inoculated with influenza virus." Nature 273(5659): 238-
239. 
Yasuda, J., et al. (1993). "Molecular assembly of influenza virus: association 
of the NS2 protein with virion matrix." Virology 196(1): 249-255. 
Young, H. A. and K. J. Hardy (1995). "Role of interferon-gamma in immune 
cell regulation." J Leukoc Biol 58(4): 373-381. 
Zhang, W. J., et al. (1996). "Lethal synergism between influenza infection and 
staphylococcal enterotoxin B in mice." J Immunol 157(11): 5049-5060. 
 
 
